Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000026.4(ADSL):c.674T>C (p.Met225Thr)	ADSL	M225T, M161T	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000002468	22	40755283	22	40359279	2468	17507	rs119450945	NC_000022.11:40359278:T:C
NM_030632.3(ASXL3):c.3106C>T (p.Arg1036Ter)	ASXL3	R1036*	not provided|Bainbridge-Ropers syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000429913	18	31322918	18	33742954	429913	422219		NC_000018.10:33742953:C:T
NM_015570.4(AUTS2):c.3169G>A (p.Gly1057Ser)	AUTS2	G1057S, G1033S	Chromosome 15q11-q13 duplication syndrome|not provided	Uncertain significance(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000386816	7	70255371	7	70790385	386816	371356	rs1057522609	NC_000007.14:70790384:G:A
NM_001323289.2(CDKL5):c.463+8A>G	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Benign(Last reviewed: Jul 28, 2019)	criteria provided, single submitter	VCV001169545	X	18600078	X	18581958	1169545	1159507		NC_000023.11:18581957:A:G
NM_001323289.2(CDKL5):c.2256A>G (p.Arg752=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001165618	X	18631375	X	18613255	1165618	1159511		NC_000023.11:18613254:A:G
NM_001323289.2(CDKL5):c.1422C>T (p.Pro474=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Benign/Likely benign(Last reviewed: Apr 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV001165315	X	18622466	X	18604346	1165315	1159509		NC_000023.11:18604345:C:T
NM_001323289.2(CDKL5):c.2022C>G (p.Ser674=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Benign/Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001165086	X	18627008	X	18608888	1165086	1159510		NC_000023.11:18608887:C:G
NM_001323289.2(CDKL5):c.1088A>G (p.Asn363Ser)	CDKL5	N363S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001164539	X	18622132	X	18604012	1164539	1159508		NC_000023.11:18604011:A:G
NM_001323289.2(CDKL5):c.555C>T (p.Gly185=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV001160525	X	18606074	X	18587954	1160525	1150624		NC_000023.11:18587953:C:T
NM_001323289.2(CDKL5):c.2152+10C>T	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV001158467	X	18627700	X	18609580	1158467	1150630		NC_000023.11:18609579:C:T
NM_001323289.2(CDKL5):c.234A>G (p.Ala78=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, single submitter	VCV001158321	X	18593562	X	18575442	1158321	1150622		NC_000023.11:18575441:A:G
NM_001323289.2(CDKL5):c.1389G>A (p.Lys463=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV001158179	X	18622433	X	18604313	1158179	1150627		NC_000023.11:18604312:G:A
NM_001323289.2(CDKL5):c.858C>T (p.Tyr286=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001155753	X	18616614	X	18598494	1155753	1150626		NC_000023.11:18598493:C:T
NM_000330.4(RS1):c.184+3151C>T	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001153917	X	18671622	X	18653502	1153917	1150635		NC_000023.11:18653501:G:A
NM_001323289.2(CDKL5):c.1827T>C (p.His609=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001150297	X	18622871	X	18604751	1150297	1150628		NC_000023.11:18604750:T:C
NM_001323289.2(CDKL5):c.2679C>G (p.Pro893=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001149266	X	18646673	X	18628553	1149266	1150631		NC_000023.11:18628552:C:G
NM_001323289.2(CDKL5):c.810A>G (p.Leu270=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001145320	X	18613533	X	18595413	1145320	1150625		NC_000023.11:18595412:A:G
NM_001323289.2(CDKL5):c.2040G>A (p.Lys680=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001144637	X	18627026	X	18608906	1144637	1150629		NC_000023.11:18608905:G:A
NM_001323289.2(CDKL5):c.480G>T (p.Leu160=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001142508	X	18602399	X	18584279	1142508	1150623		NC_000023.11:18584278:G:T
NM_000330.4(RS1):c.326+1190T>C	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001140537	X	18664121	X	18646001	1140537	1129584		NC_000023.11:18646000:A:G
NM_001323289.2(CDKL5):c.1947T>C (p.Pro649=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV001133509	X	18626933	X	18608813	1133509	1129572		NC_000023.11:18608812:T:C
NM_001323289.2(CDKL5):c.1968G>A (p.Glu656=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV001132556	X	18626954	X	18608834	1132556	1129573		NC_000023.11:18608833:G:A
NM_001323289.2(CDKL5):c.2067A>G (p.Pro689=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Mar 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001131537	X	18627605	X	18609485	1131537	1129575		NC_000023.11:18609484:A:G
NM_001323289.2(CDKL5):c.2031A>G (p.Thr677=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001130933	X	18627017	X	18608897	1130933	1129574		NC_000023.11:18608896:A:G
NM_001323289.2(CDKL5):c.1287A>G (p.Pro429=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV001129930	X	18622331	X	18604211	1129930	1129571		NC_000023.11:18604210:A:G
NM_001323289.2(CDKL5):c.2152+9A>C	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV001128122	X	18627699	X	18609579	1128122	1129576		NC_000023.11:18609578:A:C
NM_001323289.2(CDKL5):c.2244C>T (p.Asn748=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV001125161	X	18631363	X	18613243	1125161	1129577		NC_000023.11:18613242:C:T
NM_001323289.2(CDKL5):c.21T>C (p.Gly7=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV001117209	X	18525237	X	18507117	1117209	1108211		NC_000023.11:18507116:T:C
NM_000330.4(RS1):c.184+3124T>C	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001117061	X	18671649	X	18653529	1117061	1108222		NC_000023.11:18653528:A:G
NM_001323289.2(CDKL5):c.603T>C (p.Leu201=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Benign/Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV001112123	X	18606122	X	18588002	1112123	1108212		NC_000023.11:18588001:T:C
NM_001323289.2(CDKL5):c.1413C>T (p.Asp471=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001110742	X	18622457	X	18604337	1110742	1108215		NC_000023.11:18604336:C:T
NM_001323289.2(CDKL5):c.1649G>A (p.Arg550Gln)	CDKL5	R550Q	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV001110449	X	18622693	X	18604573	1110449	1108216		NC_000023.11:18604572:G:A
NM_001323289.2(CDKL5):c.1317A>G (p.Arg439=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001107826	X	18622361	X	18604241	1107826	1108214		NC_000023.11:18604240:A:G
NM_001323289.2(CDKL5):c.1086C>T (p.Ala362=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV001106381	X	18622130	X	18604010	1106381	1108213		NC_000023.11:18604009:C:T
NM_001323289.2(CDKL5):c.1989G>A (p.Ser663=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV001099625	X	18626975	X	18608855	1099625	1108217		NC_000023.11:18608854:G:A
NM_000330.4(RS1):c.326+1160T>C	CDKL5|RS1	Q913R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001093995	X	18664151	X	18646031	1093995	1086509		NC_000023.11:18646030:A:G
NM_001323289.2(CDKL5):c.2668C>A (p.Arg890=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jan 19, 2020)	criteria provided, single submitter	VCV001091899	X	18646662	X	18628542	1091899	1086503		NC_000023.11:18628541:C:A
NM_001323289.2(CDKL5):c.1233C>T (p.Ala411=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001087727	X	18622277	X	18604157	1087727	1086502		NC_000023.11:18604156:C:T
NM_001323289.2(CDKL5):c.554+4A>G	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001073273	X	18602477	X	18584357	1073273	1065254		NC_000023.11:18584356:A:G
NM_001323289.2(CDKL5):c.513C>G (p.Tyr171Ter)	CDKL5	Y171*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 26, 2020)	criteria provided, single submitter	VCV001072862	X	18602432	X	18584312	1072862	1065251		NC_000023.11:18584311:C:G
NM_001323289.2(CDKL5):c.194G>C (p.Arg65Pro)	CDKL5	R65P	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001072615	X	18593522	X	18575402	1072615	1065250		NC_000023.11:18575401:G:C
NM_001323289.2(CDKL5):c.532C>G (p.Arg178Gly)	CDKL5	R178G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001071237	X	18602451	X	18584331	1071237	1065253		NC_000023.11:18584330:C:G
NM_001323289.2(CDKL5):c.1927C>T (p.Gln643Ter)	CDKL5	Q643*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001070908	X	18622971	X	18604851	1070908	1065257		NC_000023.11:18604850:C:T
NM_001323289.2(CDKL5):c.527G>A (p.Trp176Ter)	CDKL5	W176*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001070360	X	18602446	X	18584326	1070360	1065252		NC_000023.11:18584325:G:A
NM_001323289.2(CDKL5):c.256T>G (p.Tyr86Asp)	CDKL5	Y86D	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001067592	X	18593584	X	18575464	1067592	1056750		NC_000023.11:18575463:T:G
NM_001323289.2(CDKL5):c.146-2A>C	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001067367	X	18593472	X	18575352	1067367	1056749		NC_000023.11:18575351:A:C
NM_001323289.2(CDKL5):c.2070C>G (p.His690Gln)	CDKL5	H690Q	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001061053	X	18627608	X	18609488	1061053	1052367		NC_000023.11:18609487:C:G
NM_001323289.2(CDKL5):c.1910C>G (p.Ala637Gly)	CDKL5	A637G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001058049	X	18622954	X	18604834	1058049	1052366		NC_000023.11:18604833:C:G
NM_001323289.2(CDKL5):c.238C>T (p.Arg80Cys)	CDKL5	R80C	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001053624	X	18593566	X	18575446	1053624	1052362		NC_000023.11:18575445:C:T
NM_001323289.2(CDKL5):c.217G>A (p.Val73Met)	CDKL5	V73M	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001052408	X	18593545	X	18575425	1052408	1052361		NC_000023.11:18575424:G:A
NM_001323289.2(CDKL5):c.436A>G (p.Asn146Asp)	CDKL5	N146D	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001052159	X	18600043	X	18581923	1052159	1052363		NC_000023.11:18581922:A:G
NM_001323289.2(CDKL5):c.761A>G (p.His254Arg)	CDKL5	H254R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2020)	criteria provided, conflicting interpretations	VCV001051353	X	18613484	X	18595364	1051353	1052365		NC_000023.11:18595363:A:G
NM_001323289.2(CDKL5):c.2556G>A (p.Pro852=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2020)	criteria provided, conflicting interpretations	VCV001046637	X	18646550	X	18628430	1046637	1035440		NC_000023.11:18628429:G:A
NM_001323289.2(CDKL5):c.379C>G (p.His127Asp)	CDKL5	H127D	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001046503	X	18598064	X	18579944	1046503	1035435		NC_000023.11:18579943:C:G
NM_001323289.2(CDKL5):c.1027A>G (p.Ser343Gly)	CDKL5	S343G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001043238	X	18622071	X	18603951	1043238	1035438		NC_000023.11:18603950:A:G
NM_000330.4(RS1):c.184+3173C>T	CDKL5|RS1	R1010K	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001040769	X	18671600	X	18653480	1040769	1035443		NC_000023.11:18653479:G:A
NM_001323289.2(CDKL5):c.2014A>T (p.Thr672Ser)	CDKL5	T672S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001040215	X	18627000	X	18608880	1040215	1035439		NC_000023.11:18608879:A:T
NM_001323289.2(CDKL5):c.412C>G (p.Pro138Ala)	CDKL5	P138A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001038592	X	18600019	X	18581899	1038592	1035436		NC_000023.11:18581898:C:G
NM_001323289.2(CDKL5):c.424T>G (p.Leu142Val)	CDKL5	L142V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001037382	X	18600031	X	18581911	1037382	1035437		NC_000023.11:18581910:T:G
NM_001323289.2(CDKL5):c.1404C>G (p.Ser468Arg)	CDKL5	S468R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001026357	X	18622448	X	18604328	1026357	1014854		NC_000023.11:18604327:C:G
NM_001323289.2(CDKL5):c.915T>C (p.Arg305=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001025252	X	18616671	X	18598551	1025252	1014852		NC_000023.11:18598550:T:C
NM_000330.4(RS1):c.185-3110G>C	CDKL5|RS1	P944A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001024601	X	18668562	X	18650442	1024601	1014860		NC_000023.11:18650441:C:G
NM_001323289.2(CDKL5):c.1602A>C (p.Arg534Ser)	CDKL5	R534S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001022264	X	18622646	X	18604526	1022264	1014855		NC_000023.11:18604525:A:C
NM_001323289.2(CDKL5):c.554+5G>A	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001020776	X	18602478	X	18584358	1020776	1014850		NC_000023.11:18584357:G:A
NM_001323289.2(CDKL5):c.1273C>T (p.Pro425Ser)	CDKL5	P425S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001020368	X	18622317	X	18604197	1020368	1014853		NC_000023.11:18604196:C:T
NM_001323289.2(CDKL5):c.794T>C (p.Ile265Thr)	CDKL5	I265T	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001018419	X	18613517	X	18595397	1018419	1014851		NC_000023.11:18595396:T:C
NM_000330.4(RS1):c.184+3152G>A	CDKL5|RS1	A1017V	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001017245	X	18671621	X	18653501	1017245	1014861		NC_000023.11:18653500:C:T
NM_001323289.2(CDKL5):c.2236G>A (p.Gly746Arg)	CDKL5	G746R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001013832	X	18631355	X	18613235	1013832	1014857		NC_000023.11:18613234:G:A
NM_001323289.2(CDKL5):c.377G>C (p.Cys126Ser)	CDKL5	C126S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001009865	X	18598062	X	18579942	1009865	999705		NC_000023.11:18579941:G:C
NM_001323289.2(CDKL5):c.1076G>C (p.Gly359Ala)	CDKL5	G359A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001006373	X	18622120	X	18604000	1006373	999707		NC_000023.11:18603999:G:C
NM_001323289.2(CDKL5):c.593G>A (p.Gly198Asp)	CDKL5	G198D	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV001006298	X	18606112	X	18587992	1006298	999706		NC_000023.11:18587991:G:A
NM_001323289.2(CDKL5):c.2171A>T (p.Asp724Val)	CDKL5	D724V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001004575	X	18631290	X	18613170	1004575	999709		NC_000023.11:18613169:A:T
NM_001323289.2(CDKL5):c.1337C>T (p.Ser446Leu)	CDKL5	S446L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV001003060	X	18622381	X	18604261	1003060	999708		NC_000023.11:18604260:C:T
NM_001323289.2(CDKL5):c.135G>T (p.Lys45Asn)	CDKL5	K45N	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001000784	X	18582632	X	18564512	1000784	999703		NC_000023.11:18564511:G:T
NM_001323289.2(CDKL5):c.282+5G>A	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV000999655	X	18593615	X	18575495	999655	999704		NC_000023.11:18575494:G:A
NM_001323289.2(CDKL5):c.2581C>T (p.Pro861Ser)	CDKL5	P861S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV000998581	X	18646575	X	18628455	998581	999710		NC_000023.11:18628454:C:T
NM_001323289.2(CDKL5):c.2066C>T (p.Pro689Leu)	CDKL5	P689L	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV000972202	X	18627604	X	18609484	972202	959218		NC_000023.11:18609483:C:T
NM_001323289.2(CDKL5):c.2152+5G>T	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000969068	X	18627695	X	18609575	969068	960977		NC_000023.11:18609574:G:T
NM_001323289.2(CDKL5):c.103A>C (p.Thr35Pro)	CDKL5	T35P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000968754	X	18582600	X	18564480	968754	959216		NC_000023.11:18564479:A:C
NM_001323289.2(CDKL5):c.282+1G>A	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000963731	X	18593611	X	18575491	963731	960372		NC_000023.11:18575490:G:A
NM_001323289.2(CDKL5):c.375G>C (p.Trp125Cys)	CDKL5	W125C	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000962951	X	18598060	X	18579940	962951	951693		NC_000023.11:18579939:G:C
NM_001323289.2(CDKL5):c.1673G>A (p.Arg558His)	CDKL5	R558H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000962204	X	18622717	X	18604597	962204	951697		NC_000023.11:18604596:G:A
NM_001323289.2(CDKL5):c.524G>C (p.Arg175Thr)	CDKL5	R175T	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000957873	X	18602443	X	18584323	957873	951694		NC_000023.11:18584322:G:C
NM_001323289.2(CDKL5):c.212A>G (p.Asn71Ser)	CDKL5	N71S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000957648	X	18593540	X	18575420	957648	951692		NC_000023.11:18575419:A:G
NM_001323289.2(CDKL5):c.2195T>A (p.Val732Glu)	CDKL5	V732E	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000957096	X	18631314	X	18613194	957096	951698		NC_000023.11:18613193:T:A
NM_001323289.2(CDKL5):c.680T>C (p.Leu227Pro)	CDKL5	L227P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000955434	X	18606199	X	18588079	955434	951695		NC_000023.11:18588078:T:C
NM_001323289.2(CDKL5):c.853A>G (p.Arg285Gly)	CDKL5	R285G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000954584	X	18616609	X	18598489	954584	951696		NC_000023.11:18598488:A:G
NM_000330.4(RS1):c.184+3231A>C	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000949413	X	18671542	X	18653422	949413	941293		NC_000023.11:18653421:T:G
NM_001323289.2(CDKL5):c.2389G>C (p.Asp797His)	CDKL5	D797H	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000946638	X	18643260	X	18625140	946638	929638		NC_000023.11:18625139:G:C
NM_000330.4(RS1):c.185-3261C>T	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000944458	X	18668713	X	18650593	944458	941292		NC_000023.11:18650592:G:A
NM_000330.4(RS1):c.185-3128G>A	CDKL5|RS1	P950S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000938954	X	18668580	X	18650460	938954	939515		NC_000023.11:18650459:C:T
NM_000330.4(RS1):c.184+3136A>T	CDKL5|RS1	H1022Q	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 26, 2020)	criteria provided, single submitter	VCV000938714	X	18671637	X	18653517	938714	939517		NC_000023.11:18653516:T:A
NM_001323289.2(CDKL5):c.2437A>G (p.Thr813Ala)	CDKL5	T813A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000937086	X	18643308	X	18625188	937086	939510		NC_000023.11:18625187:A:G
NM_001323289.2(CDKL5):c.2135T>C (p.Val712Ala)	CDKL5	V712A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000936799	X	18627673	X	18609553	936799	939509		NC_000023.11:18609552:T:C
NM_001323289.2(CDKL5):c.1386A>C (p.Glu462Asp)	CDKL5	E462D	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000936459	X	18622430	X	18604310	936459	939507		NC_000023.11:18604309:A:C
NM_001323289.2(CDKL5):c.1909G>C (p.Ala637Pro)	CDKL5	A637P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000935438	X	18622953	X	18604833	935438	939508		NC_000023.11:18604832:G:C
NM_000330.4(RS1):c.185-3212G>A	CDKL5|RS1	L978F	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000934650	X	18668664	X	18650544	934650	939516		NC_000023.11:18650543:C:T
NM_001323289.2(CDKL5):c.2714G>A (p.Gly905Asp)	CDKL5	G905D	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000934074	X	18646708	X	18628588	934074	940548		NC_000023.11:18628587:G:A
NM_000330.4(RS1):c.185-3221G>A	CDKL5|RS1	R981*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 4, 2020)	criteria provided, conflicting interpretations	VCV000930627	X	18668673	X	18650553	930627	920000		NC_000023.11:18650552:C:T
NM_001323289.2(CDKL5):c.38T>C (p.Phe13Ser)	CDKL5	F13S	Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000929426	X	18525254	X	18507134	929426	917738		NC_000023.11:18507133:T:C
NM_001323289.2(CDKL5):c.59G>T (p.Gly20Val)	CDKL5	G20V	CDKL5 disorder|Angelman syndrome|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000918032	X	18525275	X	18507155	918032	906351		NC_000023.11:18507154:G:T
NM_001323289.2(CDKL5):c.290T>C (p.Leu97Pro)	CDKL5	L97P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000870171	X	18597975	X	18579855	870171	858369		NC_000023.11:18579854:T:C
NM_001323289.2(CDKL5):c.744+1G>A	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000863429	X	18606264	X	18588144	863429	852972		NC_000023.11:18588143:G:A
NM_001323289.2(CDKL5):c.398A>C (p.His133Pro)	CDKL5	H133P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000863243	X	18598083	X	18579963	863243	849854		NC_000023.11:18579962:A:C
NM_001323289.2(CDKL5):c.154G>T (p.Glu52Ter)	CDKL5	E52*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000861338	X	18593482	X	18575362	861338	849853		NC_000023.11:18575361:G:T
NM_001323289.2(CDKL5):c.1382A>T (p.Asn461Ile)	CDKL5	N461I	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000858782	X	18622426	X	18604306	858782	849860		NC_000023.11:18604305:A:T
NM_001323289.2(CDKL5):c.116T>G (p.Val39Gly)	CDKL5	V39G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000857803	X	18582613	X	18564493	857803	849852		NC_000023.11:18564492:T:G
NM_001323289.2(CDKL5):c.408A>G (p.Ile136Met)	CDKL5	I136M	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000857028	X	18600015	X	18581895	857028	849855		NC_000023.11:18581894:A:G
NM_001323289.2(CDKL5):c.420T>A (p.Asn140Lys)	CDKL5	N140K	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV000853249	X	18600027	X	18581907	853249	849856		NC_000023.11:18581906:T:A
NM_000330.4(RS1):c.184+3170G>A	CDKL5|RS1	A1011V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Mar 3, 2019)	criteria provided, single submitter	VCV000850649	X	18671603	X	18653483	850649	849874		NC_000023.11:18653482:C:T
NM_001323289.2(CDKL5):c.2464C>T (p.Arg822Cys)	CDKL5	R822C	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000846246	X	18643335	X	18625215	846246	849865		NC_000023.11:18625214:C:T
NM_001323289.2(CDKL5):c.58G>A (p.Gly20Ser)	CDKL5	G20S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000844687	X	18525274	X	18507154	844687	849851		NC_000023.11:18507153:G:A
NM_001323289.2(CDKL5):c.608A>G (p.Glu203Gly)	CDKL5	E203G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000839936	X	18606127	X	18588007	839936	849857		NC_000023.11:18588006:A:G
NM_000330.4(RS1):c.326+1151T>C	CDKL5|RS1	H916R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000837329	X	18664160	X	18646040	837329	849870		NC_000023.11:18646039:A:G
NM_001323289.2(CDKL5):c.464-1G>C	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000834731	X	18602382	X	18584262	834731	851950		NC_000023.11:18584261:G:C
NM_001323289.2(CDKL5):c.783A>G (p.Arg261=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000834468	X	18613506	X	18595386	834468	849858		NC_000023.11:18595385:A:G
NM_001323289.2(CDKL5):c.988G>A (p.Gly330Ser)	CDKL5	G330S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000833743	X	18622032	X	18603912	833743	822222		NC_000023.11:18603911:G:A
NM_001323289.2(CDKL5):c.724C>A (p.Pro242Thr)	CDKL5	P242T	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000833683	X	18606243	X	18588123	833683	822221		NC_000023.11:18588122:C:A
NM_000330.4(RS1):c.184+3119G>A	CDKL5|RS1	T1028M	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2020)	criteria provided, conflicting interpretations	VCV000810524	X	18671654	X	18653534	810524	798249	rs762576315	NC_000023.11:18653533:C:T
NM_001323289.2(CDKL5):c.65G>A (p.Gly22Glu)	CDKL5	G22E	Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2020)	criteria provided, conflicting interpretations	VCV000803714	X	18528940	X	18510820	803714	792184	rs1602232972	NC_000023.11:18510819:G:A
NM_001323289.2(CDKL5):c.396C>T (p.Val132=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000797246	X	18598081	X	18579961	797246	786767	rs1602271730	NC_000023.11:18579960:C:T
NM_001323289.2(CDKL5):c.2241C>T (p.Thr747=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000795612	X	18631360	X	18613240	795612	786769	rs753606345	NC_000023.11:18613239:C:T
NM_001323289.2(CDKL5):c.231A>G (p.Glu77=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000794736	X	18593559	X	18575439	794736	786766	rs1602269399	NC_000023.11:18575438:A:G
NM_001323289.2(CDKL5):c.2217A>G (p.Leu739=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000794336	X	18631336	X	18613216	794336	786768	rs1602292116	NC_000023.11:18613215:A:G
NM_001323289.2(CDKL5):c.2277-7C>T	CDKL5		not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000762115	X	18637980	X	18619860	762115	776793	rs1245961569	NC_000023.11:18619859:C:T
NM_001323289.2(CDKL5):c.291C>G (p.Leu97=)	CDKL5		not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000761781	X	18597976	X	18579856	761781	773940	rs138125282	NC_000023.11:18579855:C:G
NM_000330.4(RS1):c.185-3124G>A	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000757158	X	18668576	X	18650456	757158	773943	rs1602315522	NC_000023.11:18650455:C:T
NM_001323289.2(CDKL5):c.291C>T (p.Leu97=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000748686	X	18597976	X	18579856	748686	758415	rs138125282	NC_000023.11:18579855:C:T
NM_001323289.2(CDKL5):c.1701G>A (p.Thr567=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000725105	X	18622745	X	18604625	725105	743269	rs751738489	NC_000023.11:18604624:G:A
NM_001323289.2(CDKL5):c.909G>A (p.Leu303=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000705311	X	18616665	X	18598545	705311	694850	rs1159901195	NC_000023.11:18598544:G:A
NM_001323289.2(CDKL5):c.933A>G (p.Ala311=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Nov 4, 2020)	criteria provided, single submitter	VCV000701541	X	18616689	X	18598569	701541	689451	rs1348754333	NC_000023.11:18598568:A:G
NM_001323289.2(CDKL5):c.554+10C>T	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000701388	X	18602483	X	18584363	701388	690267	rs755385076	NC_000023.11:18584362:C:T
NM_001323289.2(CDKL5):c.1614G>A (p.Thr538=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV000700635	X	18622658	X	18604538	700635	689453	rs147300538	NC_000023.11:18604537:G:A
NM_001323289.2(CDKL5):c.1452C>A (p.Thr484=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV000698120	X	18622496	X	18604376	698120	689452	rs760623086	NC_000023.11:18604375:C:A
NM_001323289.2(CDKL5):c.1768G>A (p.Glu590Lys)	CDKL5	E590K	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 25, 2021)	criteria provided, conflicting interpretations	VCV000680382	X	18622812	X	18604692	680382	656757	rs372629988	NC_000023.11:18604691:G:A
NM_001323289.2(CDKL5):c.2345C>G (p.Ser782Ter)	CDKL5	S782*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000662018	X	18638055	X	18619935	662018	649906	rs1555954074	NC_000023.11:18619934:C:G
NM_001323289.2(CDKL5):c.1600A>G (p.Arg534Gly)	CDKL5	R534G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000661864	X	18622644	X	18604524	661864	649899	rs749639424	NC_000023.11:18604523:A:G
NM_001323289.2(CDKL5):c.99+9A>G	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000660635	X	18528983	X	18510863	660635	653782	rs1602233003	NC_000023.11:18510862:A:G
NM_001323289.2(CDKL5):c.53T>A (p.Val18Asp)	CDKL5	V18D	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000659752	X	18525269	X	18507149	659752	649896	rs1602230515	NC_000023.11:18507148:T:A
NM_001323289.2(CDKL5):c.2444G>T (p.Ser815Ile)	CDKL5	S815I	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000659279	X	18643315	X	18625195	659279	649909	rs1449425691	NC_000023.11:18625194:G:T
NM_001323289.2(CDKL5):c.454T>C (p.Cys152Arg)	CDKL5	C152R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2018)	criteria provided, conflicting interpretations	VCV000658951	X	18600061	X	18581941	658951	649897	rs1602272932	NC_000023.11:18581940:T:C
NM_001323289.2(CDKL5):c.1948G>A (p.Gly650Arg)	CDKL5	G650R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000658591	X	18626934	X	18608814	658591	649901	rs1602289171	NC_000023.11:18608813:G:A
NM_001323289.2(CDKL5):c.2243A>C (p.Asn748Thr)	CDKL5	N748T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000657569	X	18631362	X	18613242	657569	649903	rs748459878	NC_000023.11:18613241:A:C
NM_001323289.2(CDKL5):c.1922G>T (p.Ser641Ile)	CDKL5	S641I	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000656692	X	18622966	X	18604846	656692	649900	rs1602287027	NC_000023.11:18604845:G:T
NM_001323289.2(CDKL5):c.2272C>T (p.Pro758Ser)	CDKL5	P758S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000654804	X	18631391	X	18613271	654804	649904	rs1210870589	NC_000023.11:18613270:C:T
NM_001323289.2(CDKL5):c.2785C>T (p.Gln929Ter)	CDKL5	Q929*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000648838	X	18646779	X	18628659	648838	649910	rs1602300816	NC_000023.11:18628658:C:T
NM_001323289.2(CDKL5):c.1177A>G (p.Thr393Ala)	CDKL5	T393A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV000648587	X	18622221	X	18604101	648587	649898	rs1187227979	NC_000023.11:18604100:A:G
NM_001323289.2(CDKL5):c.2426A>G (p.His809Arg)	CDKL5	H809R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000647375	X	18643297	X	18625177	647375	649908	rs1602298609	NC_000023.11:18625176:A:G
NM_001323289.2(CDKL5):c.2013C>T (p.Gly671=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000645940	X	18626999	X	18608879	645940	649902	rs1602289218	NC_000023.11:18608878:C:T
NM_001323289.2(CDKL5):c.2408C>T (p.Thr803Met)	CDKL5	T803M	Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000642554	X	18643279	X	18625159	642554	649907	rs1005844306	NC_000023.11:18625158:C:T
NM_001323289.2(CDKL5):c.1579C>T (p.Pro527Ser)	CDKL5	P527S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2019)	criteria provided, conflicting interpretations	VCV000590134	X	18622623	X	18604503	590134	580760	rs1275389347	NC_000023.11:18604502:C:T
NM_000330.4(RS1):c.184+3143G>T	CDKL5|RS1	T1020K	History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2019)	criteria provided, conflicting interpretations	VCV000590093	X	18671630	X	18653510	590093	580917	rs757994307	NC_000023.11:18653509:C:A
NM_001323289.2(CDKL5):c.480G>C (p.Leu160=)	CDKL5		History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000588018	X	18602399	X	18584279	588018	580887	rs750878642	NC_000023.11:18584278:G:C
NM_001323289.2(CDKL5):c.282+1G>T	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000582020	X	18593611	X	18575491	582020	572370	rs1569213054	NC_000023.11:18575490:G:T
NM_001323289.2(CDKL5):c.638G>A (p.Gly213Glu)	CDKL5	G213E	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000577127	X	18606157	X	18588037	577127	572376	rs1569215629	NC_000023.11:18588036:G:A
NM_001323289.2(CDKL5):c.2502G>T (p.Gln834His)	CDKL5	Q834H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000573507	X	18646496	X	18628376	573507	573760	rs1334119558	NC_000023.11:18628375:G:T
NM_001323289.2(CDKL5):c.1116T>A (p.Ala372=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000570060	X	18622160	X	18604040	570060	574380	rs148302590	NC_000023.11:18604039:T:A
NM_001323289.2(CDKL5):c.1198A>C (p.Asn400His)	CDKL5	N400H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000569644	X	18622242	X	18604122	569644	574382	rs921600020	NC_000023.11:18604121:A:C
NM_001323289.2(CDKL5):c.1286C>T (p.Pro429Leu)	CDKL5	P429L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000569630	X	18622330	X	18604210	569630	575376	rs377263491	NC_000023.11:18604209:C:T
NM_001323289.2(CDKL5):c.1891A>G (p.Ile631Val)	CDKL5	I631V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000568711	X	18622935	X	18604815	568711	574438	rs1569219817	NC_000023.11:18604814:A:G
NM_001323289.2(CDKL5):c.26T>C (p.Val9Ala)	CDKL5	V9A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000568435	X	18525242	X	18507122	568435	574377	rs1569197962	NC_000023.11:18507121:T:C
NM_001323289.2(CDKL5):c.583T>G (p.Trp195Gly)	CDKL5	W195G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000567323	X	18606102	X	18587982	567323	572373	rs1569215594	NC_000023.11:18587981:T:G
NM_001323289.2(CDKL5):c.934A>G (p.Lys312Glu)	CDKL5	K312E	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000565624	X	18616690	X	18598570	565624	572379	rs1569218064	NC_000023.11:18598569:A:G
NM_001323289.2(CDKL5):c.868C>T (p.Gln290Ter)	CDKL5	Q290*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560971	X	18616624	X	18598504	560971	552253	rs1569218019	NC_000023.11:18598503:C:T
NM_001323289.2(CDKL5):c.464-9A>G	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV000533399	X	18602374	X	18584254	533399	535117	rs374030184	NC_000023.11:18584253:A:G
NM_001323289.2(CDKL5):c.2493C>T (p.Thr831=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000533398	X	18643364	X	18625244	533398	535122	rs1555954758	NC_000023.11:18625243:C:T
NM_001323289.2(CDKL5):c.1590A>C (p.Pro530=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000533397	X	18622634	X	18604514	533397	535121	rs891117762	NC_000023.11:18604513:A:C
NM_001323289.2(CDKL5):c.1038C>T (p.Ile346=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000533396	X	18622082	X	18603962	533396	534683	rs754663076	NC_000023.11:18603961:C:T
NM_000330.4(RS1):c.185-3121C>T	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000533395	X	18668573	X	18650453	533395	534778	rs368344738	NC_000023.11:18650452:G:A
NM_001323289.2(CDKL5):c.987C>T (p.Ala329=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder	Likely benign(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533394	X	18622031	X	18603911	533394	534772	rs142665931	NC_000023.11:18603910:C:T
NM_001323289.2(CDKL5):c.2541G>A (p.Ser847=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign/Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533392	X	18646535	X	18628415	533392	534690	rs781774964	NC_000023.11:18628414:G:A
NM_001323289.2(CDKL5):c.1692T>C (p.His564=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533391	X	18622736	X	18604616	533391	534686	rs765011302	NC_000023.11:18604615:T:C
NM_001323289.2(CDKL5):c.973A>G (p.Asn325Asp)	CDKL5	N325D	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000533388	X	18616729	X	18598609	533388	534680	rs756721244	NC_000023.11:18598608:A:G
NM_001323289.2(CDKL5):c.1213C>G (p.Leu405Val)	CDKL5	L405V	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000533387	X	18622257	X	18604137	533387	534773	rs1555951984	NC_000023.11:18604136:C:G
NM_001323289.2(CDKL5):c.508G>T (p.Glu170Ter)	CDKL5	E170*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000533384	X	18602427	X	18584307	533384	535118	rs1555950066	NC_000023.11:18584306:G:T
NM_001323289.2(CDKL5):c.100-7C>T	CDKL5		Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000518418	X	18582590	X	18564470	518418	508960	rs752279222	NC_000023.11:18564469:C:T
NM_001323289.2(CDKL5):c.1122T>A (p.Ala374=)	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000517837	X	18622166	X	18604046	517837	507981	rs141452495	NC_000023.11:18604045:T:A
NM_001323289.2(CDKL5):c.1098C>T (p.Phe366=)	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign/Likely benign(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000516565	X	18622142	X	18604022	516565	508096	rs777079786	NC_000023.11:18604021:C:T
NM_000330.4(RS1):c.326+1114C>T	CDKL5|RS1		not specified|History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000516455	X	18664197	X	18646077	516455	508000	rs369383134	NC_000023.11:18646076:G:A
NM_001323289.2(CDKL5):c.2109A>T (p.Leu703=)	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000514228	X	18627647	X	18609527	514228	508099	rs761789190	NC_000023.11:18609526:A:T
NM_000330.4(RS1):c.185-3221G>C	CDKL5|RS1	R981G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000512938	X	18668673	X	18650553	512938	508488	rs374054249	NC_000023.11:18650552:C:G
NM_001323289.2(CDKL5):c.2680G>A (p.Ala894Thr)	CDKL5	A894T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Benign/Likely benign(Last reviewed: Aug 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000512529	X	18646674	X	18628554	512529	508487	rs763110247	NC_000023.11:18628553:G:A
NM_000330.4(RS1):c.184+3198C>T	CDKL5|RS1	V1002I	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000511046	X	18671575	X	18653455	511046	508623	rs987192406	NC_000023.11:18653454:G:A
NM_001323289.2(CDKL5):c.1527G>A (p.Ala509=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign/Likely benign(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000509971	X	18622571	X	18604451	509971	508483	rs369561849	NC_000023.11:18604450:G:A
NM_001323289.2(CDKL5):c.404-9A>G	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000508473	X	18600002	X	18581882	508473	508481	rs1037467164	NC_000023.11:18581881:A:G
NM_001323289.2(CDKL5):c.2086G>A (p.Ala696Thr)	CDKL5	A696T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000507662	X	18627624	X	18609504	507662	507990	rs374518046	NC_000023.11:18609503:G:A
NM_001323289.2(CDKL5):c.786C>A (p.Tyr262Ter)	CDKL5	Y262*	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489166	X	18613509	X	18595389	489166	482246	rs1555951146	NC_000023.11:18595388:C:A
NM_000330.4(RS1):c.326+1115G>A	CDKL5|RS1	T928M	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2017)	criteria provided, conflicting interpretations	VCV000464817	X	18664196	X	18646076	464817	471436	rs951430019	NC_000023.11:18646075:C:T
NM_000330.4(RS1):c.326+1182C>T	CDKL5|RS1	G906S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000464816	X	18664129	X	18646009	464816	471435	rs369009993	NC_000023.11:18646008:G:A
NM_001323289.2(CDKL5):c.2652C>T (p.Gly884=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000464815	X	18646646	X	18628526	464815	472114	rs201473442	NC_000023.11:18628525:C:T
NM_001323289.2(CDKL5):c.2490G>C (p.Gln830His)	CDKL5	Q830H	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000464814	X	18643361	X	18625241	464814	471841	rs1485485459	NC_000023.11:18625240:G:C
NM_001323289.2(CDKL5):c.2345C>A (p.Ser782Ter)	CDKL5	S782*	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000464812	X	18638055	X	18619935	464812	471434	rs1555954074	NC_000023.11:18619934:C:A
NM_001323289.2(CDKL5):c.2220A>G (p.Pro740=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000464811	X	18631339	X	18613219	464811	472113	rs142079769	NC_000023.11:18613218:A:G
NM_001323289.2(CDKL5):c.1731G>A (p.Met577Ile)	CDKL5	M577I	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000464810	X	18622775	X	18604655	464810	472112	rs757573258	NC_000023.11:18604654:G:A
NM_001323289.2(CDKL5):c.1519C>T (p.Gln507Ter)	CDKL5	Q507*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000464809	X	18622563	X	18604443	464809	471431	rs1555952052	NC_000023.11:18604442:C:T
NM_001323289.2(CDKL5):c.1246G>T (p.Glu416Ter)	CDKL5	E416*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Sep 23, 2018)	criteria provided, single submitter	VCV000464808	X	18622290	X	18604170	464808	470650	rs1555951991	NC_000023.11:18604169:G:T
NM_001323289.2(CDKL5):c.825+5G>A	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000452763	X	18613553	X	18595433	452763	446600	rs1555951149	NC_000023.11:18595432:G:A
NM_000330.4(RS1):c.185-3137C>A	CDKL5|RS1	A953S	not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2020)	criteria provided, conflicting interpretations	VCV000434667	X	18668589	X	18650469	434667	430762	rs767312604	NC_000023.11:18650468:G:T
NM_001323289.2(CDKL5):c.1684A>G (p.Thr562Ala)	CDKL5	T562A	not specified|History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 10, 2020)	criteria provided, conflicting interpretations	VCV000434666	X	18622728	X	18604608	434666	430760	rs376341076	NC_000023.11:18604607:A:G
NM_001323289.2(CDKL5):c.1564T>G (p.Leu522Val)	CDKL5	L522V	not specified|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)	criteria provided, conflicting interpretations	VCV000434664	X	18622608	X	18604488	434664	430759	rs781427744	NC_000023.11:18604487:T:G
NM_001323289.2(CDKL5):c.350A>G (p.Tyr117Cys)	CDKL5	Y117C	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2018)	criteria provided, conflicting interpretations	VCV000432427	X	18598035	X	18579915	432427	426443	rs1189749755	NC_000023.11:18579914:A:G
NM_001323289.2(CDKL5):c.1234A>G (p.Lys412Glu)	CDKL5	K412E	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|CDKL5 disorder	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000423898	X	18622278	X	18604158	423898	411223	rs770340766	NC_000023.11:18604157:A:G
NM_001323289.2(CDKL5):c.1064G>A (p.Arg355Gln)	CDKL5	R355Q	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)	criteria provided, conflicting interpretations	VCV000423478	X	18622108	X	18603988	423478	411221	rs189400843	NC_000023.11:18603987:G:A
NM_001323289.2(CDKL5):c.1945-5T>C	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423121	X	18626926	X	18608806	423121	411227	rs1064796245	NC_000023.11:18608805:T:C
NM_001323289.2(CDKL5):c.2546C>T (p.Ser849Leu)	CDKL5	S849L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2019)	criteria provided, conflicting interpretations	VCV000422765	X	18646540	X	18628420	422765	411231	rs1064795982	NC_000023.11:18628419:C:T
NM_001323289.2(CDKL5):c.743G>T (p.Arg248Leu)	CDKL5	R248L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Apr 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000422559	X	18606262	X	18588142	422559	411214	rs1064795857	NC_000023.11:18588141:G:T
NM_001323289.2(CDKL5):c.854G>A (p.Arg285Lys)	CDKL5	R285K	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000422272	X	18616610	X	18598490	422272	411215	rs1064795672	NC_000023.11:18598489:G:A
NM_001323289.2(CDKL5):c.950A>G (p.His317Arg)	CDKL5	H317R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Benign/Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420833	X	18616706	X	18598586	420833	411218	rs756537286	NC_000023.11:18598585:A:G
NM_001323289.2(CDKL5):c.1795A>G (p.Thr599Ala)	CDKL5	T599A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419920	X	18622839	X	18604719	419920	411226	rs761662406	NC_000023.11:18604718:A:G
NM_001323289.2(CDKL5):c.7A>T (p.Ile3Phe)	CDKL5	I3F	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000408122	X	18525223	X	18507103	408122	404186	rs138539908	NC_000023.11:18507102:A:T
NM_001323289.2(CDKL5):c.826-2A>G	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000408121	X	18616580	X	18598460	408121	404509	rs1060501859	NC_000023.11:18598459:A:G
NM_001323289.2(CDKL5):c.1930C>T (p.Leu644Phe)	CDKL5	L644F	not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2019)	criteria provided, conflicting interpretations	VCV000393097	X	18622974	X	18604854	393097	379152	rs1057524785	NC_000023.11:18604853:C:T
NM_001323289.2(CDKL5):c.2573G>A (p.Arg858His)	CDKL5	R858H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000392468	X	18646567	X	18628447	392468	379159	rs759083770	NC_000023.11:18628446:G:A
NM_001323289.2(CDKL5):c.886A>G (p.Thr296Ala)	CDKL5	T296A	not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Benign/Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000383412	X	18616642	X	18598522	383412	379262	rs751995225	NC_000023.11:18598521:A:G
NM_000330.4(RS1):c.185-3189C>T	CDKL5|RS1	R970Q	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000381696	X	18668641	X	18650521	381696	379266	rs570887192	NC_000023.11:18650520:G:A
NM_001323289.2(CDKL5):c.2106C>T (p.His702=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000378930	X	18627644	X	18609524	378930	380008	rs1057520416	NC_000023.11:18609523:C:T
NM_000330.4(RS1):c.185-3213A>C	CDKL5|RS1	L978R	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377651	X	18668665	X	18650545	377651	379272	rs143243059	NC_000023.11:18650544:T:G
NM_001323289.2(CDKL5):c.1730T>C (p.Met577Thr)	CDKL5	M577T	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000377647	X	18622774	X	18604654	377647	378025	rs749822712	NC_000023.11:18604653:T:C
NM_001323289.2(CDKL5):c.192T>G (p.Leu64=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377645	X	18593520	X	18575400	377645	378006	rs145496868	NC_000023.11:18575399:T:G
NM_001323289.2(CDKL5):c.2465G>A (p.Arg822His)	CDKL5	R822H	not specified|not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000377094	X	18643336	X	18625216	377094	363972	rs376429571	NC_000023.11:18625215:G:A
NM_000330.4(RS1):c.185-3260C>T	CDKL5|RS1	G994R	Epileptic encephalopathy|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2020)	criteria provided, conflicting interpretations	VCV000375543	X	18668712	X	18650592	375543	362354	rs866859766	NC_000023.11:18650591:G:A
NM_001323289.2(CDKL5):c.462T>C (p.Phe154=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373584	X	18600069	X	18581949	373584	360556	rs898874642	NC_000023.11:18581948:T:C
NM_001323289.2(CDKL5):c.2520C>T (p.Arg840=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Nov 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373525	X	18646514	X	18628394	373525	360605	rs1037569177	NC_000023.11:18628393:C:T
NM_001323289.2(CDKL5):c.1006C>T (p.Gln336Ter)	CDKL5	Q336*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373086	X	18622050	X	18603930	373086	360565	rs1057518203	NC_000023.11:18603929:C:T
NM_001323289.2(CDKL5):c.1338A>T (p.Ser446=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000288260	X	18622382	X	18604262	288260	272497	rs139329419	NC_000023.11:18604261:A:T
NM_001323289.2(CDKL5):c.2152+10C>G	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2019)	criteria provided, conflicting interpretations	VCV000287225	X	18627700	X	18609580	287225	271462	rs763466606	NC_000023.11:18609579:C:G
NM_001323289.2(CDKL5):c.2469C>T (p.Pro823=)	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2020)	criteria provided, conflicting interpretations	VCV000287145	X	18643340	X	18625220	287145	271382	rs369377144	NC_000023.11:18625219:C:T
NM_001323289.2(CDKL5):c.2151A>G (p.Arg717=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2020)	criteria provided, conflicting interpretations	VCV000286706	X	18627689	X	18609569	286706	270943	rs886043453	NC_000023.11:18609568:A:G
NM_001323289.2(CDKL5):c.2466C>G (p.Arg822=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Benign/Likely benign(Last reviewed: Nov 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000258979	X	18643337	X	18625217	258979	257791	rs146488512	NC_000023.11:18625216:C:G
NM_001323289.2(CDKL5):c.2445C>T (p.Ser815=)	CDKL5		CDKL5 disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000258978	X	18643316	X	18625196	258978	257790	rs371902632	NC_000023.11:18625195:C:T
NM_000330.4(RS1):c.185-3176C>T	CDKL5|RS1	V966I	Early infantile epileptic encephalopathy 2|CDKL5 disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000210646	X	18668628	X	18650508	210646	208993	rs747799506	NC_000023.11:18650507:G:A
NM_001323289.2(CDKL5):c.1722G>A (p.Pro574=)	CDKL5		not specified|History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Sep 17, 2020)	criteria provided, conflicting interpretations	VCV000210643	X	18622766	X	18604646	210643	208990	rs371603866	NC_000023.11:18604645:G:A
NM_001323289.2(CDKL5):c.1002T>C (p.Ala334=)	CDKL5		not specified|not provided|History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2020)	criteria provided, conflicting interpretations	VCV000210642	X	18622046	X	18603926	210642	208989	rs756986206	NC_000023.11:18603925:T:C
NM_001323289.2(CDKL5):c.2243A>G (p.Asn748Ser)	CDKL5	N748S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 9, 2020)	criteria provided, conflicting interpretations	VCV000194499	X	18631362	X	18613242	194499	191662	rs748459878	NC_000023.11:18613241:A:G
NM_001323289.2(CDKL5):c.800A>G (p.Asn267Ser)	CDKL5	N267S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000193651	X	18613523	X	18595403	193651	190814	rs794726990	NC_000023.11:18595402:A:G
NM_001323289.2(CDKL5):c.2046+1G>A	CDKL5		Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000189568	X	18627033	X	18608913	189568	187620	rs786204976	NC_000023.11:18608912:G:A
NM_000330.4(RS1):c.185-3208C>T	CDKL5|RS1		not specified|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Feb 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189535	X	18668660	X	18650540	189535	187630	rs140944590	NC_000023.11:18650539:G:A
NM_001323289.2(CDKL5):c.2673G>A (p.Gln891=)	CDKL5		not specified|not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Sep 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189534	X	18646667	X	18628547	189534	187627	rs373448935	NC_000023.11:18628546:G:A
NM_001323289.2(CDKL5):c.2389G>A (p.Asp797Asn)	CDKL5	D797N	not specified|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|not provided	Benign/Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189533	X	18643260	X	18625140	189533	187624	rs140313320	NC_000023.11:18625139:G:A
NM_000330.4(RS1):c.184+3171C>T	CDKL5|RS1	A1011T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2020)	criteria provided, conflicting interpretations	VCV000166822	X	18671602	X	18653482	166822	177440	rs727503848	NC_000023.11:18653481:G:A
NM_001323289.2(CDKL5):c.2388C>T (p.Ser796=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2020)	criteria provided, conflicting interpretations	VCV000166821	X	18643259	X	18625139	166821	177566	rs727503847	NC_000023.11:18625138:C:T
NM_001323289.2(CDKL5):c.146-1G>A	CDKL5		not provided|Early infantile epileptic encephalopathy 2|CDKL5 disorder	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000158179	X	18593473	X	18575353	158179	170097	rs587783399	NC_000023.11:18575352:G:A
NM_001323289.2(CDKL5):c.1071C>T (p.Asp357=)	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158176	X	18622115	X	18603995	158176	170103	rs144204039	NC_000023.11:18603994:C:T
NM_000330.4(RS1):c.185-3207G>A	CDKL5|RS1	P976L	CDKL5 disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000156694	X	18668659	X	18650539	156694	166548	rs587783161	NC_000023.11:18650538:C:T
NM_000330.4(RS1):c.326+1159C>G	CDKL5|RS1	Q913H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2020)	criteria provided, conflicting interpretations	VCV000156693	X	18664152	X	18646032	156693	166547	rs587783160	NC_000023.11:18646031:G:C
NM_001323289.2(CDKL5):c.2555C>T (p.Pro852Leu)	CDKL5	P852L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 17, 2020)	criteria provided, conflicting interpretations	VCV000156690	X	18646549	X	18628429	156690	166544	rs587783156	NC_000023.11:18628428:C:T
NM_001323289.2(CDKL5):c.1818A>G (p.Gln606=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign/Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156686	X	18622862	X	18604742	156686	166540	rs587783154	NC_000023.11:18604741:A:G
NM_001323289.2(CDKL5):c.1721C>T (p.Pro574Leu)	CDKL5	P574L	not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Benign/Likely benign(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000156685	X	18622765	X	18604645	156685	166539	rs199897804	NC_000023.11:18604644:C:T
NM_001323289.2(CDKL5):c.1636G>A (p.Gly546Arg)	CDKL5	G546R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000156684	X	18622680	X	18604560	156684	166538	rs587783153	NC_000023.11:18604559:G:A
NM_001323289.2(CDKL5):c.404-2A>G	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156599	X	18600009	X	18581889	156599	166453	rs587783080	NC_000023.11:18581888:A:G
NM_001323289.2(CDKL5):c.2047-1G>A	CDKL5		Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000156077	X	18627584	X	18609464	156077	165873	rs267608650	NC_000023.11:18609463:G:A
NM_001323289.2(CDKL5):c.100-2A>G	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000156073	X	18582595	X	18564475	156073	165869	rs267608423	NC_000023.11:18564474:A:G
NM_001323289.2(CDKL5):c.659T>C (p.Leu220Pro)	CDKL5	L220P	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000143830	X	18606178	X	18588058	143830	153562	rs267608511	NC_000023.11:18588057:T:C
NM_001323289.2(CDKL5):c.587C>T (p.Ser196Leu)	CDKL5	S196L	Epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143827	X	18606106	X	18587986	143827	153559	rs267608501	NC_000023.11:18587985:C:T
NM_001323289.2(CDKL5):c.578A>G (p.Asp193Gly)	CDKL5	D193G	Early infantile epileptic encephalopathy 2|CDKL5 disorder|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143826	X	18606097	X	18587977	143826	153558	rs267608500	NC_000023.11:18587976:A:G
NM_001323289.2(CDKL5):c.532C>T (p.Arg178Trp)	CDKL5	R178W	Early infantile epileptic encephalopathy 2|Intellectual disability|Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143823	X	18602451	X	18584331	143823	153555	rs267608493	NC_000023.11:18584330:C:T
NM_001323289.2(CDKL5):c.513C>A (p.Tyr171Ter)	CDKL5	Y171*	Early infantile epileptic encephalopathy 2|CDKL5 disorder|not provided	Pathogenic(Last reviewed: Mar 9, 2021)	reviewed by expert panel	VCV000143822	X	18602432	X	18584312	143822	153554	rs267608490	NC_000023.11:18584311:C:A
NM_001323289.2(CDKL5):c.380A>G (p.His127Arg)	CDKL5	H127R	not provided|Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000143818	X	18598065	X	18579945	143818	153550	rs267608468	NC_000023.11:18579944:A:G
NM_000330.4(RS1):c.184+3190C>A	CDKL5|RS1	R1004S	not specified|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143815	X	18671583	X	18653463	143815	153547	rs267608667	NC_000023.11:18653462:G:T
NM_000330.4(RS1):c.185-3188G>A	CDKL5|RS1	R970*	CDKL5 disorder|not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143812	X	18668640	X	18650520	143812	153544	rs267608665	NC_000023.11:18650519:C:T
NM_000330.4(RS1):c.185-3134G>A	CDKL5|RS1	R952*	not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Benign/Likely benign(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143811	X	18668586	X	18650466	143811	153543	rs202153551	NC_000023.11:18650465:C:T
NM_001323289.2(CDKL5):c.1892T>C (p.Ile631Thr)	CDKL5	I631T	not provided|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2020)	criteria provided, conflicting interpretations	VCV000143786	X	18622936	X	18604816	143786	153518	rs144878564	NC_000023.11:18604815:T:C
NM_001323289.2(CDKL5):c.1767C>T (p.His589=)	CDKL5		Early infantile epileptic encephalopathy 2|not specified|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143784	X	18622811	X	18604691	143784	153516	rs267608645	NC_000023.11:18604690:C:T
NM_001323289.2(CDKL5):c.175C>T (p.Arg59Ter)	CDKL5	R59*	Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Pathogenic(Last reviewed: May 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143783	X	18593503	X	18575383	143783	153515	rs62653623	NC_000023.11:18575382:C:T
NM_001323289.2(CDKL5):c.1675C>T (p.Arg559Ter)	CDKL5	R559*	not provided|Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143781	X	18622719	X	18604599	143781	153513	rs267608395	NC_000023.11:18604598:C:T
NM_001323289.2(CDKL5):c.1648C>T (p.Arg550Ter)	CDKL5	R550*	Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000143780	X	18622692	X	18604572	143780	153512	rs267608643	NC_000023.11:18604571:C:T
NM_001323289.2(CDKL5):c.1523T>C (p.Ile508Thr)	CDKL5	I508T	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Autistic disorder of childhood onset	Benign/Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143778	X	18622567	X	18604447	143778	153510	rs201893287	NC_000023.11:18604446:T:C
NM_001323289.2(CDKL5):c.1382A>G (p.Asn461Ser)	CDKL5	N461S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000143776	X	18622426	X	18604306	143776	153508	rs267608629	NC_000023.11:18604305:A:G
NM_001323289.2(CDKL5):c.1330C>T (p.Arg444Cys)	CDKL5	R444C	not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143775	X	18622374	X	18604254	143775	153507	rs61753977	NC_000023.11:18604253:C:T
NM_001323289.2(CDKL5):c.1278A>C (p.Ser426=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143773	X	18622322	X	18604202	143773	153505	rs267608620	NC_000023.11:18604201:A:C
NM_001323289.2(CDKL5):c.1196A>C (p.Asn399Thr)	CDKL5	N399T	Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|CDKL5 disorder|not provided	Likely benign(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000143770	X	18622240	X	18604120	143770	153502	rs267608611	NC_000023.11:18604119:A:C
NM_000330.4(RS1):c.184+3208G>A	CDKL5|RS1		not specified|History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136716	X	18671565	X	18653445	136716	140419	rs150900695	NC_000023.11:18653444:C:T
NM_001323289.2(CDKL5):c.2409G>A (p.Thr803=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136714	X	18643280	X	18625160	136714	140417	rs145401225	NC_000023.11:18625159:G:A
NM_001323289.2(CDKL5):c.2372A>C (p.Gln791Pro)	CDKL5	Q791P	History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|not specified	Benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000136713	X	18638082	X	18619962	136713	140416	rs35478150	NC_000023.11:18619961:A:C
NM_001323289.2(CDKL5):c.1431T>C (p.Ser477=)	CDKL5		History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136712	X	18622475	X	18604355	136712	140415	rs143992148	NC_000023.11:18604354:T:C
NM_001323289.2(CDKL5):c.1332C>T (p.Arg444=)	CDKL5		History of neurodevelopmental disorder|not specified|not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136711	X	18622376	X	18604256	136711	140414	rs150844616	NC_000023.11:18604255:C:T
NM_001323289.2(CDKL5):c.93A>G (p.Arg31=)	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2020)	criteria provided, conflicting interpretations	VCV000094115	X	18528968	X	18510848	94115	100015	rs140332992	NC_000023.11:18510847:A:G
NM_001323289.2(CDKL5):c.555-19C>G	CDKL5		not specified|not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094114	X	18606055	X	18587935	94114	100014	rs75057928	NC_000023.11:18587934:C:G
NM_001323289.2(CDKL5):c.533G>A (p.Arg178Gln)	CDKL5	R178Q	not provided|CDKL5 disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 25, 2021)	reviewed by expert panel	VCV000094113	X	18602452	X	18584332	94113	100013	rs267606715	NC_000023.11:18584331:G:A
NM_000330.4(RS1):c.184+3118C>T	CDKL5|RS1		History of neurodevelopmental disorder|not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000094112	X	18671655	X	18653535	94112	100012	rs139155110	NC_000023.11:18653534:G:A
NM_000330.4(RS1):c.184+3199G>A	CDKL5|RS1		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000094111	X	18671574	X	18653454	94111	100011	rs36022183	NC_000023.11:18653453:C:T
NM_000330.4(RS1):c.184+3207C>T	CDKL5|RS1	V999M	History of neurodevelopmental disorder|not specified|not provided|West syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094110	X	18671566	X	18653446	94110	100010	rs35693326	NC_000023.11:18653445:G:A
NM_001323289.2(CDKL5):c.2653G>A (p.Gly885Arg)	CDKL5	G885R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094109	X	18646647	X	18628527	94109	100009	rs398123694	NC_000023.11:18628526:G:A
NM_001323289.2(CDKL5):c.2200A>G (p.Thr734Ala)	CDKL5	T734A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2020)	criteria provided, conflicting interpretations	VCV000094108	X	18631319	X	18613199	94108	100008	rs55803460	NC_000023.11:18613198:A:G
NM_001323289.2(CDKL5):c.180G>A (p.Glu60=)	CDKL5		CDKL5 disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000094107	X	18593508	X	18575388	94107	100007	rs148697943	NC_000023.11:18575387:G:A
NM_001323289.2(CDKL5):c.1797C>G (p.Thr599=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094106	X	18622841	X	18604721	94106	100006	rs141478957	NC_000023.11:18604720:C:G
NM_001323289.2(CDKL5):c.533G>C (p.Arg178Pro)	CDKL5	R178P	Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000018450	X	18602452	X	18584332	18450	33489	rs267606715	NC_000023.11:18584331:G:C
NM_001323289.2(CDKL5):c.872G>A (p.Cys291Tyr)	CDKL5	C291Y	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000011505	X	18616628	X	18598508	11505	26544	rs267606714	NC_000023.11:18598507:G:A
NM_001323289.2(CDKL5):c.215T>C (p.Ile72Thr)	CDKL5	I72T	Early infantile epileptic encephalopathy 2|CDKL5 disorder|Rett syndrome|not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011503	X	18593543	X	18575423	11503	26542	rs62641235	NC_000023.11:18575422:T:C
NM_001323289.2(CDKL5):c.119C>T (p.Ala40Val)	CDKL5	A40V	Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|CDKL5 disorder|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 30, 2021)	reviewed by expert panel	VCV000011502	X	18582616	X	18564496	11502	26541	rs122460159	NC_000023.11:18564495:C:T
NM_005249.5(FOXG1):c.503G>C (p.Gly168Ala)	FOXG1	G168A	Rett syndrome, congenital variant|FOXG1 disorder|not provided|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000205474	14	29236988	14	28767782	205474	202819	rs148157138	NC_000014.9:28767781:G:C
NM_005249.5(FOXG1):c.799G>A (p.Gly267Ser)	FOXG1	G267S	Rett syndrome, congenital variant|FOXG1 disorder|not provided	Pathogenic(Last reviewed: Mar 24, 2021)	reviewed by expert panel	VCV000158602	14	29237284	14	28768078	158602	169061	rs587783643	NC_000014.9:28768077:G:A
NM_005249.5(FOXG1):c.489C>T (p.Gly163=)	FOXG1		History of neurodevelopmental disorder|FOXG1 disorder|not specified|Rett syndrome, congenital variant|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000137390	14	29236974	14	28767768	137390	141093	rs375378714	NC_000014.9:28767767:C:T
NM_005249.5(FOXG1):c.201G>T (p.Pro67=)	FOXG1		History of neurodevelopmental disorder|not specified|not provided|FOXG1 disorder|Rett syndrome, congenital variant	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000137388	14	29236686	14	28767480	137388	141091	rs587780944	NC_000014.9:28767479:G:T
NM_033223.5(GABRG3):c.1125C>T (p.Asn375=)	GABRG3		Angelman syndrome	Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV000870529	15	27777748	15	27532602	870529	858691		NC_000015.10:27532601:C:T
NM_004667.6(HERC2):c.1781C>T (p.Pro594Leu)	HERC2	P594L	Mental retardation, autosomal recessive 38	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000088738	15	28510853	15	28265707	88738	94315	rs397518474	NC_000015.10:28265706:G:A
NM_006734.4(HIVEP2):c.5935C>T (p.Arg1979Ter)	HIVEP2	R1979*	Angelman syndrome-like|Mental retardation, autosomal dominant 43|not provided	Pathogenic(Last reviewed: Oct 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000523775	6	143081490	6	142760353	523775	514525	rs1554275163	NC_000006.12:142760352:G:A
NM_004519.4(KCNQ3):c.688C>T (p.Arg230Cys)	KCNQ3	R230C, R110C	Benign familial neonatal seizures 2|Intellectual disability|Seizures, benign familial infantile, 5|Benign familial neonatal seizures|Intellectual disability|Benign familial neonatal seizures|Lennox-Gastaut syndrome|not provided|Autistic behavior|Severe neurodevelopmental delay	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000205963	8	133192493	8	132180246	205963	202181	rs796052676	NC_000008.11:132180245:G:A
NM_001244008.2(KIF1A):c.506G>C (p.Arg169Thr)	KIF1A	R169T	Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666256	2	241725854	2	240786437	666256	653809	rs876661168	NC_000002.12:240786436:C:G
NM_031206.7(LAS1L):c.1237G>A (p.Gly413Arg)	LAS1L	G396R, G413R, G354R, G94R	Wilson-Turner X-linked mental retardation syndrome	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666263	X	64743999	X	65524119	666263	653814	rs1602612611	NC_000023.11:65524118:C:T
NM_014795.4(ZEB2):c.561C>T (p.Gly187=)	LOC111721705|ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000657407	2	145162434	2	144404867	657407	628460	rs1186904900	NC_000002.12:144404866:G:A
NM_014795.4(ZEB2):c.575A>G (p.Asn192Ser)	LOC111721705|ZEB2	N192S, N168S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000580089	2	145162420	2	144404853	580089	558729	rs779549076	NC_000002.12:144404852:T:C
NM_014795.4(ZEB2):c.502C>T (p.Gln168Ter)	LOC111721705|ZEB2	Q168*, Q144*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561146	2	145162493	2	144404926	561146	552051	rs1560609721	NC_000002.12:144404925:G:A
NM_001110792.2(MECP2):c.331A>C (p.Thr111Pro)	MECP2	T111P, T6P, T99P	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000859603	X	153297740	X	154032289	859603	849791		NC_000023.11:154032288:T:G
NM_001110792.2(MECP2):c.62+2T>G	MECP2		not provided|Rett syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000503729	X	153363059	X	154097602	503729	495805	rs1557150841	NC_000023.11:154097601:A:C
NM_001110792.2(MECP2):c.414-6C>G	MECP2		Rett syndrome|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000236301	X	153296907	X	154031456	236301	237857	rs782482746	NC_000023.11:154031455:G:C
NM_001110792.2(MECP2):c.414-3C>G	MECP2		not provided|Severe neonatal-onset encephalopathy with microcephaly|not specified|Rett syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000156068	X	153296904	X	154031453	156068	165864	rs267608465	NC_000023.11:154031452:G:C
NM_001110792.2(MECP2):c.488A>G (p.Asp163Gly)	MECP2	D151G, D163G, D58G	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000143578	X	153296827	X	154031376	143578	153310	rs61748403	NC_000023.11:154031375:T:C
NM_001110792.2(MECP2):c.338C>G (p.Pro113Arg)	MECP2	P101R, P113R, P8R	Angelman syndrome|Rett syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143526	X	153297733	X	154032282	143526	153258	rs61754453	NC_000023.11:154032281:G:C
NM_001110792.2(MECP2):c.337C>T (p.Pro113Ser)	MECP2	P101S, P113S, P8S	Rett syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143524	X	153297734	X	154032283	143524	153256	rs61754452	NC_000023.11:154032282:G:A
NM_001110792.2(MECP2):c.1216G>A (p.Glu406Lys)	MECP2	E394K, E406K, E301K, E171K	not specified|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143421	X	153296099	X	154030648	143421	153153	rs63094662	NC_000023.11:154030647:C:T
NM_001110792.2(MECP2):c.1066C>T (p.Arg356Trp)	MECP2	R344W, R356W, R251W, R121W	not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143309	X	153296249	X	154030798	143309	153041	rs61752361	NC_000023.11:154030797:G:A
NM_001110792.2(MECP2):c.*36G>C	MECP2		not specified	Benign(Last reviewed: May 31, 2006)	no assertion criteria provided	VCV000143266	X	153295782	X	154030331	143266	152998	rs267608347	NC_000023.11:154030330:C:G
NM_001110792.2(MECP2):c.1176G>A (p.Val392=)	MECP2		Severe neonatal-onset encephalopathy with microcephaly|not specified|not provided|Rett syndrome	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000138194	X	153296139	X	154030688	138194	141897	rs201711454	NC_000023.11:154030687:C:T
NM_001110792.2(MECP2):c.1483G>T (p.Glu495Ter)	MECP2	E483*, E495*, E390*, E260*	not provided|Autism, susceptibility to, X-linked 3|Rett syndrome	Uncertain significance(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000133342	X	153295832	X	154030381	133342	137081	rs587777421	NC_000023.11:154030380:C:A
NM_001110792.2(MECP2):c.644C>T (p.Thr215Met)	MECP2	T203M, T215M, T110M	Rett syndrome|History of neurodevelopmental disorder|not specified|not provided|Severe neonatal-onset encephalopathy with microcephaly	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000095198	X	153296671	X	154031220	95198	101098	rs61749720	NC_000023.11:154031219:G:A
NM_001110792.2(MECP2):c.1162C>T (p.Pro388Ser)	MECP2	P388S, P283S, P153S	Rett syndrome|not specified|Severe neonatal-onset encephalopathy with microcephaly	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000095184	X	153296153	X	154030702	95184	101084	rs61752387	NC_000023.11:154030701:G:A
NM_001110792.2(MECP2):c.490C>G (p.Pro164Ala)	MECP2	P152A, P164A, P59A	Mental retardation, X-linked, syndromic 13|Rett syndrome|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome, zappella variant|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011844	X	153296825	X	154031374	11844	26883	rs179363900	NC_000023.11:154031373:G:C
NM_001110792.2(MECP2):c.459C>G (p.Tyr153Ter)	MECP2	Y141*, Y153*, Y48*	Atypical Rett syndrome|not provided|Angelman syndrome|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011833	X	153296856	X	154031405	11833	26872	rs61748396	NC_000023.11:154031404:G:C
NM_001110792.2(MECP2):c.952C>T (p.Arg318Cys)	MECP2	R306C, R318C, R213C, R83C	Severe neonatal-onset encephalopathy with microcephaly|Angelman syndrome|none provided|Intellectual disability|Rett syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011824	X	153296363	X	154030912	11824	26863	rs28935468	NC_000023.11:154030911:G:A
NM_001110792.2(MECP2):c.916C>T (p.Arg306Ter)	MECP2	R294*, R306*, R201*, R71*	Autism, susceptibility to, X-linked 3|not provided|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|See cases|Rett syndrome|Inborn genetic diseases|Severe neonatal-onset encephalopathy with microcephaly	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011819	X	153296399	X	154030948	11819	26858	rs61751362	NC_000023.11:154030947:G:A
NM_001110792.2(MECP2):c.509C>T (p.Thr170Met)	MECP2	T158M, T170M, T65M	Severe neonatal-onset encephalopathy with microcephaly|Angelman syndrome|Autism, susceptibility to, X-linked 3|Rett syndrome|History of neurodevelopmental disorder|Inborn genetic diseases|not specified|not provided|Severe neonatal-onset encephalopathy with microcephaly|Autism, susceptibility to, X-linked 3|Rett syndrome|Syndromic X-linked intellectual disability Lubs type|Mental retardation, X-linked, syndromic 13	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000011811	X	153296806	X	154031355	11811	26850	rs28934906	NC_000023.11:154031354:G:A
NM_001110792.2(MECP2):c.433C>T (p.Arg145Cys)	MECP2	R133C, R145C, R40C	Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Rett syndrome|History of neurodevelopmental disorder|Intellectual disability|not provided|not specified|Inborn genetic diseases|Rett syndrome, zappella variant|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2021)	criteria provided, conflicting interpretations	VCV000011809	X	153296882	X	154031431	11809	26848	rs28934904	NC_000023.11:154031430:G:A
NM_017909.4(RMND1):c.1286A>T (p.Glu429Val)	RMND1	E259V, E429V	Combined oxidative phosphorylation deficiency 11	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666266	6	151726886	6	151405751	666266	653811	rs1582936202	NC_000006.12:151405750:T:A
NM_017909.4(RMND1):c.1049T>C (p.Met350Thr)	RMND1	M350T, M180T	Combined oxidative phosphorylation deficiency 11	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666265	6	151742410	6	151421275	666265	653812	rs1582950315	NC_000006.12:151421274:A:G
NM_003042.4(SLC6A1):c.889G>A (p.Gly297Arg)	SLC6A1	G297R, G119R, G177R	Myoclonic-atonic epilepsy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000192369	3	11067498	3	11025812	192369	190156	rs876657400	NC_000003.12:11025811:G:A
NM_001379110.1(SLC9A6):c.1922G>A (p.Arg641Gln)	SLC9A6	R579Q, R611Q, R631Q, R641Q, R663Q	Christianson syndrome	Benign(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV001167395	X	135126765	X	136044606	1167395	1159370		NC_000023.11:136044605:G:A
NM_001379110.1(SLC9A6):c.564G>A (p.Thr188=)	SLC9A6		Christianson syndrome|not provided	Benign/Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV001164735	X	135081054	X	135998895	1164735	1159369		NC_000023.11:135998894:G:A
NM_001379110.1(SLC9A6):c.2022G>A (p.Thr674=)	SLC9A6		Christianson syndrome	Benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV001164656	X	135126865	X	136044706	1164656	1159371		NC_000023.11:136044705:G:A
NM_001379110.1(SLC9A6):c.-57+34G>C	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001156645	X	135067670	X	135985511	1156645	1150432		NC_000023.11:135985510:G:C
NM_001379110.1(SLC9A6):c.1728A>G (p.Gly576=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV001150038	X	135122301	X	136040142	1150038	1150435		NC_000023.11:136040141:A:G
NM_001379110.1(SLC9A6):c.81G>A (p.Leu27=)	SLC9A6		Christianson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)	criteria provided, conflicting interpretations	VCV001143525	X	135067898	X	135985739	1143525	1150433		NC_000023.11:135985738:G:A
NM_001379110.1(SLC9A6):c.1227T>C (p.Ile409=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV001139281	X	135104777	X	136022618	1139281	1129402		NC_000023.11:136022617:T:C
NM_001379110.1(SLC9A6):c.1578C>T (p.His526=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001134224	X	135112318	X	136030159	1134224	1129403		NC_000023.11:136030158:C:T
NM_001379110.1(SLC9A6):c.630T>C (p.Thr210=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001130989	X	135081120	X	135998961	1130989	1129401		NC_000023.11:135998960:T:C
NM_001379110.1(SLC9A6):c.1839A>T (p.Gly613=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV001118274	X	135126682	X	136044523	1118274	1108028		NC_000023.11:136044522:A:T
NM_001379110.1(SLC9A6):c.1844C>T (p.Ser615Phe)	SLC9A6	S553F, S585F, S605F, S615F, S637F	Christianson syndrome	Likely benign(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV001117529	X	135126687	X	136044528	1117529	1108029		NC_000023.11:136044527:C:T
NM_001379110.1(SLC9A6):c.1734C>T (p.Ile578=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Mar 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV001110453	X	135122307	X	136040148	1110453	1108026		NC_000023.11:136040147:C:T
NM_001379110.1(SLC9A6):c.372T>A (p.Val124=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001110428	X	135080269	X	135998110	1110428	1108021		NC_000023.11:135998109:T:A
NM_001379110.1(SLC9A6):c.1764C>T (p.Tyr588=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV001109358	X	135122337	X	136040178	1109358	1108027		NC_000023.11:136040177:C:T
NM_001379110.1(SLC9A6):c.471G>A (p.Gly157=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001106023	X	135080664	X	135998505	1106023	1108023		NC_000023.11:135998504:G:A
NM_001379110.1(SLC9A6):c.-19C>A	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001104067	X	135067799	X	135985640	1104067	1108020		NC_000023.11:135985639:C:A
NM_001379110.1(SLC9A6):c.638-8C>T	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Apr 28, 2019)	criteria provided, single submitter	VCV001101800	X	135084259	X	136002100	1101800	1108024		NC_000023.11:136002099:C:T
NM_001379110.1(SLC9A6):c.717T>C (p.Asn239=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV001100718	X	135084346	X	136002187	1100718	1108025		NC_000023.11:136002186:T:C
NM_001379110.1(SLC9A6):c.594A>G (p.Thr198=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV001096092	X	135081084	X	135998925	1096092	1086283		NC_000023.11:135998924:A:G
NM_001379110.1(SLC9A6):c.66G>A (p.Leu22=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001091661	X	135067883	X	135985724	1091661	1086280		NC_000023.11:135985723:G:A
NM_001379110.1(SLC9A6):c.504A>G (p.Ala168=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV001089982	X	135080697	X	135998538	1089982	1086282		NC_000023.11:135998537:A:G
NM_001379110.1(SLC9A6):c.756A>G (p.Ala252=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001088012	X	135092613	X	136010454	1088012	1086284		NC_000023.11:136010453:A:G
NM_001379110.1(SLC9A6):c.-1C>T	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001083896	X	135067817	X	135985658	1083896	1086279		NC_000023.11:135985657:C:T
NM_001379110.1(SLC9A6):c.1862C>T (p.Pro621Leu)	SLC9A6	P559L, P591L, P611L, P621L, P643L	Christianson syndrome	Likely benign(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001079303	X	135126705	X	136044546	1079303	1086285		NC_000023.11:136044545:C:T
NM_001379110.1(SLC9A6):c.168T>C (p.Tyr56=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001077205	X	135067985	X	135985826	1077205	1086281		NC_000023.11:135985825:T:C
NM_001379110.1(SLC9A6):c.953G>T (p.Trp318Leu)	SLC9A6	W286L, W318L, W338L, W370L	Christianson syndrome	Pathogenic(Last reviewed: Apr 14, 2018)	criteria provided, single submitter	VCV001071193	X	135095175	X	136013016	1071193	1065164		NC_000023.11:136013015:G:T
NM_001379110.1(SLC9A6):c.1958G>T (p.Arg653Leu)	SLC9A6	R591L, R623L, R643L, R653L, R675L	Christianson syndrome	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001062923	X	135126801	X	136044642	1062923	1052284		NC_000023.11:136044641:G:T
NM_001379110.1(SLC9A6):c.-56-4G>T	SLC9A6	A33S	Christianson syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001062813	X	135067758	X	135985599	1062813	1052278		NC_000023.11:135985598:G:T
NM_001379110.1(SLC9A6):c.239G>A (p.Ser80Asn)	SLC9A6	S132N, S80N	Christianson syndrome	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001061252	X	135077014	X	135994855	1061252	1052280		NC_000023.11:135994854:G:A
NM_001379110.1(SLC9A6):c.525G>A (p.Gly175=)	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV001060414	X	135081015	X	135998856	1060414	1052281		NC_000023.11:135998855:G:A
NM_001379110.1(SLC9A6):c.212C>T (p.Pro71Leu)	SLC9A6	P123L, P71L	Christianson syndrome	Uncertain significance(Last reviewed: Apr 5, 2020)	criteria provided, single submitter	VCV001054385	X	135076987	X	135994828	1054385	1052279		NC_000023.11:135994827:C:T
NM_001379110.1(SLC9A6):c.1157A>G (p.Asn386Ser)	SLC9A6	N354S, N386S, N406S, N438S	Christianson syndrome	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001052390	X	135098880	X	136016721	1052390	1052283		NC_000023.11:136016720:A:G
NM_001379110.1(SLC9A6):c.634C>G (p.Pro212Ala)	SLC9A6	P180A, P212A, P232A, P264A	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV001052092	X	135081124	X	135998965	1052092	1052282		NC_000023.11:135998964:C:G
NM_001379110.1(SLC9A6):c.-57+62C>T	SLC9A6	R13C	Christianson syndrome	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001040525	X	135067698	X	135985539	1040525	1035362		NC_000023.11:135985538:C:T
NM_001379110.1(SLC9A6):c.1876G>A (p.Ala626Thr)	SLC9A6	A596T, A564T, A616T, A648T, A626T	Christianson syndrome	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001038955	X	135126719	X	136044560	1038955	1035364		NC_000023.11:136044559:G:A
NM_001379110.1(SLC9A6):c.1420G>T (p.Gly474Cys)	SLC9A6	G474C, G442C, G526C, G494C	Christianson syndrome	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001035423	X	135106602	X	136024443	1035423	1035363		NC_000023.11:136024442:G:T
NM_001379110.1(SLC9A6):c.1080+17A>G	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV001032437	X	135095613	X	136013454	1032437	1022140		NC_000023.11:136013453:A:G
NM_001379110.1(SLC9A6):c.-57+50G>C	SLC9A6	A9P	Christianson syndrome	Uncertain significance(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV001030062	X	135067686	X	135985527	1030062	1018913		NC_000023.11:135985526:G:C
NM_001379110.1(SLC9A6):c.1711C>T (p.Leu571Phe)	SLC9A6	L509F, L541F, L561F, L571F, L593F	Christianson syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001025118	X	135122284	X	136040125	1025118	1014770		NC_000023.11:136040124:C:T
NM_001379110.1(SLC9A6):c.2018A>G (p.Asn673Ser)	SLC9A6	N611S, N643S, N663S, N673S, N695S	Christianson syndrome	Uncertain significance(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001020226	X	135126861	X	136044702	1020226	1014772		NC_000023.11:136044701:A:G
NM_001379110.1(SLC9A6):c.1768A>C (p.Asn590His)	SLC9A6	N528H, N560H, N580H, N590H, N612H	Christianson syndrome	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001014938	X	135126611	X	136044452	1014938	1014771		NC_000023.11:136044451:A:C
NM_001379110.1(SLC9A6):c.461G>A (p.Arg154Gln)	SLC9A6	R122Q, R154Q, R174Q, R206Q	Christianson syndrome	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001014912	X	135080654	X	135998495	1014912	1014769		NC_000023.11:135998494:G:A
NM_001379110.1(SLC9A6):c.1765G>A (p.Glu589Lys)	SLC9A6	E527K, E559K, E579K, E589K, E611K	Christianson syndrome	Uncertain significance(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV001006408	X	135122338	X	136040179	1006408	999622		NC_000023.11:136040178:G:A
NM_001379110.1(SLC9A6):c.982G>A (p.Gly328Ser)	SLC9A6	G296S, G328S, G348S, G380S	Christianson syndrome	Uncertain significance(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV001005501	X	135095204	X	136013045	1005501	999621		NC_000023.11:136013044:G:A
NM_001379110.1(SLC9A6):c.885+5C>T	SLC9A6		not provided|Christianson syndrome	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV001002023	X	135092747	X	136010588	1002023	999620		NC_000023.11:136010587:C:T
NM_001379110.1(SLC9A6):c.821T>C (p.Ile274Thr)	SLC9A6	I242T, I274T, I294T, I326T	Christianson syndrome	Uncertain significance(Last reviewed: Aug 6, 2020)	no assertion criteria provided	VCV000988730	X	135092678	X	136010519	988730	976679		NC_000023.11:136010518:T:C
NM_001379110.1(SLC9A6):c.506T>A (p.Ile169Asn)	SLC9A6	I137N, I169N, I189N, I221N	Christianson syndrome	Uncertain significance(Last reviewed: Jun 3, 2020)	no assertion criteria provided	VCV000988715	X	135080699	X	135998540	988715	976678		NC_000023.11:135998539:T:A
NM_001379110.1(SLC9A6):c.992-3T>C	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000969959	X	135095505	X	136013346	969959	960973		NC_000023.11:136013345:T:C
NM_001379110.1(SLC9A6):c.13A>C (p.Ile5Leu)	SLC9A6	I57L, I5L	Christianson syndrome	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000964337	X	135067830	X	135985671	964337	951617		NC_000023.11:135985670:A:C
NM_001379110.1(SLC9A6):c.1832C>T (p.Thr611Ile)	SLC9A6	T581I, T633I, T549I, T611I, T601I	Christianson syndrome	Uncertain significance(Last reviewed: Jul 28, 2019)	criteria provided, single submitter	VCV000963236	X	135126675	X	136044516	963236	951619		NC_000023.11:136044515:C:T
NM_001379110.1(SLC9A6):c.1727G>A (p.Gly576Glu)	SLC9A6	G514E, G546E, G598E, G566E, G576E	Christianson syndrome	Uncertain significance(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000959999	X	135122300	X	136040141	959999	951618		NC_000023.11:136040140:G:A
NM_001379110.1(SLC9A6):c.1582G>A (p.Gly528Ser)	SLC9A6	G466S, G518S, G550S, G498S, G528S	Christianson syndrome	Uncertain significance(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000951462	X	135115573	X	136033414	951462	929575		NC_000023.11:136033413:G:A
NM_001379110.1(SLC9A6):c.971C>T (p.Ala324Val)	SLC9A6	A344V, A324V, A376V, A292V	Christianson syndrome	Uncertain significance(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000950702	X	135095193	X	136013034	950702	929573		NC_000023.11:136013033:C:T
NM_001379110.1(SLC9A6):c.1996C>T (p.Pro666Ser)	SLC9A6	P636S, P656S, P604S, P688S, P666S	Christianson syndrome	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000945766	X	135126839	X	136044680	945766	929576		NC_000023.11:136044679:C:T
NM_001379110.1(SLC9A6):c.1555G>A (p.Gly519Ser)	SLC9A6	G519S, G457S, G489S, G509S, G541S	Christianson syndrome	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000943113	X	135112295	X	136030136	943113	939444		NC_000023.11:136030135:G:A
NM_001379110.1(SLC9A6):c.548C>T (p.Thr183Met)	SLC9A6	T183M, T203M, T235M, T151M	Intellectual disability|Christianson syndrome	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000942247	X	135081038	X	135998879	942247	939443		NC_000023.11:135998878:C:T
NM_001379110.1(SLC9A6):c.-56-21C>A	SLC9A6	P27H	Christianson syndrome	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000940098	X	135067741	X	135985582	940098	939442		NC_000023.11:135985581:C:A
NM_001379110.1(SLC9A6):c.-57+26A>G	SLC9A6	M1V	Christianson syndrome|Neurodevelopmental disorder	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000853911	X	135067662	X	135985503	853911	849665		NC_000023.11:135985502:A:G
NM_001379110.1(SLC9A6):c.1934T>G (p.Phe645Cys)	SLC9A6	F583C, F635C, F667C, F615C, F645C	Christianson syndrome	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000834464	X	135126777	X	136044618	834464	849666		NC_000023.11:136044617:T:G
NM_001379110.1(SLC9A6):c.992G>A (p.Gly331Asp)	SLC9A6	G383D, G299D, G331D, G351D	Christianson syndrome	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000813744	X	135095508	X	136013349	813744	802043	rs782108464	NC_000023.11:136013348:G:A
NM_001379110.1(SLC9A6):c.524+3A>G	SLC9A6		Christianson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2020)	criteria provided, conflicting interpretations	VCV000805479	X	135080720	X	135998561	805479	794082	rs372679456	NC_000023.11:135998560:A:G
NM_001379110.1(SLC9A6):c.1566A>C (p.Ser522=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000794285	X	135112306	X	136030147	794285	786706	rs781843930	NC_000023.11:136030146:A:C
NM_001379110.1(SLC9A6):c.2031T>A (p.Gly677=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000765727	X	135126874	X	136044715	765727	773770	rs1603225948	NC_000023.11:136044714:T:A
NM_001379110.1(SLC9A6):c.549G>A (p.Thr183=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000752199	X	135081039	X	135998880	752199	773769	rs782386487	NC_000023.11:135998879:G:A
NM_001379110.1(SLC9A6):c.213G>A (p.Pro71=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000744117	X	135076988	X	135994829	744117	758301	rs782600941	NC_000023.11:135994828:G:A
NM_001379110.1(SLC9A6):c.744-7T>C	SLC9A6		Christianson syndrome|not provided	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000701274	X	135092594	X	136010435	701274	690253	rs1556618483	NC_000023.11:136010434:T:C
NM_001379110.1(SLC9A6):c.1038G>T (p.Thr346=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000669532	X	135095554	X	136013395	669532	656732	rs782783023	NC_000023.11:136013394:G:T
NM_001379110.1(SLC9A6):c.-57+32C>T	SLC9A6	R3W	Christianson syndrome	Uncertain significance(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000657261	X	135067668	X	135985509	657261	649712	rs1556614701	NC_000023.11:135985508:C:T
NM_001379110.1(SLC9A6):c.483A>G (p.Ala161=)	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000656614	X	135080676	X	135998517	656614	649715	rs781961294	NC_000023.11:135998516:A:G
NM_001379110.1(SLC9A6):c.393T>G (p.Phe131Leu)	SLC9A6	F183L, F131L, F151L, F99L	Christianson syndrome	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000647660	X	135080290	X	135998131	647660	649714	rs1603198044	NC_000023.11:135998130:T:G
NM_001379110.1(SLC9A6):c.652A>G (p.Ile218Val)	SLC9A6	I270V, I186V, I218V, I238V	Christianson syndrome	Uncertain significance(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000646158	X	135084281	X	136002122	646158	649716	rs782677140	NC_000023.11:136002121:A:G
NM_001379110.1(SLC9A6):c.1307-1G>A	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000625179	X	135106488	X	136024329	625179	613522	rs1603215383	NC_000023.11:136024328:G:A
NM_001379110.1(SLC9A6):c.1833A>T (p.Thr611=)	SLC9A6		Christianson syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589925	X	135126676	X	136044517	589925	580775	rs782629258	NC_000023.11:136044516:A:T
NM_001379110.1(SLC9A6):c.1316G>A (p.Gly439Asp)	SLC9A6	G459D, G491D, G439D, G407D	Christianson syndrome	Likely pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000577815	X	135106498	X	136024339	577815	573553	rs1569525357	NC_000023.11:136024338:G:A
NM_001379110.1(SLC9A6):c.559G>A (p.Val187Ile)	SLC9A6	V207I, V239I, V155I, V187I	Christianson syndrome	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000575064	X	135081049	X	135998890	575064	575333	rs1556616995	NC_000023.11:135998889:G:A
NM_001379110.1(SLC9A6):c.-57+33G>T	SLC9A6	R3L	Christianson syndrome	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000572609	X	135067669	X	135985510	572609	572224	rs1016216648	NC_000023.11:135985509:G:T
NM_001379110.1(SLC9A6):c.1873A>G (p.Ser625Gly)	SLC9A6	S647G, S615G, S563G, S595G, S625G	Christianson syndrome	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000537363	X	135126716	X	136044557	537363	534533	rs558960349	NC_000023.11:136044556:A:G
NM_001379110.1(SLC9A6):c.1460+6T>C	SLC9A6		not provided|Christianson syndrome	Benign/Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516674	X	135106648	X	136024489	516674	508507	rs781963949	NC_000023.11:136024488:T:C
NM_001379110.1(SLC9A6):c.852A>T (p.Ala284=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000512180	X	135092709	X	136010550	512180	507738	rs371472909	NC_000023.11:136010549:A:T
NM_001379110.1(SLC9A6):c.1038G>A (p.Thr346=)	SLC9A6		not specified|Christianson syndrome	Likely benign(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000511385	X	135095554	X	136013395	511385	507852	rs782783023	NC_000023.11:136013394:G:A
NM_001379110.1(SLC9A6):c.886G>A (p.Val296Met)	SLC9A6	V316M, V348M, V296M, V264M	Christianson syndrome	Uncertain significance(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000469638	X	135095108	X	136012949	469638	471285	rs1556618832	NC_000023.11:136012948:G:A
NM_001379110.1(SLC9A6):c.516C>T (p.Phe172=)	SLC9A6		Christianson syndrome|not specified	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000469637	X	135080709	X	135998550	469637	472065	rs1423014570	NC_000023.11:135998549:C:T
NM_001379110.1(SLC9A6):c.425A>G (p.Tyr142Cys)	SLC9A6	Y162C, Y194C, Y110C, Y142C	Christianson syndrome	Uncertain significance(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000469636	X	135080322	X	135998163	469636	471722	rs1556616834	NC_000023.11:135998162:A:G
NM_001379110.1(SLC9A6):c.113T>C (p.Leu38Pro)	SLC9A6	L90P, L38P	Christianson syndrome	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000469635	X	135067930	X	135985771	469635	472064	rs1556614843	NC_000023.11:135985770:T:C
NM_001379110.1(SLC9A6):c.1428C>T (p.Gly476=)	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000469634	X	135106610	X	136024451	469634	471288	rs782370742	NC_000023.11:136024450:C:T
NM_001379110.1(SLC9A6):c.1164C>T (p.Val388=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000469633	X	135098887	X	136016728	469633	471736	rs1556619315	NC_000023.11:136016727:C:T
NM_001379110.1(SLC9A6):c.1083G>A (p.Leu361=)	SLC9A6		History of neurodevelopmental disorder|not provided|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000469632	X	135098806	X	136016647	469632	471733	rs151178361	NC_000023.11:136016646:G:A
NM_001379110.1(SLC9A6):c.262A>G (p.Thr88Ala)	SLC9A6	T140A, T88A	not provided|Christianson syndrome	Uncertain significance(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000450434	X	135077037	X	135994878	450434	446504	rs372003999	NC_000023.11:135994877:A:G
NM_001379110.1(SLC9A6):c.1768-6A>G	SLC9A6		Christianson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2020)	criteria provided, conflicting interpretations	VCV000436774	X	135126605	X	136044446	436774	430654	rs1556623179	NC_000023.11:136044445:A:G
NM_001379110.1(SLC9A6):c.743+1G>A	SLC9A6		Christianson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432837	X	135084373	X	136002214	432837	426407	rs1556617455	NC_000023.11:136002213:G:A
NM_001379110.1(SLC9A6):c.-20G>A	SLC9A6	G46D	not provided|Christianson syndrome	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000429629	X	135067798	X	135985639	429629	422416	rs782736274	NC_000023.11:135985638:G:A
NM_001379110.1(SLC9A6):c.1698G>A (p.Pro566=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000415903	X	135122271	X	136040112	415903	404493	rs1060504687	NC_000023.11:136040111:G:A
NM_001379110.1(SLC9A6):c.228T>C (p.Asn76=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000415902	X	135077003	X	135994844	415902	404086	rs782529317	NC_000023.11:135994843:T:C
NM_001379110.1(SLC9A6):c.960C>G (p.Thr320=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000415901	X	135095182	X	136013023	415901	404491	rs1060504686	NC_000023.11:136013022:C:G
NM_001379110.1(SLC9A6):c.603A>G (p.Leu201=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000415900	X	135081093	X	135998934	415900	404448	rs1060504685	NC_000023.11:135998933:A:G
NM_001379110.1(SLC9A6):c.1081-8C>T	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000415899	X	135098796	X	136016637	415899	404453	rs1060504684	NC_000023.11:136016636:C:T
NM_001379110.1(SLC9A6):c.206A>G (p.His69Arg)	SLC9A6	H121R, H69R	Christianson syndrome	Uncertain significance(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000409978	X	135076981	X	135994822	409978	404120	rs1060502675	NC_000023.11:135994821:A:G
NM_001379110.1(SLC9A6):c.-4A>G	SLC9A6		Christianson syndrome|not specified|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000389505	X	135067814	X	135985655	389505	379920	rs782090744	NC_000023.11:135985654:A:G
NM_001379110.1(SLC9A6):c.1143G>A (p.Leu381=)	SLC9A6		not specified|Christianson syndrome	Likely benign(Last reviewed: Aug 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000388591	X	135098866	X	136016707	388591	378895	rs782501407	NC_000023.11:136016706:G:A
NM_001379110.1(SLC9A6):c.-57+27T>G	SLC9A6	M1R	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Mar 24, 2021)	reviewed by expert panel	VCV000383439	X	135067663	X	135985504	383439	378886	rs1006154022	NC_000023.11:135985503:T:G
NM_001379110.1(SLC9A6):c.57C>T (p.Ser19=)	SLC9A6		Christianson syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379773	X	135067874	X	135985715	379773	378892	rs781963863	NC_000023.11:135985714:C:T
NM_001379110.1(SLC9A6):c.638-5A>G	SLC9A6		not specified|Christianson syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2020)	criteria provided, conflicting interpretations	VCV000379485	X	135084262	X	136002103	379485	377791	rs1057520615	NC_000023.11:136002102:A:G
NM_001379110.1(SLC9A6):c.15C>G (p.Ile5Met)	SLC9A6	I57M, I5M	not provided|Christianson syndrome	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000379120	X	135067832	X	135985673	379120	377787	rs782296172	NC_000023.11:135985672:C:G
NM_001379110.1(SLC9A6):c.1434T>C (p.Thr478=)	SLC9A6		Christianson syndrome|not specified|not provided	Likely benign(Last reviewed: Sep 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000378619	X	135106616	X	136024457	378619	377800	rs1057520374	NC_000023.11:136024456:T:C
NM_001379110.1(SLC9A6):c.2001G>A (p.Pro667=)	SLC9A6		Christianson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2020)	criteria provided, conflicting interpretations	VCV000282218	X	135126844	X	136044685	282218	266455	rs782708610	NC_000023.11:136044684:G:A
NM_001379110.1(SLC9A6):c.2021C>T (p.Thr674Met)	SLC9A6	T696M, T664M, T612M, T644M, T674M	not provided|Christianson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2020)	criteria provided, conflicting interpretations	VCV000281815	X	135126864	X	136044705	281815	266052	rs886044780	NC_000023.11:136044704:C:T
NM_001379110.1(SLC9A6):c.1588C>A (p.Pro530Thr)	SLC9A6	P520T, P552T, P468T, P500T, P530T	not provided|Christianson syndrome	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207253	X	135115579	X	136033420	207253	203997	rs782145804	NC_000023.11:136033419:C:A
NM_001379110.1(SLC9A6):c.563C>T (p.Thr188Met)	SLC9A6	T208M, T240M, T188M, T156M	not provided|Christianson syndrome	Uncertain significance(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207252	X	135081053	X	135998894	207252	203992	rs372747388	NC_000023.11:135998893:C:T
NM_001379110.1(SLC9A6):c.-9G>T	SLC9A6	A50S	Christianson syndrome|not provided	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000207247	X	135067809	X	135985650	207247	203981	rs367724979	NC_000023.11:135985649:G:T
NM_001379110.1(SLC9A6):c.487G>A (p.Ala163Thr)	SLC9A6	A183T, A215T, A163T, A131T	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000207239	X	135080680	X	135998521	207239	203988	rs796053281	NC_000023.11:135998520:G:A
NM_001379110.1(SLC9A6):c.448A>G (p.Arg150Gly)	SLC9A6	R170G, R202G, R118G, R150G	not provided|Christianson syndrome	Uncertain significance(Last reviewed: Sep 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207238	X	135080641	X	135998482	207238	203986	rs796053280	NC_000023.11:135998481:A:G
NM_001379110.1(SLC9A6):c.1287A>G (p.Gln429=)	SLC9A6		not specified|not provided|Christianson syndrome	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207234	X	135104837	X	136022678	207234	203996	rs142161862	NC_000023.11:136022677:A:G
NM_001379110.1(SLC9A6):c.452A>T (p.His151Leu)	SLC9A6	H171L, H203L, H151L, H119L	not specified|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2020)	criteria provided, conflicting interpretations	VCV000207233	X	135080645	X	135998486	207233	203987	rs796053275	NC_000023.11:135998485:A:T
NM_001379110.1(SLC9A6):c.825C>G (p.Phe275Leu)	SLC9A6	F327L, F295L, F243L, F275L	Christianson syndrome|not provided	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198540	X	135092682	X	136010523	198540	195701	rs797044779	NC_000023.11:136010522:C:G
NM_001379110.1(SLC9A6):c.448-1G>A	SLC9A6		not provided|Christianson syndrome	Pathogenic(Last reviewed: Mar 2, 2021)	reviewed by expert panel	VCV000167702	X	135080640	X	135998481	167702	178080	rs797044508	NC_000023.11:135998480:G:A
NM_001379110.1(SLC9A6):c.529A>G (p.Ile177Val)	SLC9A6	I229V, I145V, I197V, I177V	Christianson syndrome	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	VCV000159936	X	135081019	X	135998860	159936	169941	rs587784402	NC_000023.11:135998859:A:G
NM_001379110.1(SLC9A6):c.256A>G (p.Ser86Gly)	SLC9A6	S138G, S86G	Christianson syndrome	Uncertain significance(Last reviewed: Aug 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159935	X	135077031	X	135994872	159935	169940	rs587784401	NC_000023.11:135994871:A:G
NM_001379110.1(SLC9A6):c.211C>T (p.Pro71Ser)	SLC9A6	P123S, P71S	Christianson syndrome	Uncertain significance(Last reviewed: Jul 16, 2013)	criteria provided, single submitter	VCV000159934	X	135076986	X	135994827	159934	169939	rs587784400	NC_000023.11:135994826:C:T
NM_001379110.1(SLC9A6):c.-57+50G>T	SLC9A6	A9S	History of neurodevelopmental disorder|not specified|Christianson syndrome|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000159933	X	135067686	X	135985527	159933	169937	rs201523857	NC_000023.11:135985526:G:T
NM_001379110.1(SLC9A6):c.2012T>G (p.Leu671Ter)	SLC9A6	L693*, L641*, L609*, L661*, L671*	Christianson syndrome	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	VCV000159932	X	135126855	X	136044696	159932	169942	rs587784399	NC_000023.11:136044695:T:G
NM_001379110.1(SLC9A6):c.-16C>T	SLC9A6		not provided|Christianson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 8, 2020)	criteria provided, conflicting interpretations	VCV000139211	X	135067802	X	135985643	139211	142914	rs139299794	NC_000023.11:135985642:C:T
NM_001379110.1(SLC9A6):c.*8A>T	SLC9A6		History of neurodevelopmental disorder|Intellectual disability|not specified|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000139210	X	135126891	X	136044732	139210	142913	rs200171451	NC_000023.11:136044731:A:T
NM_001379110.1(SLC9A6):c.1689C>T (p.Ser563=)	SLC9A6		Christianson syndrome|History of neurodevelopmental disorder|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139209	X	135122262	X	136040103	139209	142912	rs2307131	NC_000023.11:136040102:C:T
NM_001379110.1(SLC9A6):c.1662-4G>A	SLC9A6		Christianson syndrome|History of neurodevelopmental disorder|not specified|not provided	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139208	X	135122231	X	136040072	139208	142911	rs188072063	NC_000023.11:136040071:G:A
NM_001379110.1(SLC9A6):c.1637G>A (p.Arg546Gln)	SLC9A6	R568Q, R536Q, R516Q, R484Q, R546Q	not specified|Intellectual disability|not provided|Christianson syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139207	X	135115628	X	136033469	139207	142910	rs146263125	NC_000023.11:136033468:G:A
NM_001379110.1(SLC9A6):c.1582-3C>T	SLC9A6		Christianson syndrome|not specified|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000139206	X	135115570	X	136033411	139206	142909	rs563279759	NC_000023.11:136033410:C:T
NM_001379110.1(SLC9A6):c.1460+10A>G	SLC9A6		Christianson syndrome|not specified	Benign(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139204	X	135106652	X	136024493	139204	142907	rs185533973	NC_000023.11:136024492:A:G
NM_001379110.1(SLC9A6):c.1029A>C (p.Ala343=)	SLC9A6		History of neurodevelopmental disorder|Christianson syndrome|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139203	X	135095545	X	136013386	139203	142906	rs142049079	NC_000023.11:136013385:A:C
NM_001379110.1(SLC9A6):c.744-6C>T	SLC9A6		not specified|Christianson syndrome	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139201	X	135092595	X	136010436	139201	142904	rs17001258	NC_000023.11:136010435:C:T
NM_001379110.1(SLC9A6):c.474T>C (p.Ser158=)	SLC9A6		History of neurodevelopmental disorder|not specified|Christianson syndrome	Benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139200	X	135080667	X	135998508	139200	142903	rs144316388	NC_000023.11:135998507:T:C
NM_001379110.1(SLC9A6):c.916C>T (p.Gln306Ter)	SLC9A6	Q326*, Q358*, Q274*, Q306*	not provided|Christianson syndrome	Pathogenic(Last reviewed: Feb 10, 2021)	reviewed by expert panel	VCV000095378	X	135095138	X	136012979	95378	101277	rs398124224	NC_000023.11:136012978:C:T
NM_001379110.1(SLC9A6):c.1460+4A>G	SLC9A6		History of neurodevelopmental disorder|Christianson syndrome|not specified|not provided	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095376	X	135106646	X	136024487	95376	101275	rs180727016	NC_000023.11:136024486:A:G
NM_001379110.1(SLC9A6):c.1306+8G>A	SLC9A6		not specified|Christianson syndrome	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095375	X	135104864	X	136022705	95375	101274	rs6654310	NC_000023.11:136022704:G:A
NM_001379110.1(SLC9A6):c.1573G>T (p.Glu525Ter)	SLC9A6	E547*, E463*, E495*, E515*, E525*	Christianson syndrome	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000092121	X	135112313	X	136030154	92121	97547	rs398123003	NC_000023.11:136030153:G:T
NM_001379110.1(SLC9A6):c.1342C>T (p.Arg448Ter)	SLC9A6	R468*, R448*, R500*, R416*	Christianson syndrome|not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000011477	X	135106524	X	136024365	11477	26516	rs122461162	NC_000023.11:136024364:C:T
NM_003079.5(SMARCE1):c.237+1G>T	SMARCE1		Coffin-Siris syndrome 5	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666261	17	38793743	17	40637491	666261	653822	rs1426841589	NC_000017.11:40637490:C:A
NM_130839.5(UBE3A):c.2547C>G (p.Tyr849Ter)	SNHG14|UBE3A	Y412*, Y432*, Y774*, Y777*, Y790*, Y797*, Y829*, Y849*, Y852*	Angelman syndrome	Likely pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001285431	15	25584356	15	25339209	1285431	1275274		NC_000015.10:25339208:G:C
NM_130839.5(UBE3A):c.807G>A (p.Thr269=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001117017	15	25616514	15	25371367	1117017	1102754		NC_000015.10:25371366:C:T
NM_130839.5(UBE3A):c.858C>T (p.Ile286=)	SNHG14|UBE3A		not provided|Angelman syndrome	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV001114731	15	25616463	15	25371316	1114731	1102753		NC_000015.10:25371315:G:A
NM_130839.5(UBE3A):c.2313A>G (p.Thr771=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV001112990	15	25599541	15	25354394	1112990	1102750		NC_000015.10:25354393:T:C
NM_130839.5(UBE3A):c.961C>T (p.Leu321=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001106558	15	25616360	15	25371213	1106558	1102752		NC_000015.10:25371212:G:A
NM_130839.5(UBE3A):c.303C>T (p.Pro101=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001101100	15	25620670	15	25375523	1101100	1102755		NC_000015.10:25375522:G:A
NM_130839.5(UBE3A):c.270C>T (p.Ser90=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV001093909	15	25620703	15	25375556	1093909	1080915		NC_000015.10:25375555:G:A
NM_130839.5(UBE3A):c.62+9A>G	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV001088843	15	25650599	15	25405452	1088843	1080917		NC_000015.10:25405451:T:C
NM_130839.5(UBE3A):c.81G>A (p.Lys27=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001082932	15	25620892	15	25375745	1082932	1080916		NC_000015.10:25375744:C:T
NM_130839.5(UBE3A):c.618A>G (p.Ala206=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Feb 24, 2019)	criteria provided, single submitter	VCV001081593	15	25616703	15	25371556	1081593	1080912		NC_000015.10:25371555:T:C
NM_130839.5(UBE3A):c.444T>G (p.Arg148=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001080162	15	25616877	15	25371730	1080162	1080914		NC_000015.10:25371729:A:C
NM_130839.5(UBE3A):c.2423G>A (p.Gly808Asp)	SNHG14|UBE3A	G371D, G391D, G733D, G736D, G749D, G756D, G788D, G808D, G811D	Angelman syndrome	Likely pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001067820	15	25585307	15	25340160	1067820	1056209		NC_000015.10:25340159:C:T
NM_130839.5(UBE3A):c.238T>C (p.Cys80Arg)	SNHG14|UBE3A	C21R, C60R, C80R, C83R	Angelman syndrome	Likely pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV001066645	15	25620735	15	25375588	1066645	1056210		NC_000015.10:25375587:A:G
NM_130839.5(UBE3A):c.1960G>C (p.Val654Leu)	SNHG14|UBE3A	V217L, V237L, V595L, V634L, V654L, V657L	Angelman syndrome	Pathogenic	no assertion criteria provided	VCV001064603	15	25601203	15	25356056	1064603	1052867		NC_000015.10:25356055:C:G
NM_130839.5(UBE3A):c.361+6A>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001059360	15	25620606	15	25375459	1059360	1048816		NC_000015.10:25375458:T:C
NM_130839.5(UBE3A):c.1477G>A (p.Asp493Asn)	SNHG14|UBE3A	D493N, D434N, D496N, D473N	Angelman syndrome	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001046274	15	25615844	15	25370697	1046274	1031868		NC_000015.10:25370696:C:T
NM_130839.5(UBE3A):c.2416A>G (p.Thr806Ala)	SNHG14|UBE3A	T734A, T747A, T809A, T389A, T754A, T369A, T731A, T786A, T806A	Angelman syndrome	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001043090	15	25585314	15	25340167	1043090	1031865		NC_000015.10:25340166:T:C
NM_130839.5(UBE3A):c.2181C>G (p.Phe727Leu)	SNHG14|UBE3A	F668L, F290L, F727L, F652L, F707L, F310L, F730L	Angelman syndrome	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001038124	15	25599774	15	25354627	1038124	1031866		NC_000015.10:25354626:G:C
NM_130839.5(UBE3A):c.790G>A (p.Val264Met)	SNHG14|UBE3A	V244M, V267M, V205M, V264M	Angelman syndrome	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001036134	15	25616531	15	25371384	1036134	1031869		NC_000015.10:25371383:C:T
NM_130839.5(UBE3A):c.511A>T (p.Thr171Ser)	SNHG14|UBE3A	T112S, T151S, T174S, T171S	Angelman syndrome	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001035320	15	25616810	15	25371663	1035320	1031870		NC_000015.10:25371662:T:A
NM_130839.5(UBE3A):c.2498+3A>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001018622	15	25585229	15	25340082	1018622	1011362		NC_000015.10:25340081:T:C
NM_130839.5(UBE3A):c.1153G>T (p.Val385Leu)	SNHG14|UBE3A	V326L, V365L, V385L, V388L	not provided|Angelman syndrome	Uncertain significance(Last reviewed: Apr 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV001018602	15	25616168	15	25371021	1018602	1011364		NC_000015.10:25371020:C:A
NM_130839.5(UBE3A):c.1221G>A (p.Gln407=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Jan 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001013058	15	25616100	15	25370953	1013058	1000886		NC_000015.10:25370952:C:T
NM_130839.5(UBE3A):c.835A>G (p.Asn279Asp)	SNHG14|UBE3A	N220D, N259D, N279D, N282D	Angelman syndrome	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001011080	15	25616486	15	25371339	1011080	996129		NC_000015.10:25371338:T:C
NM_130839.5(UBE3A):c.131A>C (p.Glu44Ala)	SNHG14|UBE3A	E24A, E44A, E47A	Angelman syndrome	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001009993	15	25620842	15	25375695	1009993	996130		NC_000015.10:25375694:T:G
NM_130839.5(UBE3A):c.853A>G (p.Ile285Val)	SNHG14|UBE3A	I226V, I265V, I285V, I288V	Angelman syndrome	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001008821	15	25616468	15	25371321	1008821	996128		NC_000015.10:25371320:T:C
NM_130839.5(UBE3A):c.1937G>T (p.Arg646Leu)	SNHG14|UBE3A	R209L, R229L, R587L, R626L, R646L, R649L	Angelman syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001007836	15	25601860	15	25356713	1007836	996126		NC_000015.10:25356712:C:A
NM_130839.5(UBE3A):c.916T>A (p.Phe306Ile)	SNHG14|UBE3A	F247I, F286I, F306I, F309I	Angelman syndrome	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001006109	15	25616405	15	25371258	1006109	996127		NC_000015.10:25371257:A:T
NM_130839.5(UBE3A):c.2033A>G (p.Gln678Arg)	SNHG14|UBE3A	Q241R, Q261R, Q619R, Q658R, Q678R, Q681R	Angelman syndrome	Likely pathogenic	criteria provided, single submitter	VCV000981483	15	25601130	15	25355983	981483	969569		NC_000015.10:25355982:T:C
NM_130839.5(UBE3A):c.826C>A (p.Arg276=)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000963514	15	25616495	15	25371348	963514	948781		NC_000015.10:25371347:G:T
NM_130839.5(UBE3A):c.400C>A (p.Leu134Ile)	SNHG14|UBE3A	L134I, L114I, L137I, L75I	Angelman syndrome	Uncertain significance(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000954947	15	25616921	15	25371774	954947	948783		NC_000015.10:25371773:G:T
NM_130839.5(UBE3A):c.659A>G (p.Asn220Ser)	SNHG14|UBE3A	N161S, N223S, N200S, N220S	Angelman syndrome	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000949921	15	25616662	15	25371515	949921	927259		NC_000015.10:25371514:T:C
NM_130839.5(UBE3A):c.295G>T (p.Gly99Cys)	SNHG14|UBE3A	G40C, G99C, G79C, G102C	not provided|Angelman syndrome	Uncertain significance(Last reviewed: Jun 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000945944	15	25620678	15	25375531	945944	927260		NC_000015.10:25375530:C:A
NM_130839.5(UBE3A):c.172C>T (p.Leu58Phe)	SNHG14|UBE3A	L38F, L58F, L61F	Angelman syndrome	Uncertain significance(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000937562	15	25620801	15	25375654	937562	936831		NC_000015.10:25375653:G:A
NM_130839.5(UBE3A):c.147G>T (p.Glu49Asp)	SNHG14|UBE3A	E49D, E52D, E29D	Angelman syndrome	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000937339	15	25620826	15	25375679	937339	936832		NC_000015.10:25375678:C:A
NM_130839.5(UBE3A):c.2279G>A (p.Arg760Gln)	SNHG14|UBE3A	R323Q, R685Q, R701Q, R763Q, R343Q, R740Q, R760Q	Angelman syndrome	Uncertain significance(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000934467	15	25599676	15	25354529	934467	936830		NC_000015.10:25354528:C:T
NM_130839.5(UBE3A):c.2355-3T>C	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000934151	15	25585378	15	25340231	934151	940321		NC_000015.10:25340230:A:G
NM_130839.5(UBE3A):c.410G>A (p.Cys137Tyr)	SNHG14|UBE3A	C117Y, C137Y, C140Y, C78Y	Angelman syndrome	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000864774	15	25616911	15	25371764	864774	842088		NC_000015.10:25371763:C:T
NM_130839.5(UBE3A):c.1067G>A (p.Arg356Gln)	SNHG14|UBE3A	R297Q, R359Q, R356Q, R336Q	Angelman syndrome	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000858207	15	25616254	15	25371107	858207	842083		NC_000015.10:25371106:C:T
NM_130839.5(UBE3A):c.1006A>C (p.Met336Leu)	SNHG14|UBE3A	M277L, M336L, M316L, M339L	Angelman syndrome	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000857446	15	25616315	15	25371168	857446	842085		NC_000015.10:25371167:T:G
NM_130839.5(UBE3A):c.1568A>G (p.Lys523Arg)	SNHG14|UBE3A	K503R, K523R, K464R, K526R	Angelman syndrome	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000855495	15	25615753	15	25370606	855495	842081		NC_000015.10:25370605:T:C
NM_130839.5(UBE3A):c.589G>A (p.Ala197Thr)	SNHG14|UBE3A	A138T, A197T, A177T, A200T	Angelman syndrome	Uncertain significance(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000855279	15	25616732	15	25371585	855279	842087		NC_000015.10:25371584:C:T
NM_130839.5(UBE3A):c.592G>T (p.Ala198Ser)	SNHG14|UBE3A	A178S, A201S, A139S, A198S	not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 30, 2019)	criteria provided, conflicting interpretations	VCV000850340	15	25616729	15	25371582	850340	842086		NC_000015.10:25371581:C:A
NM_130839.5(UBE3A):c.343G>A (p.Ala115Thr)	SNHG14|UBE3A	A118T, A56T, A95T, A115T	Angelman syndrome	Uncertain significance(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000845079	15	25620630	15	25375483	845079	842090		NC_000015.10:25375482:C:T
NM_130839.5(UBE3A):c.161G>A (p.Cys54Tyr)	SNHG14|UBE3A	C34Y, C54Y, C57Y	Angelman syndrome	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV000838590	15	25620812	15	25375665	838590	842092		NC_000015.10:25375664:C:T
NM_130839.5(UBE3A):c.927G>A (p.Ala309=)	SNHG14|UBE3A		not provided|Angelman syndrome	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000807191	15	25616394	15	25371247	807191	797098	rs576963061	NC_000015.10:25371246:C:T
NM_130839.5(UBE3A):c.826C>T (p.Arg276Ter)	SNHG14|UBE3A	R276*, R217*, R279*, R256*	Angelman syndrome|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803059	15	25616495	15	25371348	803059	791436	rs997044541	NC_000015.10:25371347:G:A
NM_130839.5(UBE3A):c.2198G>T (p.Gly733Val)	SNHG14|UBE3A	G658V, G674V, G713V, G736V, G296V, G316V, G733V	Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803056	15	25599757	15	25354610	803056	791433	rs1595572384	NC_000015.10:25354609:C:A
NM_130839.5(UBE3A):c.883A>G (p.Ser295Gly)	SNHG14|UBE3A	S295G, S236G, S298G, S275G	Angelman syndrome	Uncertain significance(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800841	15	25616438	15	25371291	800841	788886	rs1595810000	NC_000015.10:25371290:T:C
NM_130839.5(UBE3A):c.362-10G>T	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000776866	15	25616969	15	25371822	776866	778228	rs1407383738	NC_000015.10:25371821:C:A
NM_130839.5(UBE3A):c.558T>C (p.Asp186=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000765969	15	25616763	15	25371616	765969	770057	rs1595814554	NC_000015.10:25371615:A:G
NM_130839.5(UBE3A):c.1002G>A (p.Arg334=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000765373	15	25616319	15	25371172	765373	770055	rs1595808837	NC_000015.10:25371171:C:T
NM_130839.5(UBE3A):c.1273C>T (p.Leu425=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000750387	15	25616048	15	25370901	750387	754325	rs778060771	NC_000015.10:25370900:G:A
NM_130839.5(UBE3A):c.1770T>C (p.Asp590=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000711626	15	25602027	15	25356880	711626	725924	rs781556374	NC_000015.10:25356879:A:G
NM_130839.5(UBE3A):c.1428A>G (p.Thr476=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000703061	15	25615893	15	25370746	703061	693648	rs138049263	NC_000015.10:25370745:T:C
NM_130839.5(UBE3A):c.1854G>C (p.Leu618=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Aug 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000699444	15	25601943	15	25356796	699444	688393	rs370142725	NC_000015.10:25356795:C:G
NM_130839.5(UBE3A):c.211G>T (p.Glu71Ter)	SNHG14|UBE3A	E51*, E74*, E71*, E12*	Angelman syndrome	Likely pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000692239	15	25620762	15	25375615	692239	680053	rs1207660411	NC_000015.10:25375614:C:A
NM_130839.5(UBE3A):c.425A>C (p.Asp142Ala)	SNHG14|UBE3A	D122A, D142A, D145A, D83A	Angelman syndrome	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000661226	15	25616896	15	25371749	661226	643002	rs1595815771	NC_000015.10:25371748:T:G
NM_130839.5(UBE3A):c.2444G>A (p.Gly815Glu)	SNHG14|UBE3A	G398E, G756E, G818E, G740E, G743E, G795E, G378E, G763E, G815E	Angelman syndrome	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000654655	15	25585286	15	25340139	654655	642994	rs1595375255	NC_000015.10:25340138:C:T
NM_130839.5(UBE3A):c.986A>G (p.Asn329Ser)	SNHG14|UBE3A	N270S, N329S, N309S, N332S	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000654347	15	25616335	15	25371188	654347	643000	rs556829175	NC_000015.10:25371187:T:C
NM_130839.5(UBE3A):c.1482T>C (p.Asn494=)	SNHG14|UBE3A		Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000650099	15	25615839	15	25370692	650099	642997	rs776564692	NC_000015.10:25370691:A:G
NM_130839.5(UBE3A):c.589G>T (p.Ala197Ser)	SNHG14|UBE3A	A138S, A177S, A197S, A200S	Angelman syndrome	Uncertain significance(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000650098	15	25616732	15	25371585	650098	643001	rs752711811	NC_000015.10:25371584:C:A
NM_130839.5(UBE3A):c.1060A>G (p.Asn354Asp)	SNHG14|UBE3A	N354D, N357D, N295D, N334D	Angelman syndrome	Uncertain significance(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000646776	15	25616261	15	25371114	646776	642999	rs1595808009	NC_000015.10:25371113:T:C
NM_130839.5(UBE3A):c.2003A>G (p.Asn668Ser)	SNHG14|UBE3A	N671S, N231S, N251S, N609S, N648S, N668S	Angelman syndrome	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000644506	15	25601160	15	25356013	644506	642996	rs557434570	NC_000015.10:25356012:T:C
NM_130839.5(UBE3A):c.406T>C (p.Leu136=)	SNHG14|UBE3A		Angelman syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589830	15	25616915	15	25371768	589830	579932	rs1566962877	NC_000015.10:25371767:A:G
NM_130839.5(UBE3A):c.2322C>T (p.Asp774=)	SNHG14|UBE3A		Angelman syndrome|not provided|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000588417	15	25599532	15	25354385	588417	580004	rs759095902	NC_000015.10:25354384:G:A
NM_130839.5(UBE3A):c.342C>T (p.Gly114=)	SNHG14|UBE3A		not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	VCV000581141	15	25620631	15	25375484	581141	569224	rs142726511	NC_000015.10:25375483:G:A
NM_130839.5(UBE3A):c.2030T>C (p.Phe677Ser)	SNHG14|UBE3A	F657S, F240S, F260S, F618S, F677S, F680S	Angelman syndrome	Uncertain significance(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000577325	15	25601133	15	25355986	577325	573137	rs1566894864	NC_000015.10:25355985:A:G
NM_130839.5(UBE3A):c.854T>C (p.Ile285Thr)	SNHG14|UBE3A	I265T, I226T, I285T, I288T	Angelman syndrome	Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000577015	15	25616467	15	25371320	577015	573142	rs1566959617	NC_000015.10:25371319:A:G
NM_130839.5(UBE3A):c.2604A>T (p.Gly868=)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000573621	15	25584299	15	25339152	573621	573133	rs965417906	NC_000015.10:25339151:T:A
NM_130839.5(UBE3A):c.2323G>A (p.Gly775Ser)	SNHG14|UBE3A	G755S, G716S, G700S, G703S, G775S, G338S, G778S, G358S, G723S	Angelman syndrome	Uncertain significance(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000573464	15	25599531	15	25354384	573464	568615	rs1566887391	NC_000015.10:25354383:C:T
NM_130839.5(UBE3A):c.1153G>A (p.Val385Met)	SNHG14|UBE3A	V365M, V388M, V326M, V385M	Angelman syndrome	Uncertain significance(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000571708	15	25616168	15	25371021	571708	573140	rs763388142	NC_000015.10:25371020:C:T
NM_130839.5(UBE3A):c.733T>G (p.Ser245Ala)	SNHG14|UBE3A	S225A, S186A, S245A, S248A	Angelman syndrome	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000570995	15	25616588	15	25371441	570995	569220	rs760844102	NC_000015.10:25371440:A:C
NM_130839.5(UBE3A):c.647A>C (p.Gln216Pro)	SNHG14|UBE3A	Q196P, Q216P, Q219P, Q157P	Angelman syndrome	Uncertain significance(Last reviewed: Sep 8, 2019)	criteria provided, single submitter	VCV000570862	15	25616674	15	25371527	570862	566886	rs144950303	NC_000015.10:25371526:T:G
NM_130839.5(UBE3A):c.1133C>G (p.Ala378Gly)	SNHG14|UBE3A	A358G, A319G, A378G, A381G	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Mar 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000569445	15	25616188	15	25371041	569445	568620	rs1219606975	NC_000015.10:25371040:G:C
NM_130839.5(UBE3A):c.1207G>T (p.Glu403Ter)	SNHG14|UBE3A	E383*, E344*, E403*, E406*	Angelman syndrome|not provided	Pathogenic(Last reviewed: Mar 1, 2021)	reviewed by expert panel	VCV000546267	15	25616114	15	25370967	546267	536881	rs1555400239	NC_000015.10:25370966:C:A
NM_130839.5(UBE3A):c.2162A>T (p.Lys721Ile)	SNHG14|UBE3A	K701I, K284I, K304I, K646I, K721I, K724I, K662I	Angelman syndrome	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000528367	15	25599793	15	25354646	528367	528982	rs1555389881	NC_000015.10:25354645:T:A
NM_130839.5(UBE3A):c.570G>T (p.Lys190Asn)	SNHG14|UBE3A	K170N, K193N, K131N, K190N	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Jun 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000528366	15	25616751	15	25371604	528366	528617	rs780715298	NC_000015.10:25371603:C:A
NM_130839.5(UBE3A):c.2354+10T>C	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000528360	15	25599490	15	25354343	528360	528974	rs1555389575	NC_000015.10:25354342:A:G
NM_130839.5(UBE3A):c.1945G>A (p.Gly649Arg)	SNHG14|UBE3A	G629R, G590R, G652R, G232R, G649R, G212R	not provided|Angelman syndrome|Inborn genetic diseases	Uncertain significance(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000521447	15	25601852	15	25356705	521447	512117	rs747626553	NC_000015.10:25356704:C:T
NM_130839.5(UBE3A):c.1228T>C (p.Leu410=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000517984	15	25616093	15	25370946	517984	504694	rs143310195	NC_000015.10:25370945:A:G
NM_130839.5(UBE3A):c.582A>G (p.Ala194=)	SNHG14|UBE3A		Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2018)	criteria provided, conflicting interpretations	VCV000500854	15	25616739	15	25371592	500854	492278	rs764101035	NC_000015.10:25371591:T:C
NM_130839.5(UBE3A):c.2135A>G (p.Asn712Ser)	SNHG14|UBE3A	N692S, N295S, N637S, N712S, N653S, N715S, N275S	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000500116	15	25599820	15	25354673	500116	491540	rs916720140	NC_000015.10:25354672:T:C
NM_130839.5(UBE3A):c.981A>G (p.Lys327=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000458667	15	25616340	15	25371193	458667	464796	rs1555400511	NC_000015.10:25371192:T:C
NM_130839.5(UBE3A):c.1608+1G>A	SNHG14|UBE3A		not provided	Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	VCV000449699	15	25615712	15	25370565	449699	445275	rs1555399890	NC_000015.10:25370564:C:T
NM_130839.5(UBE3A):c.1504C>T (p.Arg502Ter)	SNHG14|UBE3A	R482*, R502*, R505*, R443*	Angelman syndrome|not provided	Pathogenic(Last reviewed: Jan 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000446052	15	25615817	15	25370670	446052	439324	rs1555399937	NC_000015.10:25370669:G:A
NM_130839.5(UBE3A):c.1009A>T (p.Met337Leu)	SNHG14|UBE3A	M317L, M337L, M340L, M278L	not specified|Angelman syndrome	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437195	15	25616312	15	25371165	437195	429628	rs368318081	NC_000015.10:25371164:T:A
NM_130839.5(UBE3A):c.1169A>G (p.Asn390Ser)	SNHG14|UBE3A	N370S, N331S, N390S, N393S	not specified|Angelman syndrome	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437194	15	25616152	15	25371005	437194	429627	rs147446244	NC_000015.10:25371004:T:C
NM_130839.5(UBE3A):c.936G>A (p.Lys312=)	SNHG14|UBE3A		not specified|Angelman syndrome	Uncertain significance(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000437192	15	25616385	15	25371238	437192	429629	rs867585000	NC_000015.10:25371237:C:T
NM_130839.5(UBE3A):c.1754-4A>G	SNHG14|UBE3A		not provided|Angelman syndrome|not specified	Uncertain significance(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000437190	15	25602047	15	25356900	437190	429625	rs780429591	NC_000015.10:25356899:T:C
NM_130839.5(UBE3A):c.1577G>A (p.Arg526His)	SNHG14|UBE3A	R506H, R529H, R526H, R467H	Angelman syndrome|Inborn genetic diseases|not provided	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421257	15	25615744	15	25370597	421257	409190	rs1064795012	NC_000015.10:25370596:C:T
NM_130839.5(UBE3A):c.2125-1G>A	SNHG14|UBE3A		not provided|Angelman syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000421239	15	25599831	15	25354684	421239	409187	rs1064795001	NC_000015.10:25354683:C:T
NM_130839.5(UBE3A):c.1576C>T (p.Arg526Cys)	SNHG14|UBE3A	R506C, R529C, R467C, R526C	not provided|Angelman syndrome	Likely pathogenic(Last reviewed: Mar 25, 2021)	reviewed by expert panel	VCV000418572	15	25615745	15	25370598	418572	409191	rs1064793307	NC_000015.10:25370597:G:A
NM_130839.5(UBE3A):c.1620C>T (p.Ile540=)	SNHG14|UBE3A		Angelman syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2020)	criteria provided, conflicting interpretations	VCV000390176	15	25605663	15	25360516	390176	373993	rs1057523671	NC_000015.10:25360515:G:A
NM_130839.5(UBE3A):c.2124+8A>G	SNHG14|UBE3A		not specified|Angelman syndrome	Likely benign(Last reviewed: Jun 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000386394	15	25601031	15	25355884	386394	376319	rs1057522487	NC_000015.10:25355883:T:C
NM_130839.5(UBE3A):c.141G>A (p.Thr47=)	SNHG14|UBE3A		not specified|not provided|Angelman syndrome	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000386168	15	25620832	15	25375685	386168	373346	rs760283316	NC_000015.10:25375684:C:T
NM_130839.5(UBE3A):c.2592G>A (p.Thr864=)	SNHG14|UBE3A		not specified|Angelman syndrome	Benign/Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000378845	15	25584311	15	25339164	378845	373970	rs377110924	NC_000015.10:25339163:C:T
NM_130839.5(UBE3A):c.1272C>T (p.Pro424=)	SNHG14|UBE3A		not specified|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2019)	criteria provided, conflicting interpretations	VCV000378843	15	25616049	15	25370902	378843	373336	rs1057520392	NC_000015.10:25370901:G:A
NM_130839.5(UBE3A):c.457G>A (p.Val153Ile)	SNHG14|UBE3A	V133I, V94I, V153I, V156I	not specified|Angelman syndrome	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372667	15	25616864	15	25371717	372667	360214	rs199636913	NC_000015.10:25371716:C:T
NM_130839.5(UBE3A):c.1007T>C (p.Met336Thr)	SNHG14|UBE3A	M316T, M339T, M277T, M336T	not specified|Angelman syndrome	Likely pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000217366	15	25616314	15	25371167	217366	196439	rs863225071	NC_000015.10:25371166:A:G
NM_130839.5(UBE3A):c.1338T>C (p.Phe446=)	SNHG14|UBE3A		Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000196572	15	25615983	15	25370836	196572	193733	rs371154816	NC_000015.10:25370835:A:G
NM_130839.5(UBE3A):c.1024C>T (p.Gln342Ter)	SNHG14|UBE3A	Q322*, Q283*, Q345*, Q342*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160228	15	25616297	15	25371150	160228	169100	rs587784534	NC_000015.10:25371149:G:A
NM_130839.5(UBE3A):c.889G>T (p.Glu297Ter)	SNHG14|UBE3A	E277*, E300*, E238*, E297*	Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	VCV000160227	15	25616432	15	25371285	160227	169101	rs587784533	NC_000015.10:25371284:C:A
NM_130839.5(UBE3A):c.2609G>A (p.Gly870Asp)	SNHG14|UBE3A	G850D, G433D, G811D, G818D, G453D, G795D, G798D, G870D, G873D	not provided|Angelman syndrome	Uncertain significance(Last reviewed: Jan 15, 2014)	criteria provided, multiple submitters, no conflicts	VCV000160221	15	25584294	15	25339147	160221	169077	rs587784528	NC_000015.10:25339146:C:T
NM_130839.5(UBE3A):c.2545T>C (p.Tyr849His)	SNHG14|UBE3A	Y829H, Y774H, Y852H, Y432H, Y849H, Y412H, Y777H, Y790H, Y797H	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160219	15	25584358	15	25339211	160219	169079	rs587784526	NC_000015.10:25339210:A:G
NM_130839.5(UBE3A):c.1881T>C (p.Asp627=)	SNHG14|UBE3A		Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2020)	criteria provided, conflicting interpretations	VCV000160215	15	25601916	15	25356769	160215	169083	rs587784522	NC_000015.10:25356768:A:G
NM_130839.5(UBE3A):c.1865A>G (p.Asn622Ser)	SNHG14|UBE3A	N602S, N563S, N625S, N185S, N205S, N622S	Angelman syndrome|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2016)	criteria provided, conflicting interpretations	VCV000160214	15	25601932	15	25356785	160214	169084	rs587784521	NC_000015.10:25356784:T:C
NM_130839.5(UBE3A):c.1823A>G (p.Gln608Arg)	SNHG14|UBE3A	Q588R, Q608R, Q611R, Q171R, Q191R, Q549R	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160212	15	25601974	15	25356827	160212	169086	rs587782919	NC_000015.10:25356826:T:C
NM_130839.5(UBE3A):c.1753+12A>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160210	15	25605518	15	25360371	160210	169088	rs368720379	NC_000015.10:25360370:T:C
NM_130839.5(UBE3A):c.1748A>G (p.Asp583Gly)	SNHG14|UBE3A	D563G, D166G, D586G, D524G, D146G, D583G	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160209	15	25605535	15	25360388	160209	169089	rs587784518	NC_000015.10:25360387:T:C
NM_130839.5(UBE3A):c.1742A>G (p.Asn581Ser)	SNHG14|UBE3A	N561S, N144S, N164S, N522S, N581S, N584S	Angelman syndrome	Uncertain significance(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000160208	15	25605541	15	25360394	160208	169090	rs587784517	NC_000015.10:25360393:T:C
NM_130839.5(UBE3A):c.1694G>A (p.Gly565Glu)	SNHG14|UBE3A	G545E, G128E, G506E, G565E, G568E, G148E	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160207	15	25605589	15	25360442	160207	169091	rs587784516	NC_000015.10:25360441:C:T
NM_130839.5(UBE3A):c.1659T>A (p.Tyr553Ter)	SNHG14|UBE3A	Y533*, Y136*, Y494*, Y553*, Y556*, Y116*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160206	15	25605624	15	25360477	160206	169092	rs587784515	NC_000015.10:25360476:A:T
NM_130839.5(UBE3A):c.1627G>T (p.Glu543Ter)	SNHG14|UBE3A	E523*, E484*, E106*, E543*, E546*, E126*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160205	15	25605656	15	25360509	160205	169093	rs587784514	NC_000015.10:25360508:C:A
NM_130839.5(UBE3A):c.176G>A (p.Arg59His)	SNHG14|UBE3A	R39H, R59H, R62H	not specified|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000160202	15	25620797	15	25375650	160202	169107	rs587784511	NC_000015.10:25375649:C:T
NM_130839.5(UBE3A):c.1192A>C (p.Ile398Leu)	SNHG14|UBE3A	I378L, I339L, I401L, I398L	Angelman syndrome	Uncertain significance(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	VCV000160201	15	25616129	15	25370982	160201	169096	rs200380619	NC_000015.10:25370981:T:G
NM_130839.5(UBE3A):c.1176A>T (p.Glu392Asp)	SNHG14|UBE3A	E372D, E392D, E395D, E333D	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160200	15	25616145	15	25370998	160200	169097	rs587784510	NC_000015.10:25370997:T:A
NM_130839.5(UBE3A):c.1150G>T (p.Glu384Ter)	SNHG14|UBE3A	E364*, E384*, E325*, E387*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160198	15	25616171	15	25371024	160198	169099	rs587784508	NC_000015.10:25371023:C:A
NM_130839.5(UBE3A):c.2420C>T (p.Thr807Met)	SNHG14|UBE3A	T787M, T807M, T755M, T810M, T370M, T748M, T390M, T735M, T732M	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000156679	15	25585310	15	25340163	156679	166533	rs587783148	NC_000015.10:25340162:G:A
NM_130839.5(UBE3A):c.442C>T (p.Arg148Cys)	SNHG14|UBE3A	R128C, R148C, R89C, R151C	Angelman syndrome	Uncertain significance(Last reviewed: Apr 3, 2016)	criteria provided, single submitter	VCV000156624	15	25616879	15	25371732	156624	166478	rs587783101	NC_000015.10:25371731:G:A
NM_130839.5(UBE3A):c.2563C>T (p.Leu855Phe)	SNHG14|UBE3A	L835F, L855F, L418F, L796F, L783F, L438F, L780F, L803F, L858F	not provided|Angelman syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000156620	15	25584340	15	25339193	156620	166474	rs587783097	NC_000015.10:25339192:G:A
NM_130839.5(UBE3A):c.2124+19T>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156145	15	25601020	15	25355873	156145	165945	rs587782925	NC_000015.10:25355872:A:C
NM_130839.5(UBE3A):c.2096A>C (p.Lys699Thr)	SNHG14|UBE3A	K679T, K699T, K262T, K282T, K640T, K702T	not specified|not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2021)	criteria provided, conflicting interpretations	VCV000156144	15	25601067	15	25355920	156144	165944	rs202161423	NC_000015.10:25355919:T:G
NM_130839.5(UBE3A):c.2091T>C (p.Gly697=)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156143	15	25601072	15	25355925	156143	165943	rs587782924	NC_000015.10:25355924:A:G
NM_130839.5(UBE3A):c.915A>G (p.Leu305=)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156142	15	25616406	15	25371259	156142	165942	rs587782923	NC_000015.10:25371258:T:C
NM_130839.5(UBE3A):c.815A>G (p.Asn272Ser)	SNHG14|UBE3A	N252S, N213S, N272S, N275S	not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2020)	criteria provided, conflicting interpretations	VCV000156141	15	25616506	15	25371359	156141	165941	rs139928148	NC_000015.10:25371358:T:C
NM_130839.5(UBE3A):c.671T>C (p.Leu224Ser)	SNHG14|UBE3A	L204S, L165S, L224S, L227S	not provided|not specified|Angelman syndrome	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156140	15	25616650	15	25371503	156140	165940	rs587782922	NC_000015.10:25371502:A:G
NM_130839.5(UBE3A):c.2078T>G (p.Leu693Arg)	SNHG14|UBE3A	L673R, L276R, L693R, L696R, L256R, L634R	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156138	15	25601085	15	25355938	156138	165938	rs587782920	NC_000015.10:25355937:A:C
NM_130839.5(UBE3A):c.1823A>C (p.Gln608Pro)	SNHG14|UBE3A	Q588P, Q171P, Q549P, Q611P, Q191P, Q608P	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156137	15	25601974	15	25356827	156137	165937	rs587782919	NC_000015.10:25356826:T:G
NM_130839.5(UBE3A):c.1822C>G (p.Gln608Glu)	SNHG14|UBE3A	Q588E, Q608E, Q611E, Q171E, Q191E, Q549E	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156136	15	25601975	15	25356828	156136	165936	rs587782918	NC_000015.10:25356827:G:C
NM_130839.5(UBE3A):c.1753+32G>A	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156135	15	25605498	15	25360351	156135	165935	rs373746667	NC_000015.10:25360350:C:T
NM_130839.5(UBE3A):c.1608+34T>C	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156134	15	25615679	15	25370532	156134	165934	rs587782917	NC_000015.10:25370531:A:G
NM_130839.5(UBE3A):c.1494G>A (p.Met498Ile)	SNHG14|UBE3A	M478I, M498I, M439I, M501I	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156133	15	25615827	15	25370680	156133	165933	rs587782916	NC_000015.10:25370679:C:T
NM_130839.5(UBE3A):c.1064G>C (p.Ser355Thr)	SNHG14|UBE3A	S335T, S358T, S355T, S296T	History of neurodevelopmental disorder|not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 9, 2021)	criteria provided, conflicting interpretations	VCV000156132	15	25616257	15	25371110	156132	165932	rs141984760	NC_000015.10:25371109:C:G
NM_130839.5(UBE3A):c.458T>G (p.Val153Gly)	SNHG14|UBE3A	V133G, V153G, V156G, V94G	Angelman syndrome	Uncertain significance(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	VCV000156131	15	25616863	15	25371716	156131	165931	rs587782915	NC_000015.10:25371715:A:C
NM_130839.5(UBE3A):c.361+30G>A	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156130	15	25620582	15	25375435	156130	165930	rs367646993	NC_000015.10:25375434:C:T
NM_130839.5(UBE3A):c.361+29T>C	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156129	15	25620583	15	25375436	156129	165929	rs587782914	NC_000015.10:25375435:A:G
NM_130839.5(UBE3A):c.2499-40C>T	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156128	15	25584444	15	25339297	156128	165928	rs373042168	NC_000015.10:25339296:G:A
NM_130839.5(UBE3A):c.2499-31T>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156126	15	25584435	15	25339288	156126	165926	rs587782912	NC_000015.10:25339287:A:C
NM_130839.5(UBE3A):c.2354+20A>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156125	15	25599480	15	25354333	156125	165925	rs587782911	NC_000015.10:25354332:T:C
NM_130839.5(UBE3A):c.2344G>A (p.Val782Ile)	SNHG14|UBE3A	V762I, V782I, V365I, V723I, V707I, V730I, V785I, V345I, V710I	not specified|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2016)	criteria provided, conflicting interpretations	VCV000156124	15	25599510	15	25354363	156124	165924	rs587782910	NC_000015.10:25354362:C:T
NM_130839.5(UBE3A):c.2281-42T>C	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156123	15	25599615	15	25354468	156123	165923	rs543571933	NC_000015.10:25354467:A:G
NM_130839.5(UBE3A):c.869A>C (p.Asn290Thr)	SNHG14|UBE3A	N270T, N231T, N290T, N293T	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156121	15	25616452	15	25371305	156121	165921	rs587782908	NC_000015.10:25371304:T:G
NM_130839.5(UBE3A):c.409T>C (p.Cys137Arg)	SNHG14|UBE3A	C117R, C137R, C140R, C78R	not provided|Angelman syndrome	Likely pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000156120	15	25616912	15	25371765	156120	165920	rs587782907	NC_000015.10:25371764:A:G
NM_130839.5(UBE3A):c.62+20G>A	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156119	15	25650588	15	25405441	156119	165919	rs587782906	NC_000015.10:25405440:C:T
NM_130839.5(UBE3A):c.1757T>A (p.Met586Lys)	SNHG14|UBE3A	M566K, M527K, M589K, M169K, M149K, M586K	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155998	15	25602040	15	25356893	155998	165802	rs587781244	NC_000015.10:25356892:A:T
NM_130839.5(UBE3A):c.1490G>C (p.Arg497Pro)	SNHG14|UBE3A	R477P, R497P, R500P, R438P	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155997	15	25615831	15	25370684	155997	165801	rs587781243	NC_000015.10:25370683:C:G
NM_130839.5(UBE3A):c.1364T>C (p.Leu455Pro)	SNHG14|UBE3A	L435P, L396P, L455P, L458P	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155996	15	25615957	15	25370810	155996	165800	rs587781242	NC_000015.10:25370809:A:G
NM_130839.5(UBE3A):c.770T>A (p.Leu257His)	SNHG14|UBE3A	L237H, L257H, L198H, L260H	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155995	15	25616551	15	25371404	155995	165799	rs587780582	NC_000015.10:25371403:A:T
NM_130839.5(UBE3A):c.377C>A (p.Thr126Lys)	SNHG14|UBE3A	T106K, T129K, T126K, T67K	Angelman syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000155994	15	25616944	15	25371797	155994	165798	rs587781241	NC_000015.10:25371796:G:T
NM_130839.5(UBE3A):c.2540C>T (p.Pro847Leu)	SNHG14|UBE3A	P827L, P430L, P772L, P410L, P847L, P850L, P775L, P788L, P795L	Angelman syndrome	Likely pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000155992	15	25584363	15	25339216	155992	165796	rs587781239	NC_000015.10:25339215:G:A
NM_130839.5(UBE3A):c.2129T>G (p.Phe710Cys)	SNHG14|UBE3A	F690C, F273C, F293C, F635C, F651C, F710C, F713C	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155990	15	25599826	15	25354679	155990	165794	rs587781237	NC_000015.10:25354678:A:C
NM_130839.5(UBE3A):c.2027C>T (p.Thr676Ile)	SNHG14|UBE3A	T656I, T259I, T239I, T676I, T617I, T679I	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155989	15	25601136	15	25355989	155989	165793	rs587781236	NC_000015.10:25355988:G:A
NM_130839.5(UBE3A):c.1810G>C (p.Glu604Gln)	SNHG14|UBE3A	E584Q, E604Q, E167Q, E545Q, E187Q, E607Q	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155988	15	25601987	15	25356840	155988	165792	rs587781235	NC_000015.10:25356839:C:G
NM_130839.5(UBE3A):c.1693G>A (p.Gly565Arg)	SNHG14|UBE3A	G545R, G506R, G128R, G148R, G565R, G568R	Inborn genetic diseases|Angelman syndrome	Likely pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000155986	15	25605590	15	25360443	155986	165790	rs587781233	NC_000015.10:25360442:C:T
NM_130839.5(UBE3A):c.2549C>G (p.Ser850Ter)	SNHG14|UBE3A	S830*, S778*, S413*, S775*, S791*, S433*, S850*, S798*, S853*	Angelman syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000155981	15	25584354	15	25339207	155981	165785	rs587781228	NC_000015.10:25339206:G:C
NM_130839.5(UBE3A):c.2534T>A (p.Leu845Ter)	SNHG14|UBE3A	L825*, L845*, L770*, L428*, L773*, L848*, L408*, L786*, L793*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155978	15	25584369	15	25339222	155978	165782	rs587781226	NC_000015.10:25339221:A:T
NM_130839.5(UBE3A):c.2305G>T (p.Glu769Ter)	SNHG14|UBE3A	E749*, E694*, E769*, E772*, E332*, E352*, E710*, E697*, E717*	Angelman syndrome	Pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	VCV000155971	15	25599549	15	25354402	155971	165775	rs587781220	NC_000015.10:25354401:C:A
NM_130839.5(UBE3A):c.2293C>T (p.Gln765Ter)	SNHG14|UBE3A	Q745*, Q693*, Q328*, Q690*, Q765*, Q768*, Q348*, Q706*, Q713*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155970	15	25599561	15	25354414	155970	165774	rs587781219	NC_000015.10:25354413:G:A
NM_130839.5(UBE3A):c.2237T>A (p.Leu746Ter)	SNHG14|UBE3A	L726*, L329*, L671*, L749*, L309*, L687*, L746*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155968	15	25599718	15	25354571	155968	165772	rs587781217	NC_000015.10:25354570:A:T
NM_130839.5(UBE3A):c.2032C>T (p.Gln678Ter)	SNHG14|UBE3A	Q658*, Q678*, Q681*, Q619*, Q241*, Q261*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155964	15	25601131	15	25355984	155964	165768	rs587781213	NC_000015.10:25355983:G:A
NM_130839.5(UBE3A):c.1790G>A (p.Trp597Ter)	SNHG14|UBE3A	W577*, W160*, W180*, W600*, W538*, W597*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000155959	15	25602007	15	25356860	155959	165763	rs587781208	NC_000015.10:25356859:C:T
NM_130839.5(UBE3A):c.1431T>A (p.Cys477Ter)	SNHG14|UBE3A	C457*, C477*, C480*, C418*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155952	15	25615890	15	25370743	155952	165756	rs587781201	NC_000015.10:25370742:A:T
NM_130839.5(UBE3A):c.1345G>T (p.Glu449Ter)	SNHG14|UBE3A	E429*, E390*, E449*, E452*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155949	15	25615976	15	25370829	155949	165753	rs587781198	NC_000015.10:25370828:C:A
NM_130839.5(UBE3A):c.1330G>T (p.Glu444Ter)	SNHG14|UBE3A	E424*, E447*, E385*, E444*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155948	15	25615991	15	25370844	155948	165752	rs587781197	NC_000015.10:25370843:C:A
NM_130839.5(UBE3A):c.1261C>T (p.Arg421Ter)	SNHG14|UBE3A	R401*, R362*, R421*, R424*	Inborn genetic diseases|Angelman syndrome	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000155947	15	25616060	15	25370913	155947	165751	rs587781196	NC_000015.10:25370912:G:A
NM_130839.5(UBE3A):c.1174G>T (p.Glu392Ter)	SNHG14|UBE3A	E372*, E333*, E395*, E392*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155946	15	25616147	15	25371000	155946	165750	rs587781195	NC_000015.10:25370999:C:A
NM_130839.5(UBE3A):c.1021C>T (p.Gln341Ter)	SNHG14|UBE3A	Q321*, Q282*, Q341*, Q344*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155942	15	25616300	15	25371153	155942	165746	rs587781191	NC_000015.10:25371152:G:A
NM_130839.5(UBE3A):c.810T>A (p.Tyr270Ter)	SNHG14|UBE3A	Y250*, Y211*, Y270*, Y273*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155941	15	25616511	15	25371364	155941	165745	rs587781190	NC_000015.10:25371363:A:T
NM_130839.5(UBE3A):c.2415T>C (p.Phe805=)	SNHG14|UBE3A		not provided|Angelman syndrome	Likely benign(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000137887	15	25585315	15	25340168	137887	141590	rs587780991	NC_000015.10:25340167:A:G
NM_130839.5(UBE3A):c.1767C>T (p.Tyr589=)	SNHG14|UBE3A		History of neurodevelopmental disorder|not specified|not provided|Angelman syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137886	15	25602030	15	25356883	137886	141589	rs139082033	NC_000015.10:25356882:G:A
NM_130839.5(UBE3A):c.1404A>G (p.Thr468=)	SNHG14|UBE3A		History of neurodevelopmental disorder|Angelman syndrome|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000137885	15	25615917	15	25370770	137885	141588	rs150331504	NC_000015.10:25370769:T:C
NM_130839.5(UBE3A):c.1185A>G (p.Glu395=)	SNHG14|UBE3A		History of neurodevelopmental disorder|not specified|Angelman syndrome	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137884	15	25616136	15	25370989	137884	141587	rs114056442	NC_000015.10:25370988:T:C
NM_130839.5(UBE3A):c.1179T>C (p.Asp393=)	SNHG14|UBE3A		Angelman syndrome|not specified|not provided	Likely benign(Last reviewed: Apr 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000137883	15	25616142	15	25370995	137883	141586	rs143000400	NC_000015.10:25370994:A:G
NM_130839.5(UBE3A):c.618A>T (p.Ala206=)	SNHG14|UBE3A		Angelman syndrome|not provided|not specified	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137882	15	25616703	15	25371556	137882	141585	rs143484751	NC_000015.10:25371555:T:A
NM_130839.5(UBE3A):c.1433C>T (p.Pro478Leu)	SNHG14|UBE3A	P458L, P419L, P481L, P478L	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136207	15	25615888	15	25370741	136207	139911	rs587780584	NC_000015.10:25370740:G:A
NM_130839.5(UBE3A):c.848T>G (p.Leu283Trp)	SNHG14|UBE3A	L263W, L283W, L224W, L286W	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136206	15	25616473	15	25371326	136206	139910	rs587780583	NC_000015.10:25371325:A:C
NM_130839.5(UBE3A):c.770T>C (p.Leu257Pro)	SNHG14|UBE3A	L237P, L198P, L257P, L260P	Angelman syndrome	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000136205	15	25616551	15	25371404	136205	139909	rs587780582	NC_000015.10:25371403:A:G
NM_130839.5(UBE3A):c.695A>T (p.Asp232Val)	SNHG14|UBE3A	D212V, D235V, D173V, D232V	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136204	15	25616626	15	25371479	136204	139908	rs587780581	NC_000015.10:25371478:T:A
NM_130839.5(UBE3A):c.2618A>T (p.Ter873Leu)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136203	15	25584285	15	25339138	136203	139907	rs76794400	NC_000015.10:25339137:T:A
NM_130839.5(UBE3A):c.2125-2A>C	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136202	15	25599832	15	25354685	136202	139906	rs587780580	NC_000015.10:25354684:T:G
NM_130839.5(UBE3A):c.1754-2A>G	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136201	15	25602045	15	25356898	136201	139905	rs587780579	NC_000015.10:25356897:T:C
NM_130839.5(UBE3A):c.362-2A>T	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136200	15	25616961	15	25371814	136200	139904	rs587780578	NC_000015.10:25371813:T:A
NM_130839.5(UBE3A):c.777T>A (p.Tyr259Ter)	SNHG14|UBE3A	Y239*, Y200*, Y259*, Y262*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136198	15	25616544	15	25371397	136198	139902	rs587780576	NC_000015.10:25371396:A:T
NM_130839.5(UBE3A):c.748G>T (p.Glu250Ter)	SNHG14|UBE3A	E230*, E191*, E250*, E253*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136197	15	25616573	15	25371426	136197	139901	rs587780575	NC_000015.10:25371425:C:A
NM_130839.5(UBE3A):c.592G>A (p.Ala198Thr)	SNHG14|UBE3A	A178T, A198T, A201T, A139T	Angelman syndrome|History of neurodevelopmental disorder|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096265	15	25616729	15	25371582	96265	102159	rs147145506	NC_000015.10:25371581:C:T
NM_130839.5(UBE3A):c.477A>T (p.Ala159=)	SNHG14|UBE3A		Angelman syndrome|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096264	15	25616844	15	25371697	96264	102158	rs28528079	NC_000015.10:25371696:T:A
NM_130839.5(UBE3A):c.373T>C (p.Leu125=)	SNHG14|UBE3A		Angelman syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096263	15	25616948	15	25371801	96263	102157	rs61734190	NC_000015.10:25371800:A:G
NM_130839.5(UBE3A):c.2618A>G (p.Ter873=)	SNHG14|UBE3A		Angelman syndrome|not specified|History of neurodevelopmental disorder|not provided	Benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096262	15	25584285	15	25339138	96262	102156	rs76794400	NC_000015.10:25339137:T:C
NM_130839.5(UBE3A):c.2124+9T>C	SNHG14|UBE3A		Angelman syndrome|not specified|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000096260	15	25601030	15	25355883	96260	102154	rs79328837	NC_000015.10:25355882:A:G
NM_130839.5(UBE3A):c.1933T>C (p.Phe645Leu)	SNHG14|UBE3A	F625L, F208L, F586L, F228L, F645L, F648L	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096259	15	25601864	15	25356717	96259	102153	rs398124439	NC_000015.10:25356716:A:G
NM_130839.5(UBE3A):c.1773A>G (p.Glu591=)	SNHG14|UBE3A		Angelman syndrome|History of neurodevelopmental disorder|not specified|not provided	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096258	15	25602024	15	25356877	96258	102152	rs34670662	NC_000015.10:25356876:T:C
NM_130839.5(UBE3A):c.1269C>T (p.Asp423=)	SNHG14|UBE3A		not specified|History of neurodevelopmental disorder|not provided|Angelman syndrome	Benign/Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096256	15	25616052	15	25370905	96256	102150	rs149506027	NC_000015.10:25370904:G:A
NM_130839.5(UBE3A):c.449T>C (p.Ile150Thr)	SNHG14|UBE3A	I130T, I91T, I150T, I153T	Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007969	15	25616872	15	25371725	7969	23008	rs111033597	NC_000015.10:25371724:A:G
NM_130839.5(UBE3A):c.376A>C (p.Thr126Pro)	SNHG14|UBE3A	T106P, T67P, T126P, T129P	Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007968	15	25616945	15	25371798	7968	23007	rs111033596	NC_000015.10:25371797:T:G
NM_130839.5(UBE3A):c.2364G>A (p.Trp788Ter)	SNHG14|UBE3A	W768*, W791*, W351*, W371*, W713*, W716*, W736*, W729*, W788*	Angelman syndrome	Pathogenic(Last reviewed: Mar 1, 2021)	reviewed by expert panel	VCV000007967	15	25585366	15	25340219	7967	23006	rs111033595	NC_000015.10:25340218:C:T
NM_130839.5(UBE3A):c.1309C>T (p.Arg437Ter)	SNHG14|UBE3A	R417*, R440*, R378*, R437*	Angelman syndrome	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000007966	15	25616012	15	25370865	7966	23005		NC_000015.10:25370864:G:A
NM_006772.3(SYNGAP1):c.1861C>T (p.Arg621Ter)	SYNGAP1	R621*	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411589	6	33408690	6	33440913	411589	395450	rs1060503386	NC_000006.12:33440912:C:T
NM_024665.7(TBL1XR1):c.1043A>G (p.His348Arg)	TBL1XR1	H261R, H348R	Mental retardation, autosomal dominant 41|See cases	Likely pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000666259	3	176756105	3	177038317	666259	653815	rs1576994053	NC_000003.12:177038316:T:C
NM_024665.7(TBL1XR1):c.1000T>C (p.Cys334Arg)	TBL1XR1	C334R, C247R	Mental retardation, autosomal dominant 41	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666258	3	176756148	3	177038360	666258	653810	rs1576994101	NC_000003.12:177038359:A:G
NM_001083962.2(TCF4):c.1486G>T (p.Gly496Cys)	TCF4	G280C, G335C, G336C, G366C, G425C, G454C, G471C, G472C, G473C, G493C, G495C, G496C, G502C, G598C	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: May 11, 2021)	reviewed by expert panel	VCV000690393	18	52901779	18	55234548	690393	678075	rs1599570613	NC_000018.10:55234547:C:A
NM_001083962.2(TCF4):c.1283G>T (p.Gly428Val)	TCF4	G428V, G267V, G357V, G386V, G427V, G212V, G403V, G404V, G405V, G425V, G530V, G268V, G298V, G434V	Pitt-Hopkins syndrome|not provided|History of neurodevelopmental disorder	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000574403	18	52921795	18	55254564	574403	572666	rs186508321	NC_000018.10:55254563:C:A
NM_001083962.2(TCF4):c.759C>G (p.Ser253Arg)	TCF4	S253R, S37R, S123R, S182R, S229R, S251R, S252R, S93R, S211R, S355R, S228R, S259R	Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000432062	18	52942880	18	55275649	432062	426274	rs1555796785	NC_000018.10:55275648:G:C
NM_001083962.2(TCF4):c.1826T>C (p.Leu609Pro)	TCF4	L609P, L393P, L479P, L534P, L584P, L538P, L563P, L567P, L585P, L602P, L608P, L444P, L445P, L449P, L475P, L580P, L581P, L586P, L604P, L615P, L605P, L711P	not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000393171	18	52896131	18	55228900	393171	379059	rs1057524821	NC_000018.10:55228899:A:G
NM_001083962.2(TCF4):c.1727G>A (p.Arg576Gln)	TCF4	R576Q, R553Q, R360Q, R411Q, R501Q, R505Q, R530Q, R548Q, R582Q, R678Q, R416Q, R534Q, R547Q, R551Q, R552Q, R571Q, R575Q, R412Q, R442Q, R446Q, R569Q, R572Q	not provided|Inborn genetic diseases|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000381549	18	52896230	18	55228999	381549	375991	rs1057521070	NC_000018.10:55228998:C:T
NM_001083962.2(TCF4):c.687C>A (p.Ser229=)	TCF4		Pitt-Hopkins syndrome|not specified	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000327305	18	52942952	18	55275721	327305	342039	rs200800656	NC_000018.10:55275720:G:T
NM_001083962.2(TCF4):c.269A>G (p.Asn90Ser)	TCF4|TCF4-AS1	N90S, N66S, N192S, N88S, N48S	Pitt-Hopkins syndrome|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000167731	18	53128285	18	55461054	167731	177427	rs143244149	NC_000018.10:55461053:T:C
NM_001083962.2(TCF4):c.990G>A (p.Ser330=)	TCF4		Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000160092	18	52928697	18	55261466	160092	169445	rs587784469	NC_000018.10:55261465:C:T
NM_001083962.2(TCF4):c.944C>T (p.Ala315Val)	TCF4	A315V, A185V, A244V, A273V, A99V, A291V, A313V, A321V, A290V, A155V, A314V, A417V	History of neurodevelopmental disorder|not provided|Pitt-Hopkins syndrome|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000160091	18	52928743	18	55261512	160091	169446	rs147445499	NC_000018.10:55261511:G:A
NM_001083962.2(TCF4):c.1733G>A (p.Arg578His)	TCF4	R578H, R680H, R413H, R448H, R503H, R536H, R574H, R554H, R555H, R571H, R573H, R418H, R532H, R549H, R550H, R553H, R362H, R414H, R444H, R507H, R577H, R584H	not provided|Pitt-Hopkins syndrome|Microcephaly	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000093542	18	52896224	18	55228993	93542	99447	rs121909123	NC_000018.10:55228992:C:T
NM_001083962.2(TCF4):c.1086G>A (p.Trp362Ter)	TCF4	W362*, W146*, W232*, W320*, W337*, W361*, W464*, W201*, W202*, W291*, W338*, W359*, W339*, W368*	not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000093540	18	52924606	18	55257375	93540	99445	rs398123560	NC_000018.10:55257374:C:T
NM_001083962.2(TCF4):c.1739G>A (p.Arg580Gln)	TCF4	R576Q, R580Q, R446Q, R552Q, R364Q, R415Q, R450Q, R538Q, R586Q, R416Q, R420Q, R509Q, R534Q, R551Q, R556Q, R575Q, R682Q, R505Q, R555Q, R557Q, R573Q, R579Q	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000007371	18	52896218	18	55228987	7371	22410	rs121909121	NC_000018.10:55228986:C:T
NM_001083962.2(TCF4):c.1738C>T (p.Arg580Trp)	TCF4	R576W, R580W, R682W, R364W, R505W, R534W, R552W, R557W, R420W, R446W, R509W, R555W, R573W, R575W, R579W, R415W, R416W, R450W, R538W, R551W, R556W, R586W	not provided|Inborn genetic diseases|Severe intellectual deficiency|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000007370	18	52896219	18	55228988	7370	22409	rs121909120	NC_000018.10:55228987:G:A
NM_130839.5(UBE3A):c.1860T>A (p.Ile620=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV001158916	15	25601937	15	25356790	1158916	1145021		NC_000015.10:25356789:A:T
NM_130839.5(UBE3A):c.1800A>G (p.Pro600=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV001141879	15	25601997	15	25356850	1141879	1145022		NC_000015.10:25356849:T:C
NM_130839.5(UBE3A):c.1719G>A (p.Gln573=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001138218	15	25605564	15	25360417	1138218	1124156		NC_000015.10:25360416:C:T
NM_130839.5(UBE3A):c.1347A>G (p.Glu449=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001137592	15	25615974	15	25370827	1137592	1124158		NC_000015.10:25370826:T:C
NM_130839.5(UBE3A):c.87A>G (p.Leu29=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV001131091	15	25620886	15	25375739	1131091	1124162		NC_000015.10:25375738:T:C
NM_130839.5(UBE3A):c.861A>G (p.Val287=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001130068	15	25616460	15	25371313	1130068	1124160		NC_000015.10:25371312:T:C
NM_130839.5(UBE3A):c.1248C>T (p.Asn416=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 18, 2020)	criteria provided, single submitter	VCV001126825	15	25616073	15	25370926	1126825	1124159		NC_000015.10:25370925:G:A
NM_130839.5(UBE3A):c.1596T>C (p.Asp532=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001123889	15	25615725	15	25370578	1123889	1124157		NC_000015.10:25370577:A:G
NM_130839.5(UBE3A):c.660T>C (p.Asn220=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001123155	15	25616661	15	25371514	1123155	1124161		NC_000015.10:25371513:A:G
NM_130839.5(UBE3A):c.1764A>T (p.Thr588=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 18, 2020)	criteria provided, single submitter	VCV001100353	15	25602033	15	25356886	1100353	1102751		NC_000015.10:25356885:T:A
NM_130839.5(UBE3A):c.1830T>C (p.Thr610=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001094304	15	25601967	15	25356820	1094304	1080911		NC_000015.10:25356819:A:G
NM_130839.5(UBE3A):c.459T>G (p.Val153=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001091534	15	25616862	15	25371715	1091534	1080913		NC_000015.10:25371714:A:C
NM_130839.5(UBE3A):c.580G>C (p.Ala194Pro)	UBE3A|SNHG14	A135P, A174P, A194P, A197P	Angelman syndrome	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001024047	15	25616741	15	25371594	1024047	1011365		NC_000015.10:25371593:C:G
NM_130839.5(UBE3A):c.1936C>A (p.Arg646Ser)	UBE3A|SNHG14	R209S, R229S, R587S, R626S, R646S, R649S	Angelman syndrome	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001020143	15	25601861	15	25356714	1020143	1011363		NC_000015.10:25356713:G:T
NM_130839.5(UBE3A):c.2421G>A (p.Thr807=)	UBE3A|SNHG14		Angelman syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001011641	15	25585309	15	25340162	1011641	996124		NC_000015.10:25340161:C:T
NM_130839.5(UBE3A):c.2263C>G (p.Leu755Val)	UBE3A|SNHG14	L318V, L338V, L680V, L696V, L735V, L755V, L758V	Angelman syndrome	Uncertain significance(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001008062	15	25599692	15	25354545	1008062	996125		NC_000015.10:25354544:G:C
NM_130839.5(UBE3A):c.2410C>T (p.Gln804Ter)	UBE3A|SNHG14	Q367*, Q387*, Q729*, Q732*, Q745*, Q752*, Q784*, Q804*, Q807*	Angelman syndrome	Pathogenic(Last reviewed: Apr 10, 2020)	criteria provided, single submitter	VCV000984971	15	25585320	15	25340173	984971	973104		NC_000015.10:25340172:G:A
NM_130839.5(UBE3A):c.1864A>G (p.Asn622Asp)	UBE3A|SNHG14	N185D, N205D, N563D, N602D, N622D, N625D	Angelman syndrome	Likely pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000984645	15	25601933	15	25356786	984645	972727		NC_000015.10:25356785:T:C
NM_130839.5(UBE3A):c.578C>G (p.Ala193Gly)	UBE3A|SNHG14	A173G, A196G, A134G, A193G	Angelman syndrome	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000962683	15	25616743	15	25371596	962683	948782		NC_000015.10:25371595:G:C
NM_130839.5(UBE3A):c.167C>A (p.Thr56Asn)	UBE3A|SNHG14	T36N, T56N, T59N	Angelman syndrome	Uncertain significance(Last reviewed: Jul 21, 2019)	criteria provided, single submitter	VCV000956987	15	25620806	15	25375659	956987	948784		NC_000015.10:25375658:G:T
NM_130839.5(UBE3A):c.1012G>T (p.Glu338Ter)	UBE3A|SNHG14	E318*, E338*, E341*, E279*	Angelman syndrome	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000949904	15	25616309	15	25371162	949904	927258		NC_000015.10:25371161:C:A
NM_130839.5(UBE3A):c.2198G>A (p.Gly733Asp)	UBE3A|SNHG14	G674D, G733D, G296D, G316D, G736D, G658D, G713D	not specified	Uncertain significance(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV000917692	15	25599757	15	25354610	917692	906033		NC_000015.10:25354609:C:T
NM_130839.5(UBE3A):c.1066C>T (p.Arg356Ter)	UBE3A|SNHG14	R356*, R336*, R359*, R297*	Angelman syndrome	Pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV000864214	15	25616255	15	25371108	864214	842084		NC_000015.10:25371107:G:A
NM_130839.5(UBE3A):c.368C>G (p.Thr123Ser)	UBE3A|SNHG14	T103S, T64S, T123S, T126S	Angelman syndrome	Uncertain significance(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000860708	15	25616953	15	25371806	860708	842089		NC_000015.10:25371805:G:C
NM_130839.5(UBE3A):c.1131T>A (p.Tyr377Ter)	UBE3A|SNHG14	Y318*, Y357*, Y380*, Y377*	Angelman syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000846659	15	25616190	15	25371043	846659	842082		NC_000015.10:25371042:A:T
NM_130839.5(UBE3A):c.330G>C (p.Met110Ile)	UBE3A|SNHG14	M90I, M110I, M113I, M51I	Angelman syndrome	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000846201	15	25620643	15	25375496	846201	842091		NC_000015.10:25375495:C:G
NM_130839.5(UBE3A):c.2273G>A (p.Gly758Glu)	UBE3A|SNHG14	G321E, G699E, G738E, G341E, G758E, G683E, G761E	Angelman syndrome	Likely pathogenic(Last reviewed: Mar 19, 2017)	criteria provided, single submitter	VCV000813761	15	25599682	15	25354535	813761	802004		NC_000015.10:25354534:C:T
NM_130839.5(UBE3A):c.1976T>G (p.Leu659Ter)	UBE3A|SNHG14	L222*, L600*, L659*, L662*, L639*, L242*	Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803057	15	25601187	15	25356040	803057	791434	rs1595591164	NC_000015.10:25356039:A:C
NM_130839.5(UBE3A):c.291G>A (p.Ser97=)	UBE3A|SNHG14		Angelman syndrome|not provided	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000766757	15	25620682	15	25375535	766757	770058	rs1411368065	NC_000015.10:25375534:C:T
NM_130839.5(UBE3A):c.2442G>A (p.Val814=)	UBE3A|SNHG14		Angelman syndrome|not provided	Likely benign(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000764976	15	25585288	15	25340141	764976	770054	rs1595375310	NC_000015.10:25340140:C:T
NM_130839.5(UBE3A):c.873A>G (p.Arg291=)	UBE3A|SNHG14		Angelman syndrome|not provided	Likely benign(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000751517	15	25616448	15	25371301	751517	770056	rs1213980033	NC_000015.10:25371300:T:C
NM_130839.5(UBE3A):c.626C>G (p.Ser209Ter)	UBE3A|SNHG14	S189*, S150*, S212*, S209*	not provided|Angelman syndrome	Pathogenic(Last reviewed: Mar 1, 2021)	reviewed by expert panel	VCV000620293	15	25616695	15	25371548	620293	611790	rs1566961418	NC_000015.10:25371547:G:C
NM_130839.5(UBE3A):c.1696G>A (p.Gly566Ser)	UBE3A|SNHG14	G546S, G149S, G507S, G566S, G129S, G569S	Angelman syndrome	Likely pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000559871	15	25605587	15	25360440	559871	550660	rs1555393242	NC_000015.10:25360439:C:T
NM_130839.5(UBE3A):c.1876C>T (p.Leu626=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV000528369	15	25601921	15	25356774	528369	529041	rs376089007	NC_000015.10:25356773:G:A
NM_130839.5(UBE3A):c.342C>A (p.Gly114=)	UBE3A|SNHG14		Angelman syndrome|not specified	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000511245	15	25620631	15	25375484	511245	504939	rs142726511	NC_000015.10:25375483:G:T
NM_130839.5(UBE3A):c.507A>G (p.Gln169=)	UBE3A|SNHG14		not specified|Angelman syndrome	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000507495	15	25616814	15	25371667	507495	505609	rs1555401033	NC_000015.10:25371666:T:C
NM_130839.5(UBE3A):c.1052A>G (p.Asn351Ser)	UBE3A|SNHG14	N331S, N292S, N351S, N354S	Angelman syndrome	Uncertain significance(Last reviewed: Aug 20, 2017)	criteria provided, single submitter	VCV000458668	15	25616269	15	25371122	458668	463959	rs747932207	NC_000015.10:25371121:T:C
NM_130839.5(UBE3A):c.1196C>G (p.Pro399Arg)	UBE3A|SNHG14	P379R, P340R, P399R, P402R	Angelman syndrome	Uncertain significance(Last reviewed: Mar 5, 2017)	criteria provided, single submitter	VCV000458665	15	25616125	15	25370978	458665	464538	rs267604140	NC_000015.10:25370977:G:C
NM_130839.5(UBE3A):c.859G>A (p.Val287Ile)	UBE3A|SNHG14	V267I, V287I, V290I, V228I	not provided|Angelman syndrome	Uncertain significance(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000420601	15	25616462	15	25371315	420601	409195	rs1064794579	NC_000015.10:25371314:C:T
NM_130839.5(UBE3A):c.732C>T (p.Leu244=)	UBE3A|SNHG14		Angelman syndrome|not provided	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000414973	15	25616589	15	25371442	414973	400860	rs1060504406	NC_000015.10:25371441:G:A
NM_130839.5(UBE3A):c.1038T>C (p.Tyr346=)	UBE3A|SNHG14		not specified|Angelman syndrome|not provided	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379058	15	25616283	15	25371136	379058	374434	rs1057520481	NC_000015.10:25371135:A:G
NM_130839.5(UBE3A):c.1521C>T (p.Leu507=)	UBE3A|SNHG14		not provided|Angelman syndrome|not specified	Likely benign(Last reviewed: May 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000241835	15	25615800	15	25370653	241835	242028	rs878855201	NC_000015.10:25370652:G:A
NM_130839.5(UBE3A):c.119G>T (p.Gly40Val)	UBE3A|SNHG14	G20V, G43V, G40V	Angelman syndrome	Pathogenic(Last reviewed: Dec 7, 2006)	no assertion criteria provided	VCV000218318	15	25620854	15	25375707	218318	215015	rs864309506	NC_000015.10:25375706:C:A
NM_130839.5(UBE3A):c.1032T>C (p.Ile344=)	UBE3A|SNHG14		not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2019)	criteria provided, conflicting interpretations	VCV000196571	15	25616289	15	25371142	196571	193732	rs755119609	NC_000015.10:25371141:A:G
NM_130839.5(UBE3A):c.62T>C (p.Met21Thr)	UBE3A|SNHG14	M1T, M21T, M24T	Angelman syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000136199	15	25650608	15	25405461	136199	139903	rs587780577	NC_000015.10:25405460:A:G
UBE3A, IVS9, A-G, -8	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007964					7964	23003		
NM_014795.4(ZEB2):c.357T>G (p.Thr119=)	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001169303	2	145182409	2	144424842	1169303	1153804		NC_000002.12:144424841:A:C
NM_014795.4(ZEB2):c.1711A>G (p.Met571Val)	ZEB2	M547V, M571V	Mowat-Wilson syndrome	Benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001167087	2	145157043	2	144399476	1167087	1153801		NC_000002.12:144399475:T:C
NM_014795.4(ZEB2):c.593-8G>A	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV001166379	2	145161705	2	144404138	1166379	1153803		NC_000002.12:144404137:C:T
NM_014795.4(ZEB2):c.1361A>T (p.Asn454Ile)	ZEB2	N430I, N454I	Mowat-Wilson syndrome	Benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001164196	2	145157393	2	144399826	1164196	1153802		NC_000002.12:144399825:T:A
NM_014795.4(ZEB2):c.2622T>C (p.Asn874=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV001158813	2	145156132	2	144398565	1158813	1131964		NC_000002.12:144398564:A:G
NM_014795.4(ZEB2):c.597G>A (p.Leu199=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001158337	2	145161693	2	144404126	1158337	1131973		NC_000002.12:144404125:C:T
NM_014795.4(ZEB2):c.1905C>T (p.Leu635=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001158320	2	145156849	2	144399282	1158320	1131967		NC_000002.12:144399281:G:A
NM_014795.4(ZEB2):c.3420C>T (p.His1140=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV001157765	2	145147243	2	144389676	1157765	1131959		NC_000002.12:144389675:G:A
NM_014795.4(ZEB2):c.2946C>T (p.Ser982=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV001157434	2	145154100	2	144396533	1157434	1131960		NC_000002.12:144396532:G:A
NM_014795.4(ZEB2):c.91G>T (p.Val31Leu)	ZEB2	V31L	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001157385	2	145187576	2	144430009	1157385	1131975		NC_000002.12:144430008:C:A
NM_014795.4(ZEB2):c.1209T>C (p.Leu403=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV001154682	2	145157545	2	144399978	1154682	1131972		NC_000002.12:144399977:A:G
NM_014795.4(ZEB2):c.564G>T (p.Thr188=)	ZEB2|LOC111721705		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV001154592	2	145162431	2	144404864	1154592	1131974		NC_000002.12:144404863:C:A
NM_014795.4(ZEB2):c.1875C>T (p.Ala625=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001153341	2	145156879	2	144399312	1153341	1131968		NC_000002.12:144399311:G:A
NM_014795.4(ZEB2):c.1803T>C (p.Arg601=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV001152795	2	145156951	2	144399384	1152795	1131970		NC_000002.12:144399383:A:G
NM_014795.4(ZEB2):c.2133C>T (p.Ser711=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: May 31, 2020)	criteria provided, single submitter	VCV001150309	2	145156621	2	144399054	1150309	1131966		NC_000002.12:144399053:G:A
NM_014795.4(ZEB2):c.3466G>T (p.Gly1156Cys)	ZEB2	G1132C, G1156C	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001149290	2	145147197	2	144389630	1149290	1131958		NC_000002.12:144389629:C:A
NM_014795.4(ZEB2):c.2887-4G>C	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001149125	2	145154163	2	144396596	1149125	1131961		NC_000002.12:144396595:C:G
NM_014795.4(ZEB2):c.1830C>T (p.Ile610=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV001148673	2	145156924	2	144399357	1148673	1131969		NC_000002.12:144399356:G:A
NM_014795.4(ZEB2):c.2742G>A (p.Gln914=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV001145661	2	145156012	2	144398445	1145661	1131963		NC_000002.12:144398444:C:T
NM_014795.4(ZEB2):c.1482A>G (p.Pro494=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV001143256	2	145157272	2	144399705	1143256	1131971		NC_000002.12:144399704:T:C
NM_014795.4(ZEB2):c.2481C>T (p.Pro827=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 28, 2019)	criteria provided, single submitter	VCV001143013	2	145156273	2	144398706	1143013	1131965		NC_000002.12:144398705:G:A
NM_014795.4(ZEB2):c.2850G>A (p.Gln950=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV001142001	2	145155904	2	144398337	1142001	1131962		NC_000002.12:144398336:C:T
NM_014795.4(ZEB2):c.3068-5C>T	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001140477	2	145147600	2	144390033	1140477	1111090		NC_000002.12:144390032:G:A
NM_014795.4(ZEB2):c.2304T>C (p.Asn768=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001138433	2	145156450	2	144398883	1138433	1111094		NC_000002.12:144398882:A:G
NM_014795.4(ZEB2):c.15C>T (p.Ile5=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001138263	2	145274903	2	144517336	1138263	1111101		NC_000002.12:144517335:G:A
NM_014795.4(ZEB2):c.2896C>A (p.Leu966Ile)	ZEB2	L942I, L966I	Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001138174	2	145154150	2	144396583	1138174	1111092		NC_000002.12:144396582:G:T
NM_014795.4(ZEB2):c.2220A>T (p.Thr740=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001135964	2	145156534	2	144398967	1135964	1111095		NC_000002.12:144398966:T:A
NM_014795.4(ZEB2):c.436G>A (p.Glu146Lys)	ZEB2	E122K, E146K	Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001133054	2	145162559	2	144404992	1133054	1111100		NC_000002.12:144404991:C:T
NM_014795.4(ZEB2):c.507C>T (p.Arg169=)	ZEB2|LOC111721705		Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, single submitter	VCV001128115	2	145162488	2	144404921	1128115	1111098		NC_000002.12:144404920:G:A
NM_014795.4(ZEB2):c.624C>T (p.Ala208=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV001125521	2	145161666	2	144404099	1125521	1111097		NC_000002.12:144404098:G:A
NM_014795.4(ZEB2):c.495G>A (p.Glu165=)	ZEB2|LOC111721705		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001124735	2	145162500	2	144404933	1124735	1111099		NC_000002.12:144404932:C:T
NM_014795.4(ZEB2):c.3006C>T (p.Asp1002=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001121311	2	145154040	2	144396473	1121311	1111091		NC_000002.12:144396472:G:A
NM_014795.4(ZEB2):c.2826A>G (p.Gly942=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001121307	2	145155928	2	144398361	1121307	1111093		NC_000002.12:144398360:T:C
NM_014795.4(ZEB2):c.1344T>G (p.Leu448=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001118004	2	145157410	2	144399843	1118004	1089555		NC_000002.12:144399842:A:C
NM_014795.4(ZEB2):c.3318G>T (p.Leu1106=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001115638	2	145147345	2	144389778	1115638	1089549		NC_000002.12:144389777:C:A
NM_014795.4(ZEB2):c.1407T>C (p.Asn469=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001106940	2	145157347	2	144399780	1106940	1089554		NC_000002.12:144399779:A:G
NM_014795.4(ZEB2):c.1728C>T (p.Asn576=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001106552	2	145157026	2	144399459	1106552	1089552		NC_000002.12:144399458:G:A
NM_014795.4(ZEB2):c.2823T>C (p.Thr941=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV001106396	2	145155931	2	144398364	1106396	1089550		NC_000002.12:144398363:A:G
NM_014795.4(ZEB2):c.1305A>C (p.Pro435=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001104471	2	145157449	2	144399882	1104471	1089556		NC_000002.12:144399881:T:G
NM_014795.4(ZEB2):c.1668A>G (p.Lys556=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV001104101	2	145157086	2	144399519	1104101	1089553		NC_000002.12:144399518:T:C
NM_014795.4(ZEB2):c.2549C>A (p.Ser850Tyr)	ZEB2	S826Y, S850Y	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV001101915	2	145156205	2	144398638	1101915	1089551		NC_000002.12:144398637:G:T
NM_014795.4(ZEB2):c.912C>T (p.His304=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 5, 2020)	criteria provided, single submitter	VCV001101207	2	145158770	2	144401203	1101207	1089557		NC_000002.12:144401202:G:A
NM_014795.4(ZEB2):c.74-9C>T	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV001099087	2	145187602	2	144430035	1099087	1089558		NC_000002.12:144430034:G:A
NM_014795.4(ZEB2):c.2223A>G (p.Ser741=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001094860	2	145156531	2	144398964	1094860	1067825		NC_000002.12:144398963:T:C
NM_014795.4(ZEB2):c.3384G>C (p.Glu1128Asp)	ZEB2	E1104D, E1128D	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001092607	2	145147279	2	144389712	1092607	1067824		NC_000002.12:144389711:C:G
NM_014795.4(ZEB2):c.1079C>G (p.Ser360Cys)	ZEB2	S336C, S360C	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001088637	2	145157675	2	144400108	1088637	1067829		NC_000002.12:144400107:G:C
NM_014795.4(ZEB2):c.732T>C (p.Pro244=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV001082619	2	145161558	2	144403991	1082619	1067830		NC_000002.12:144403990:A:G
NM_014795.4(ZEB2):c.3557G>C (p.Gly1186Ala)	ZEB2	G1162A, G1186A	Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001082252	2	145147106	2	144389539	1082252	1067823		NC_000002.12:144389538:C:G
NM_014795.4(ZEB2):c.2148T>C (p.Ala716=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001081730	2	145156606	2	144399039	1081730	1067826		NC_000002.12:144399038:A:G
NM_014795.4(ZEB2):c.1944C>T (p.Pro648=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV001081533	2	145156810	2	144399243	1081533	1067828		NC_000002.12:144399242:G:A
NM_014795.4(ZEB2):c.1950C>T (p.Asn650=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001080126	2	145156804	2	144399237	1080126	1067827		NC_000002.12:144399236:G:A
NM_014795.4(ZEB2):c.696C>A (p.Tyr232Ter)	ZEB2	Y208*, Y232*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001076322	2	145161594	2	144404027	1076322	1058923		NC_000002.12:144404026:G:T
NM_014795.4(ZEB2):c.874A>T (p.Lys292Ter)	ZEB2	K268*, K292*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001069634	2	145158808	2	144401241	1069634	1058921		NC_000002.12:144401240:T:A
NM_014795.4(ZEB2):c.916+1G>T	ZEB2		Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001067668	2	145158765	2	144401198	1067668	1054908		NC_000002.12:144401197:C:A
NM_014795.4(ZEB2):c.968G>T (p.Gly323Val)	ZEB2	G299V, G323V	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV001065427	2	145157786	2	144400219	1065427	1053733		NC_000002.12:144400218:C:A
NM_014795.4(ZEB2):c.2380A>G (p.Lys794Glu)	ZEB2	K770E, K794E	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV001064554	2	145156374	2	144398807	1064554	1052794		NC_000002.12:144398806:T:C
NM_014795.4(ZEB2):c.193G>A (p.Val65Met)	ZEB2	V65M	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001064340	2	145187474	2	144429907	1064340	1040541		NC_000002.12:144429906:C:T
NM_014795.4(ZEB2):c.1954T>C (p.Tyr652His)	ZEB2	Y628H, Y652H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001062186	2	145156800	2	144399233	1062186	1040539		NC_000002.12:144399232:A:G
NM_014795.4(ZEB2):c.75G>A (p.Val25=)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001061759	2	145187592	2	144430025	1061759	1040543		NC_000002.12:144430024:C:T
NM_014795.4(ZEB2):c.2917A>G (p.Met973Val)	ZEB2	M949V, M973V	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001055790	2	145154129	2	144396562	1055790	1040538		NC_000002.12:144396561:T:C
NM_014795.4(ZEB2):c.97G>A (p.Asp33Asn)	ZEB2	D33N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001055240	2	145187570	2	144430003	1055240	1040542		NC_000002.12:144430002:C:T
NM_014795.4(ZEB2):c.44G>T (p.Arg15Leu)	ZEB2	R15L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001053591	2	145274874	2	144517307	1053591	1040544		NC_000002.12:144517306:C:A
NM_014795.4(ZEB2):c.829G>A (p.Ala277Thr)	ZEB2	A253T, A277T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001052110	2	145158853	2	144401286	1052110	1040540		NC_000002.12:144401285:C:T
NM_014795.4(ZEB2):c.2263G>A (p.Asp755Asn)	ZEB2	D755N, D731N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001047712	2	145156491	2	144398924	1047712	1023700		NC_000002.12:144398923:C:T
NM_014795.4(ZEB2):c.167T>C (p.Leu56Pro)	ZEB2	L56P	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001046836	2	145187500	2	144429933	1046836	1023707		NC_000002.12:144429932:A:G
NM_014795.4(ZEB2):c.932A>T (p.Glu311Val)	ZEB2	E287V, E311V	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001046624	2	145157822	2	144400255	1046624	1023704		NC_000002.12:144400254:T:A
NM_014795.4(ZEB2):c.2764C>T (p.Pro922Ser)	ZEB2	P898S, P922S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001046534	2	145155990	2	144398423	1046534	1023698		NC_000002.12:144398422:G:A
NM_014795.4(ZEB2):c.370G>A (p.Ala124Thr)	ZEB2	A124T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001043958	2	145182396	2	144424829	1043958	1023706		NC_000002.12:144424828:C:T
NM_014795.4(ZEB2):c.2665T>C (p.Phe889Leu)	ZEB2	F865L, F889L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001043093	2	145156089	2	144398522	1043093	1023699		NC_000002.12:144398521:A:G
NM_014795.4(ZEB2):c.151G>A (p.Gly51Ser)	ZEB2	G51S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001041823	2	145187516	2	144429949	1041823	1023708		NC_000002.12:144429948:C:T
NM_014795.4(ZEB2):c.2162C>G (p.Pro721Arg)	ZEB2	P721R, P697R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV001041272	2	145156592	2	144399025	1041272	1023701		NC_000002.12:144399024:G:C
NM_014795.4(ZEB2):c.1850A>G (p.His617Arg)	ZEB2	H593R, H617R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001039201	2	145156904	2	144399337	1039201	1023702		NC_000002.12:144399336:T:C
NM_014795.4(ZEB2):c.3454G>C (p.Gly1152Arg)	ZEB2	G1128R, G1152R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001036642	2	145147209	2	144389642	1036642	1023697		NC_000002.12:144389641:C:G
NM_014795.4(ZEB2):c.1286A>G (p.His429Arg)	ZEB2	H405R, H429R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001036414	2	145157468	2	144399901	1036414	1023703		NC_000002.12:144399900:T:C
NM_014795.4(ZEB2):c.31C>T (p.Arg11Trp)	ZEB2	R11W	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV001032637	2	145274887	2	144517320	1032637	1019456		NC_000002.12:144517319:G:A
NM_014795.4(ZEB2):c.2840C>G (p.Ala947Gly)	ZEB2	A923G, A947G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV001032636	2	145155914	2	144398347	1032636	1019455		NC_000002.12:144398346:G:C
NM_014795.4(ZEB2):c.3467G>C (p.Gly1156Ala)	ZEB2	G1156A, G1132A	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001029312	2	145147196	2	144389629	1029312	1015833		NC_000002.12:144389628:C:G
NM_014795.4(ZEB2):c.3133C>T (p.His1045Tyr)	ZEB2	H1021Y, H1045Y	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001029311	2	145147530	2	144389963	1029311	1015834		NC_000002.12:144389962:G:A
NM_014795.4(ZEB2):c.2944T>C (p.Ser982Pro)	ZEB2	S982P, S958P	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV001029310	2	145154102	2	144396535	1029310	1015835		NC_000002.12:144396534:A:G
NM_014795.4(ZEB2):c.2886+1G>A	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001029309	2	145155867	2	144398300	1029309	1015836		NC_000002.12:144398299:C:T
NM_014795.4(ZEB2):c.2176T>C (p.Ser726Pro)	ZEB2	S726P, S702P	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001027896	2	145156578	2	144399011	1027896	1015837		NC_000002.12:144399010:A:G
NM_014795.4(ZEB2):c.1112A>T (p.Asn371Ile)	ZEB2	N371I, N347I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV001027895	2	145157642	2	144400075	1027895	1015838		NC_000002.12:144400074:T:A
NM_014795.4(ZEB2):c.2970G>T (p.Lys990Asn)	ZEB2	K966N, K990N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001027239	2	145154076	2	144396509	1027239	1003205		NC_000002.12:144396508:C:A
NM_014795.4(ZEB2):c.3146A>G (p.His1049Arg)	ZEB2	H1025R, H1049R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001026904	2	145147517	2	144389950	1026904	1003204		NC_000002.12:144389949:T:C
NM_014795.4(ZEB2):c.1466A>G (p.Tyr489Cys)	ZEB2	Y465C, Y489C	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001021419	2	145157288	2	144399721	1021419	1003209		NC_000002.12:144399720:T:C
NM_014795.4(ZEB2):c.422C>T (p.Thr141Ile)	ZEB2	T117I, T141I	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV001020884	2	145162573	2	144405006	1020884	1003210		NC_000002.12:144405005:G:A
NM_014795.4(ZEB2):c.50A>G (p.Gln17Arg)	ZEB2	Q17R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001020883	2	145274868	2	144517301	1020883	1003211		NC_000002.12:144517300:T:C
NM_014795.4(ZEB2):c.3400G>A (p.Gly1134Ser)	ZEB2	G1110S, G1134S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001018933	2	145147263	2	144389696	1018933	1003203		NC_000002.12:144389695:C:T
NM_014795.4(ZEB2):c.2150C>G (p.Pro717Arg)	ZEB2	P693R, P717R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001016453	2	145156604	2	144399037	1016453	1003206		NC_000002.12:144399036:G:C
NM_014795.4(ZEB2):c.2093A>G (p.Tyr698Cys)	ZEB2	Y674C, Y698C	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001014021	2	145156661	2	144399094	1014021	1003207		NC_000002.12:144399093:T:C
NM_014795.4(ZEB2):c.100A>C (p.Thr34Pro)	ZEB2	T34P	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001010313	2	145187567	2	144430000	1010313	987942		NC_000002.12:144429999:T:G
NM_014795.4(ZEB2):c.25G>A (p.Gly9Ser)	ZEB2	G9S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001008621	2	145274893	2	144517326	1008621	987943		NC_000002.12:144517325:C:T
NM_014795.4(ZEB2):c.554G>A (p.Arg185His)	ZEB2|LOC111721705	R161H, R185H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001005524	2	145162441	2	144404874	1005524	987940		NC_000002.12:144404873:C:T
NM_014795.4(ZEB2):c.2516C>G (p.Ala839Gly)	ZEB2	A815G, A839G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001001252	2	145156238	2	144398671	1001252	987939		NC_000002.12:144398670:G:C
NM_014795.4(ZEB2):c.338T>C (p.Met113Thr)	ZEB2	M113T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001000942	2	145182428	2	144424861	1000942	987941		NC_000002.12:144424860:A:G
NM_014795.4(ZEB2):c.917G>A (p.Gly306Asp)	ZEB2	G282D, G306D	Inborn genetic diseases|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000985660	2	145157837	2	144400270	985660	973239		NC_000002.12:144400269:C:T
NM_014795.4(ZEB2):c.1309C>T (p.Gln437Ter)	ZEB2	Q413*, Q437*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000983020	2	145157445	2	144399878	983020	970711		NC_000002.12:144399877:G:A
NM_014795.4(ZEB2):c.2825G>T (p.Gly942Val)	ZEB2	G918V, G942V	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000982850	2	145155929	2	144398362	982850	970710		NC_000002.12:144398361:C:A
NM_014795.4(ZEB2):c.441C>G (p.Tyr147Ter)	ZEB2	Y123*, Y147*	Mowat-Wilson syndrome	Likely pathogenic	no assertion criteria provided	VCV000977911	2	145162554	2	144404987	977911	965956		NC_000002.12:144404986:G:C
NM_014795.4(ZEB2):c.331+1G>T	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000975784	2	145187335	2	144429768	975784	964019		NC_000002.12:144429767:C:A
NM_014795.4(ZEB2):c.851G>A (p.Cys284Tyr)	ZEB2	C260Y, C284Y	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV000974618	2	145158831	2	144401264	974618	962915		NC_000002.12:144401263:C:T
NM_014795.4(ZEB2):c.2425G>T (p.Glu809Ter)	ZEB2	E785*, E809*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000973223	2	145156329	2	144398762	973223	961589		NC_000002.12:144398761:C:A
NM_014795.4(ZEB2):c.2419T>A (p.Ser807Thr)	ZEB2	S807T, S783T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000972300	2	145156335	2	144398768	972300	952632		NC_000002.12:144398767:A:T
NM_014795.4(ZEB2):c.2204C>G (p.Pro735Arg)	ZEB2	P711R, P735R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000970657	2	145156550	2	144398983	970657	952633		NC_000002.12:144398982:G:C
NM_014795.4(ZEB2):c.2847G>A (p.Met949Ile)	ZEB2	M925I, M949I	not provided|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000961764	2	145155907	2	144398340	961764	942231		NC_000002.12:144398339:C:T
NM_014795.4(ZEB2):c.1354A>G (p.Thr452Ala)	ZEB2	T428A, T452A	Mowat-Wilson syndrome	Benign(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000960463	2	145157400	2	144399833	960463	942236		NC_000002.12:144399832:T:C
NM_014795.4(ZEB2):c.1722C>A (p.Asn574Lys)	ZEB2	N574K, N550K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000959767	2	145157032	2	144399465	959767	942234		NC_000002.12:144399464:G:T
NM_014795.4(ZEB2):c.3610G>A (p.Asp1204Asn)	ZEB2	D1180N, D1204N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000958873	2	145147053	2	144389486	958873	942230		NC_000002.12:144389485:C:T
NM_014795.4(ZEB2):c.1947C>G (p.Ile649Met)	ZEB2	I649M, I625M	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000957556	2	145156807	2	144399240	957556	942232		NC_000002.12:144399239:G:C
NM_014795.4(ZEB2):c.1714A>C (p.Ile572Leu)	ZEB2	I548L, I572L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000957425	2	145157040	2	144399473	957425	942235		NC_000002.12:144399472:T:G
NM_014795.4(ZEB2):c.199A>C (p.Asn67His)	ZEB2	N67H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000956159	2	145187468	2	144429901	956159	942238		NC_000002.12:144429900:T:G
NM_014795.4(ZEB2):c.1028G>A (p.Arg343Gln)	ZEB2	R343Q, R319Q	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 4, 2019)	criteria provided, single submitter	VCV000955846	2	145157726	2	144400159	955846	942237		NC_000002.12:144400158:C:T
NM_014795.4(ZEB2):c.1879G>A (p.Val627Ile)	ZEB2	V603I, V627I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000952294	2	145156875	2	144399308	952294	922242		NC_000002.12:144399307:C:T
NM_014795.4(ZEB2):c.2993T>C (p.Met998Thr)	ZEB2	M998T, M974T	Mowat-Wilson syndrome	Benign(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000951741	2	145154053	2	144396486	951741	922241		NC_000002.12:144396485:A:G
NM_014795.4(ZEB2):c.1601A>G (p.Asn534Ser)	ZEB2	N534S, N510S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000950301	2	145157153	2	144399586	950301	922244		NC_000002.12:144399585:T:C
NM_014795.4(ZEB2):c.1655G>A (p.Ser552Asn)	ZEB2	S528N, S552N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000946656	2	145157099	2	144399532	946656	922243		NC_000002.12:144399531:C:T
NM_014795.4(ZEB2):c.3430G>A (p.Gly1144Ser)	ZEB2	G1120S, G1144S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000946596	2	145147233	2	144389666	946596	922240		NC_000002.12:144389665:C:T
NM_014795.4(ZEB2):c.3512G>A (p.Ser1171Asn)	ZEB2	S1147N, S1171N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000946194	2	145147151	2	144389584	946194	922239		NC_000002.12:144389583:C:T
NM_014795.4(ZEB2):c.916+5G>A	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000945657	2	145158761	2	144401194	945657	940654		NC_000002.12:144401193:C:T
NM_014795.4(ZEB2):c.1091C>T (p.Ser364Leu)	ZEB2	S340L, S364L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000945233	2	145157663	2	144400096	945233	922246		NC_000002.12:144400095:G:A
NM_014795.4(ZEB2):c.2124G>A (p.Leu708=)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV000941757	2	145156630	2	144399063	941757	930801		NC_000002.12:144399062:C:T
NM_014795.4(ZEB2):c.1885G>C (p.Val629Leu)	ZEB2	V629L, V605L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000939431	2	145156869	2	144399302	939431	930802		NC_000002.12:144399301:C:G
NM_014795.4(ZEB2):c.67A>T (p.Lys23Ter)	ZEB2	K23*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000937858	2	145274851	2	144517284	937858	930806		NC_000002.12:144517283:T:A
NM_014795.4(ZEB2):c.3527C>A (p.Pro1176His)	ZEB2	P1152H, P1176H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000935467	2	145147136	2	144389569	935467	930800		NC_000002.12:144389568:G:T
NM_014795.4(ZEB2):c.128A>G (p.Lys43Arg)	ZEB2	K43R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV000934845	2	145187539	2	144429972	934845	930805		NC_000002.12:144429971:T:C
NM_014795.4(ZEB2):c.1745C>T (p.Ser582Leu)	ZEB2	S582L, S558L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000934548	2	145157009	2	144399442	934548	930803		NC_000002.12:144399441:G:A
NM_014795.4(ZEB2):c.26G>A (p.Gly9Asp)	ZEB2	G9D	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000933393	2	145274892	2	144517325	933393	930807		NC_000002.12:144517324:C:T
NM_014795.4(ZEB2):c.1471A>T (p.Met491Leu)	ZEB2	M467L, M491L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000862431	2	145157283	2	144399716	862431	824768		NC_000002.12:144399715:T:A
NM_014795.4(ZEB2):c.757C>A (p.Arg253Ser)	ZEB2	R229S, R253S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000861296	2	145161533	2	144403966	861296	824774		NC_000002.12:144403965:G:T
NM_014795.4(ZEB2):c.2044G>C (p.Gly682Arg)	ZEB2	G658R, G682R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 13, 2019)	criteria provided, single submitter	VCV000857080	2	145156710	2	144399143	857080	824767		NC_000002.12:144399142:C:G
NM_014795.4(ZEB2):c.2967A>G (p.Lys989=)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000856579	2	145154079	2	144396512	856579	824761		NC_000002.12:144396511:T:C
NM_014795.4(ZEB2):c.3280G>A (p.Glu1094Lys)	ZEB2	E1094K, E1070K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000852429	2	145147383	2	144389816	852429	824759		NC_000002.12:144389815:C:T
NM_014795.4(ZEB2):c.1434C>A (p.Cys478Ter)	ZEB2	C478*, C454*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000846691	2	145157320	2	144399753	846691	824769		NC_000002.12:144399752:G:T
NM_014795.4(ZEB2):c.1277T>A (p.Leu426Ter)	ZEB2	L426*, L402*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000844347	2	145157477	2	144399910	844347	824770		NC_000002.12:144399909:A:T
NM_014795.4(ZEB2):c.785C>T (p.Thr262Ile)	ZEB2	T262I, T238I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV000844344	2	145161505	2	144403938	844344	824773		NC_000002.12:144403937:G:A
NM_014795.4(ZEB2):c.493G>T (p.Glu165Ter)	ZEB2	E141*, E165*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000843162	2	145162502	2	144404935	843162	824775		NC_000002.12:144404934:C:A
NM_014795.4(ZEB2):c.2707G>A (p.Ala903Thr)	ZEB2	A879T, A903T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000841521	2	145156047	2	144398480	841521	824763		NC_000002.12:144398479:C:T
NM_014795.4(ZEB2):c.2275A>G (p.Arg759Gly)	ZEB2	R735G, R759G	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 26, 2021)	criteria provided, conflicting interpretations	VCV000841461	2	145156479	2	144398912	841461	824765		NC_000002.12:144398911:T:C
NM_014795.4(ZEB2):c.2935A>G (p.Met979Val)	ZEB2	M955V, M979V	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000840243	2	145154111	2	144396544	840243	824762		NC_000002.12:144396543:T:C
NM_014795.4(ZEB2):c.1130A>C (p.Lys377Thr)	ZEB2	K377T, K353T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000840157	2	145157624	2	144400057	840157	824772		NC_000002.12:144400056:T:G
NM_014795.4(ZEB2):c.1211T>C (p.Met404Thr)	ZEB2	M380T, M404T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000839876	2	145157543	2	144399976	839876	824771		NC_000002.12:144399975:A:G
NM_014795.4(ZEB2):c.29C>T (p.Pro10Leu)	ZEB2	P10L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000839856	2	145274889	2	144517322	839856	824777		NC_000002.12:144517321:G:A
NM_014795.4(ZEB2):c.11C>T (p.Pro4Leu)	ZEB2	P4L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000839637	2	145274907	2	144517340	839637	824778		NC_000002.12:144517339:G:A
NM_014795.4(ZEB2):c.469G>A (p.Asp157Asn)	ZEB2	D133N, D157N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000838010	2	145162526	2	144404959	838010	824776		NC_000002.12:144404958:C:T
NM_014795.4(ZEB2):c.3196C>T (p.His1066Tyr)	ZEB2	H1042Y, H1066Y	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000837537	2	145147467	2	144389900	837537	824760		NC_000002.12:144389899:G:A
NM_014795.4(ZEB2):c.1387G>A (p.Val463Ile)	ZEB2	V439I, V463I	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000833993	2	145157367	2	144399800	833993	821848		NC_000002.12:144399799:C:T
NM_014795.4(ZEB2):c.2119T>A (p.Ser707Thr)	ZEB2	S707T, S683T	Mowat-Wilson syndrome	Benign(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000833970	2	145156635	2	144399068	833970	821847		NC_000002.12:144399067:A:T
NM_014795.4(ZEB2):c.3311C>T (p.Thr1104Ile)	ZEB2	T1080I, T1104I	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000833882	2	145147352	2	144389785	833882	821843		NC_000002.12:144389784:G:A
NM_014795.4(ZEB2):c.2824G>A (p.Gly942Arg)	ZEB2	G918R, G942R	Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000833740	2	145155930	2	144398363	833740	821845		NC_000002.12:144398362:C:T
NM_014795.4(ZEB2):c.3295G>C (p.Gly1099Arg)	ZEB2	G1075R, G1099R	Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000833618	2	145147368	2	144389801	833618	821844		NC_000002.12:144389800:C:G
NM_014795.4(ZEB2):c.224G>A (p.Ser75Asn)	ZEB2	S75N	Mowat-Wilson syndrome	Benign(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000833588	2	145187443	2	144429876	833588	821850		NC_000002.12:144429875:C:T
NM_014795.4(ZEB2):c.242G>C (p.Arg81Thr)	ZEB2	R81T	Mowat-Wilson syndrome	Benign(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000833587	2	145187425	2	144429858	833587	821849		NC_000002.12:144429857:C:G
NM_014795.4(ZEB2):c.2374T>C (p.Ser792Pro)	ZEB2	S768P, S792P	Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000833534	2	145156380	2	144398813	833534	821846		NC_000002.12:144398812:A:G
NM_014795.4(ZEB2):c.899A>G (p.His300Arg)	ZEB2	H300R, H276R	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000807725	2	145158783	2	144401216	807725	798481	rs1573718595	NC_000002.12:144401215:T:C
NM_014795.4(ZEB2):c.244G>A (p.Glu82Lys)	ZEB2	E82K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801756	2	145187423	2	144429856	801756	790049	rs1573743847	NC_000002.12:144429855:C:T
NM_014795.4(ZEB2):c.2095C>T (p.Gln699Ter)	ZEB2	Q675*, Q699*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801755	2	145156659	2	144399092	801755	790048	rs1573716158	NC_000002.12:144399091:G:A
NM_014795.4(ZEB2):c.3122A>G (p.His1041Arg)	ZEB2	H1017R, H1041R	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801753	2	145147541	2	144389974	801753	790046	rs1573708153	NC_000002.12:144389973:T:C
NM_014795.4(ZEB2):c.3114C>G (p.His1038Gln)	ZEB2	H1014Q, H1038Q	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000800745	2	145147549	2	144389982	800745	788742	rs1573708173	NC_000002.12:144389981:G:C
NM_014795.4(ZEB2):c.471T>C (p.Asp157=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000797260	2	145162524	2	144404957	797260	780835	rs775694100	NC_000002.12:144404956:A:G
NM_014795.4(ZEB2):c.403+10G>A	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000795207	2	145182353	2	144424786	795207	787196	rs1573739611	NC_000002.12:144424785:C:T
NM_014795.4(ZEB2):c.2175C>T (p.Asp725=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000794938	2	145156579	2	144399012	794938	780833	rs1184693387	NC_000002.12:144399011:G:A
NM_014795.4(ZEB2):c.3459A>G (p.Arg1153=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000794862	2	145147204	2	144389637	794862	780832	rs1573707737	NC_000002.12:144389636:T:C
NM_014795.4(ZEB2):c.3067+8T>A	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV000794443	2	145153971	2	144396404	794443	787188	rs1573713416	NC_000002.12:144396403:A:T
NM_014795.4(ZEB2):c.1965C>T (p.His655=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000765456	2	145156789	2	144399222	765456	762194	rs1290881093	NC_000002.12:144399221:G:A
NM_014795.4(ZEB2):c.1470C>T (p.His490=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000762704	2	145157284	2	144399717	762704	762196	rs767360787	NC_000002.12:144399716:G:A
NM_014795.4(ZEB2):c.1353C>T (p.Pro451=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000755821	2	145157401	2	144399834	755821	762197	rs1573717237	NC_000002.12:144399833:G:A
NM_014795.4(ZEB2):c.2085A>G (p.Arg695=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000755079	2	145156669	2	144399102	755079	762193	rs1573716167	NC_000002.12:144399101:T:C
NM_014795.4(ZEB2):c.2385C>T (p.Asn795=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000754025	2	145156369	2	144398802	754025	762192	rs759505392	NC_000002.12:144398801:G:A
NM_014795.4(ZEB2):c.1890T>C (p.Asp630=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000753258	2	145156864	2	144399297	753258	762195	rs1220461554	NC_000002.12:144399296:A:G
NM_014795.4(ZEB2):c.2547T>C (p.Val849=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 2, 2020)	criteria provided, single submitter	VCV000745011	2	145156207	2	144398640	745011	746783	rs908943407	NC_000002.12:144398639:A:G
NM_014795.4(ZEB2):c.1240C>A (p.Pro414Thr)	ZEB2	P390T, P414T	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000741718	2	145157514	2	144399947	741718	746784	rs755425183	NC_000002.12:144399946:G:T
NM_014795.4(ZEB2):c.2565C>G (p.Asn855Lys)	ZEB2	N855K, N831K	Mowat-Wilson syndrome	Benign(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000719246	2	145156189	2	144398622	719246	719275	rs904620951	NC_000002.12:144398621:G:C
NM_014795.4(ZEB2):c.3495A>G (p.Glu1165=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000703403	2	145147168	2	144389601	703403	690742	rs907774736	NC_000002.12:144389600:T:C
NM_014795.4(ZEB2):c.2373A>G (p.Thr791=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000703060	2	145156381	2	144398814	703060	690743	rs775082191	NC_000002.12:144398813:T:C
NM_014795.4(ZEB2):c.180G>A (p.Thr60=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000702433	2	145187487	2	144429920	702433	690744	rs372888487	NC_000002.12:144429919:C:T
NM_014795.4(ZEB2):c.3489A>G (p.Glu1163=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV000701712	2	145147174	2	144389607	701712	685839	rs1573707668	NC_000002.12:144389606:T:C
NM_014795.4(ZEB2):c.3285G>A (p.Ala1095=)	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV000700655	2	145147378	2	144389811	700655	685840	rs201630448	NC_000002.12:144389810:C:T
NM_014795.4(ZEB2):c.2541C>T (p.Asn847=)	ZEB2		not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000698870	2	145156213	2	144398646	698870	685841	rs759097498	NC_000002.12:144398645:G:A
NM_014795.4(ZEB2):c.2342A>G (p.Asn781Ser)	ZEB2	N757S, N781S	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000698511	2	145156412	2	144398845	698511	685842	rs750936389	NC_000002.12:144398844:T:C
NM_014795.4(ZEB2):c.2808C>T (p.Ala936=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000697223	2	145155946	2	144398379	697223	683391	rs749708858	NC_000002.12:144398378:G:A
NM_014795.4(ZEB2):c.2538T>A (p.His846Gln)	ZEB2	H822Q, H846Q	Mowat-Wilson syndrome|not provided	Benign(Last reviewed: Apr 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000696826	2	145156216	2	144398649	696826	683393	rs557767273	NC_000002.12:144398648:A:T
NM_014795.4(ZEB2):c.2804T>C (p.Met935Thr)	ZEB2	M911T, M935T	not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000696738	2	145155950	2	144398383	696738	683392	rs201902790	NC_000002.12:144398382:A:G
NM_014795.4(ZEB2):c.2627A>G (p.Asp876Gly)	ZEB2	D876G, D852G	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2020)	criteria provided, conflicting interpretations	VCV000681961	2	145156127	2	144398560	681961	655139	rs779103467	NC_000002.12:144398559:T:C
NM_014795.4(ZEB2):c.2733A>G (p.Pro911=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000681072	2	145156021	2	144398454	681072	655138	rs750408329	NC_000002.12:144398453:T:C
NM_014795.4(ZEB2):c.1008T>C (p.Gly336=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000671958	2	145157746	2	144400179	671958	655141	rs149510351	NC_000002.12:144400178:A:G
NM_014795.4(ZEB2):c.3308C>A (p.Pro1103His)	ZEB2	P1103H, P1079H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000665219	2	145147355	2	144389788	665219	628448	rs1385679012	NC_000002.12:144389787:G:T
NM_014795.4(ZEB2):c.2337G>C (p.Arg779Ser)	ZEB2	R779S, R755S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000661027	2	145156417	2	144398850	661027	628453	rs1573715809	NC_000002.12:144398849:C:G
NM_014795.4(ZEB2):c.933G>T (p.Glu311Asp)	ZEB2	E287D, E311D	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000660079	2	145157821	2	144400254	660079	628456	rs1573717761	NC_000002.12:144400253:C:A
NM_014795.4(ZEB2):c.2239C>T (p.Leu747Phe)	ZEB2	L723F, L747F	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000659354	2	145156515	2	144398948	659354	628454	rs1160664411	NC_000002.12:144398947:G:A
NM_014795.4(ZEB2):c.3070A>G (p.Lys1024Glu)	ZEB2	K1000E, K1024E	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 23, 2018)	criteria provided, single submitter	VCV000657836	2	145147593	2	144390026	657836	628450	rs1573708232	NC_000002.12:144390025:T:C
NM_014795.4(ZEB2):c.751G>A (p.Ala251Thr)	ZEB2	A227T, A251T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000657562	2	145161539	2	144403972	657562	628458	rs1437414345	NC_000002.12:144403971:C:T
NM_014795.4(ZEB2):c.364C>T (p.Pro122Ser)	ZEB2	P122S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000645462	2	145182402	2	144424835	645462	628461	rs1573739706	NC_000002.12:144424834:G:A
NM_014795.4(ZEB2):c.3298C>T (p.His1100Tyr)	ZEB2	H1100Y, H1076Y	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 4, 2018)	criteria provided, single submitter	VCV000645103	2	145147365	2	144389798	645103	628449	rs1573707949	NC_000002.12:144389797:G:A
NM_014795.4(ZEB2):c.2647G>A (p.Val883Met)	ZEB2	V883M, V859M	not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000644069	2	145156107	2	144398540	644069	628452	rs550047043	NC_000002.12:144398539:C:T
NM_014795.4(ZEB2):c.2692C>T (p.Leu898Phe)	ZEB2	L874F, L898F	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000640254	2	145156062	2	144398495	640254	628451	rs1573715321	NC_000002.12:144398494:G:A
NM_014795.4(ZEB2):c.703G>T (p.Glu235Ter)	ZEB2	E235*, E211*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000619079	2	145161587	2	144404020	619079	610477	rs1553962069	NC_000002.12:144404019:C:A
NM_014795.4(ZEB2):c.1554T>C (p.His518=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000590043	2	145157200	2	144399633	590043	578911	rs1431508601	NC_000002.12:144399632:A:G
NM_014795.4(ZEB2):c.2589T>C (p.Thr863=)	ZEB2		Mowat-Wilson syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589784	2	145156165	2	144398598	589784	578929	rs985918539	NC_000002.12:144398597:A:G
NM_014795.4(ZEB2):c.1049C>T (p.Thr350Met)	ZEB2	T350M, T326M	Mowat-Wilson syndrome|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589364	2	145157705	2	144400138	589364	578917	rs975397942	NC_000002.12:144400137:G:A
NM_014795.4(ZEB2):c.1956C>A (p.Tyr652Ter)	ZEB2	Y652*, Y628*	Mowat-Wilson syndrome|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000589324	2	145156798	2	144399231	589324	578959	rs587784563	NC_000002.12:144399230:G:T
NM_014795.4(ZEB2):c.2774G>A (p.Gly925Glu)	ZEB2	G925E, G901E	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000580028	2	145155980	2	144398413	580028	559210	rs1408659659	NC_000002.12:144398412:C:T
NM_014795.4(ZEB2):c.2418C>A (p.Phe806Leu)	ZEB2	F806L, F782L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000575923	2	145156336	2	144398769	575923	557514	rs770951243	NC_000002.12:144398768:G:T
NM_014795.4(ZEB2):c.2541C>A (p.Asn847Lys)	ZEB2	N847K, N823K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000575296	2	145156213	2	144398646	575296	558721	rs759097498	NC_000002.12:144398645:G:T
NM_014795.4(ZEB2):c.2354C>G (p.Pro785Arg)	ZEB2	P785R, P761R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000574367	2	145156400	2	144398833	574367	557518	rs1560606278	NC_000002.12:144398832:G:C
NM_014795.4(ZEB2):c.3599A>G (p.Glu1200Gly)	ZEB2	E1200G, E1176G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000574019	2	145147064	2	144389497	574019	558719	rs1273805127	NC_000002.12:144389496:T:C
NM_014795.4(ZEB2):c.1222G>A (p.Gly408Arg)	ZEB2	G408R, G384R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV000572911	2	145157532	2	144399965	572911	558727	rs770190727	NC_000002.12:144399964:C:T
NM_014795.4(ZEB2):c.3538C>G (p.Arg1180Gly)	ZEB2	R1180G, R1156G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000572414	2	145147125	2	144389558	572414	559206	rs756424812	NC_000002.12:144389557:G:C
NM_014795.4(ZEB2):c.3025C>T (p.Gln1009Ter)	ZEB2	Q1009*, Q985*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000572098	2	145154021	2	144396454	572098	559208	rs1560604977	NC_000002.12:144396453:G:A
NM_014795.4(ZEB2):c.2390A>G (p.His797Arg)	ZEB2	H797R, H773R	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000569903	2	145156364	2	144398797	569903	557516	rs201227541	NC_000002.12:144398796:T:C
NM_014795.4(ZEB2):c.808-2A>G	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000569478	2	145158876	2	144401309	569478	557565	rs1560607925	NC_000002.12:144401308:T:C
NM_014795.4(ZEB2):c.2545G>A (p.Val849Ile)	ZEB2	V849I, V825I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000569360	2	145156209	2	144398642	569360	557563	rs1560606101	NC_000002.12:144398641:C:T
NM_014795.4(ZEB2):c.1845G>T (p.Gln615His)	ZEB2	Q615H, Q591H	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000568984	2	145156909	2	144399342	568984	557522	rs757485792	NC_000002.12:144399341:C:A
NM_014795.4(ZEB2):c.1975C>T (p.Leu659Phe)	ZEB2	L659F, L635F	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000568915	2	145156779	2	144399212	568915	557520	rs1560606673	NC_000002.12:144399211:G:A
NM_014795.4(ZEB2):c.351T>A (p.Tyr117Ter)	ZEB2	Y117*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000567647	2	145182415	2	144424848	567647	557526	rs1560618505	NC_000002.12:144424847:A:T
NM_014795.4(ZEB2):c.1571G>A (p.Ser524Asn)	ZEB2	S524N, S500N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000566943	2	145157183	2	144399616	566943	558723	rs1560606972	NC_000002.12:144399615:C:T
NM_014795.4(ZEB2):c.3200C>A (p.Ser1067Ter)	ZEB2	S1067*, S1043*	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547837	2	145147463	2	144389896	547837	537690	rs1423851170	NC_000002.12:144389895:G:T
NM_014795.4(ZEB2):c.3023T>G (p.Phe1008Cys)	ZEB2	F1008C, F984C	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547836	2	145154023	2	144396456	547836	537691	rs1553961332	NC_000002.12:144396455:A:C
NM_014795.4(ZEB2):c.1162C>T (p.Leu388Phe)	ZEB2	L388F, L364F	Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547833	2	145157592	2	144400025	547833	537694	rs1553961748	NC_000002.12:144400024:G:A
NM_014795.4(ZEB2):c.216A>C (p.Pro72=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000534646	2	145187451	2	144429884	534646	516360	rs764560219	NC_000002.12:144429883:T:G
NM_014795.4(ZEB2):c.2120C>T (p.Ser707Phe)	ZEB2	S707F, S683F	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000534645	2	145156634	2	144399067	534645	516426	rs1174325176	NC_000002.12:144399066:G:A
NM_014795.4(ZEB2):c.807+3G>A	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000534644	2	145161480	2	144403913	534644	516344	rs144925893	NC_000002.12:144403912:C:T
NM_014795.4(ZEB2):c.168G>C (p.Leu56=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000534643	2	145187499	2	144429932	534643	516456	rs1553964156	NC_000002.12:144429931:C:G
NM_014795.4(ZEB2):c.1426A>C (p.Met476Leu)	ZEB2	M476L, M452L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000534642	2	145157328	2	144399761	534642	516454	rs778246270	NC_000002.12:144399760:T:G
NM_014795.4(ZEB2):c.1491A>C (p.Gln497His)	ZEB2	Q497H, Q473H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000534641	2	145157263	2	144399696	534641	516446	rs200378546	NC_000002.12:144399695:T:G
NM_014795.4(ZEB2):c.3357G>C (p.Gln1119His)	ZEB2	Q1119H, Q1095H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000534639	2	145147306	2	144389739	534639	516436	rs1332911302	NC_000002.12:144389738:C:G
NM_014795.4(ZEB2):c.1880T>A (p.Val627Asp)	ZEB2	V627D, V603D	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 4, 2020)	criteria provided, conflicting interpretations	VCV000534638	2	145156874	2	144399307	534638	516357	rs730881176	NC_000002.12:144399306:A:T
NM_014795.4(ZEB2):c.467G>A (p.Arg156His)	ZEB2	R156H, R132H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV000534637	2	145162528	2	144404961	534637	516437	rs1250217464	NC_000002.12:144404960:C:T
NM_014795.4(ZEB2):c.3575A>C (p.Asp1192Ala)	ZEB2	D1192A, D1168A	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000534636	2	145147088	2	144389521	534636	516411	rs752093966	NC_000002.12:144389520:T:G
NM_014795.4(ZEB2):c.3267A>C (p.Glu1089Asp)	ZEB2	E1089D, E1065D	Mowat-Wilson syndrome|Lennox-Gastaut syndrome	Uncertain significance(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000534635	2	145147396	2	144389829	534635	516418	rs1553960775	NC_000002.12:144389828:T:G
NM_014795.4(ZEB2):c.703G>A (p.Glu235Lys)	ZEB2	E235K, E211K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000534634	2	145161587	2	144404020	534634	516428	rs1553962069	NC_000002.12:144404019:C:T
NM_014795.4(ZEB2):c.2621A>C (p.Asn874Thr)	ZEB2	N874T, N850T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000534633	2	145156133	2	144398566	534633	516423	rs1477010525	NC_000002.12:144398565:T:G
NM_014795.4(ZEB2):c.2327A>G (p.Asp776Gly)	ZEB2	D776G, D752G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000534630	2	145156427	2	144398860	534630	516355	rs1553961558	NC_000002.12:144398859:T:C
NM_014795.4(ZEB2):c.1527G>A (p.Pro509=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516856	2	145157227	2	144399660	516856	498656	rs759999662	NC_000002.12:144399659:C:T
NM_014795.4(ZEB2):c.1336C>T (p.Pro446Ser)	ZEB2	P446S, P422S	Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516349	2	145157418	2	144399851	516349	498659	rs1435380197	NC_000002.12:144399850:G:A
NM_014795.4(ZEB2):c.384C>T (p.Thr128=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000514330	2	145182382	2	144424815	514330	498668	rs573552493	NC_000002.12:144424814:G:A
NM_014795.4(ZEB2):c.2300C>T (p.Thr767Ile)	ZEB2	T767I, T743I	not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2020)	criteria provided, conflicting interpretations	VCV000513556	2	145156454	2	144398887	513556	498911	rs755233964	NC_000002.12:144398886:G:A
NM_014795.4(ZEB2):c.3057C>T (p.Tyr1019=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000512784	2	145153989	2	144396422	512784	498643	rs541915540	NC_000002.12:144396421:G:A
NM_014795.4(ZEB2):c.2226A>T (p.Pro742=)	ZEB2		not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 30, 2020)	criteria provided, conflicting interpretations	VCV000511735	2	145156528	2	144398961	511735	498654	rs540345773	NC_000002.12:144398960:T:A
NM_014795.4(ZEB2):c.720C>T (p.Asn240=)	ZEB2		Mowat-Wilson syndrome|not specified|not provided	Likely benign(Last reviewed: Jun 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000510555	2	145161570	2	144404003	510555	498660	rs1022840384	NC_000002.12:144404002:G:A
NM_014795.4(ZEB2):c.981G>A (p.Ser327=)	ZEB2		Mowat-Wilson syndrome|not provided	Benign(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000510410	2	145157773	2	144400206	510410	498875	rs201579452	NC_000002.12:144400205:C:T
NM_014795.4(ZEB2):c.828A>G (p.Gly276=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000509911	2	145158854	2	144401287	509911	498876	rs1161704021	NC_000002.12:144401286:T:C
NM_014795.4(ZEB2):c.2855G>C (p.Arg952Thr)	ZEB2	R952T, R928T	not specified|not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	VCV000506473	2	145155899	2	144398332	506473	498650	rs151256895	NC_000002.12:144398331:C:G
NM_014795.4(ZEB2):c.3118C>T (p.His1040Tyr)	ZEB2	H1016Y, H1040Y	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000496685	2	145147545	2	144389978	496685	488152	rs1553960788	NC_000002.12:144389977:G:A
NM_014795.4(ZEB2):c.807+8G>A	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000466291	2	145161475	2	144403908	466291	448710	rs367991951	NC_000002.12:144403907:C:T
NM_014795.4(ZEB2):c.593-9C>T	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000466290	2	145161706	2	144404139	466290	448726	rs372216323	NC_000002.12:144404138:G:A
NM_014795.4(ZEB2):c.3451C>A (p.Leu1151Met)	ZEB2	L1151M, L1127M	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000466288	2	145147212	2	144389645	466288	448789	rs772764893	NC_000002.12:144389644:G:T
NM_014795.4(ZEB2):c.3327C>A (p.Asn1109Lys)	ZEB2	N1109K, N1085K	not provided|Mowat-Wilson syndrome	Benign(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000466287	2	145147336	2	144389769	466287	448790	rs1288140327	NC_000002.12:144389768:G:T
NM_014795.4(ZEB2):c.324T>C (p.Asp108=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000466286	2	145187343	2	144429776	466286	448797	rs148117680	NC_000002.12:144429775:A:G
NM_014795.4(ZEB2):c.30C>T (p.Pro10=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000466285	2	145274888	2	144517321	466285	448713	rs747483109	NC_000002.12:144517320:G:A
NM_014795.4(ZEB2):c.2951C>T (p.Ser984Phe)	ZEB2	S984F, S960F	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000466284	2	145154095	2	144396528	466284	448695	rs143474223	NC_000002.12:144396527:G:A
NM_014795.4(ZEB2):c.2869C>T (p.Arg957Trp)	ZEB2	R957W, R933W	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000466283	2	145155885	2	144398318	466283	448699	rs1354236085	NC_000002.12:144398317:G:A
NM_014795.4(ZEB2):c.2762G>A (p.Arg921Gln)	ZEB2	R921Q, R897Q	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000466282	2	145155992	2	144398425	466282	448703	rs147716561	NC_000002.12:144398424:C:T
NM_014795.4(ZEB2):c.2325G>A (p.Leu775=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV000466280	2	145156429	2	144398862	466280	448572	rs1553961560	NC_000002.12:144398861:C:T
NM_014795.4(ZEB2):c.1993A>G (p.Met665Val)	ZEB2	M665V, M641V	Mowat-Wilson syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2019)	criteria provided, conflicting interpretations	VCV000466278	2	145156761	2	144399194	466278	448712	rs1388932284	NC_000002.12:144399193:T:C
NM_014795.4(ZEB2):c.1836G>A (p.Ala612=)	ZEB2		Mowat-Wilson syndrome|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000466277	2	145156918	2	144399351	466277	448792	rs754916469	NC_000002.12:144399350:C:T
NM_014795.4(ZEB2):c.1503A>G (p.Gln501=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000466276	2	145157251	2	144399684	466276	448714	rs1269576350	NC_000002.12:144399683:T:C
NM_014795.4(ZEB2):c.1309C>A (p.Gln437Lys)	ZEB2	Q437K, Q413K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000466275	2	145157445	2	144399878	466275	448706	rs760437173	NC_000002.12:144399877:G:T
NM_014795.4(ZEB2):c.1221C>T (p.His407=)	ZEB2		Mowat-Wilson syndrome|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000466274	2	145157533	2	144399966	466274	448717	rs144613207	NC_000002.12:144399965:G:A
NM_014795.4(ZEB2):c.1053T>C (p.Gly351=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000466273	2	145157701	2	144400134	466273	448718	rs1553961766	NC_000002.12:144400133:A:G
NM_014795.4(ZEB2):c.2471T>C (p.Met824Thr)	ZEB2	M824T, M800T	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000450276	2	145156283	2	144398716	450276	442923	rs1553961536	NC_000002.12:144398715:A:G
NM_014795.4(ZEB2):c.74-3C>T	ZEB2		not specified|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000448886	2	145187596	2	144430029	448886	440523	rs984545941	NC_000002.12:144430028:G:A
NM_014795.4(ZEB2):c.1489C>T (p.Gln497Ter)	ZEB2	Q497*, Q473*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000437333	2	145157265	2	144399698	437333	427889	rs1553961702	NC_000002.12:144399697:G:A
NM_014795.4(ZEB2):c.2072G>A (p.Trp691Ter)	ZEB2	W691*, W667*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000437332	2	145156682	2	144399115	437332	427887	rs1553961610	NC_000002.12:144399114:C:T
NM_014795.4(ZEB2):c.220G>A (p.Val74Met)	ZEB2	V74M	Mowat-Wilson syndrome|not specified	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437331	2	145187447	2	144429880	437331	427895	rs767169568	NC_000002.12:144429879:C:T
NM_014795.4(ZEB2):c.466C>T (p.Arg156Cys)	ZEB2	R156C, R132C	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2019)	criteria provided, conflicting interpretations	VCV000437330	2	145162529	2	144404962	437330	427893	rs147021269	NC_000002.12:144404961:G:A
NM_014795.4(ZEB2):c.2497A>G (p.Thr833Ala)	ZEB2	T833A, T809A	not specified|Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437325	2	145156257	2	144398690	437325	427885	rs1490526407	NC_000002.12:144398689:T:C
NM_014795.4(ZEB2):c.3109A>T (p.Lys1037Ter)	ZEB2	K1037*, K1013*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000437324	2	145147554	2	144389987	437324	427883	rs1553960793	NC_000002.12:144389986:T:A
NM_014795.4(ZEB2):c.3164A>G (p.Tyr1055Cys)	ZEB2	Y1055C, Y1031C	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000431481	2	145147499	2	144389932	431481	424988	rs1135402759	NC_000002.12:144389931:T:C
NM_014795.4(ZEB2):c.3170G>A (p.Cys1057Tyr)	ZEB2	C1057Y, C1033Y	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431116	2	145147493	2	144389926	431116	424640	rs1135401790	NC_000002.12:144389925:C:T
NM_014795.4(ZEB2):c.1315T>C (p.Leu439=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000413313	2	145157439	2	144399872	413313	391506	rs1060503991	NC_000002.12:144399871:A:G
NM_014795.4(ZEB2):c.702C>T (p.His234=)	ZEB2		Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: Feb 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000413312	2	145161588	2	144404021	413312	391419	rs140169964	NC_000002.12:144404020:G:A
NM_014795.4(ZEB2):c.1386G>C (p.Lys462Asn)	ZEB2	K462N, K438N	not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV000413311	2	145157368	2	144399801	413311	391364	rs780523431	NC_000002.12:144399800:C:G
NM_014795.4(ZEB2):c.696C>T (p.Tyr232=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000413310	2	145161594	2	144404027	413310	391421	rs1060503990	NC_000002.12:144404026:G:A
NM_014795.4(ZEB2):c.1071T>G (p.Val357=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000413309	2	145157683	2	144400116	413309	391508	rs200510665	NC_000002.12:144400115:A:C
NM_014795.4(ZEB2):c.3408C>G (p.Ser1136Arg)	ZEB2	S1136R, S1112R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000405333	2	145147255	2	144389688	405333	391602	rs1060500655	NC_000002.12:144389687:G:C
NM_014795.4(ZEB2):c.2622T>A (p.Asn874Lys)	ZEB2	N874K, N850K	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	VCV000392737	2	145156132	2	144398565	392737	365558	rs745927130	NC_000002.12:144398564:A:T
NM_014795.4(ZEB2):c.621T>C (p.Phe207=)	ZEB2		Mowat-Wilson syndrome|not specified|not provided	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391948	2	145161669	2	144404102	391948	365575	rs934470843	NC_000002.12:144404101:A:G
NM_014795.4(ZEB2):c.396T>C (p.Asn132=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391187	2	145182370	2	144424803	391187	365390	rs147072510	NC_000002.12:144424802:A:G
NM_014795.4(ZEB2):c.3557G>T (p.Gly1186Val)	ZEB2	G1186V, G1162V	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2019)	criteria provided, conflicting interpretations	VCV000391143	2	145147106	2	144389539	391143	365376	rs748213160	NC_000002.12:144389538:C:A
NM_014795.4(ZEB2):c.1534G>A (p.Gly512Ser)	ZEB2	G512S, G488S	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2020)	criteria provided, conflicting interpretations	VCV000390228	2	145157220	2	144399653	390228	365562	rs141781307	NC_000002.12:144399652:C:T
NM_014795.4(ZEB2):c.564G>A (p.Thr188=)	ZEB2|LOC111721705		not specified|History of neurodevelopmental disorder|Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000389320	2	145162431	2	144404864	389320	365771	rs747482254	NC_000002.12:144404863:C:T
NM_014795.4(ZEB2):c.395A>G (p.Asn132Ser)	ZEB2	N132S	not provided|Mowat-Wilson syndrome	Benign(Last reviewed: Aug 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000388778	2	145182371	2	144424804	388778	365576	rs369622877	NC_000002.12:144424803:T:C
NM_014795.4(ZEB2):c.1288C>T (p.Pro430Ser)	ZEB2	P430S, P406S	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2018)	criteria provided, conflicting interpretations	VCV000388030	2	145157466	2	144399899	388030	365759	rs753804606	NC_000002.12:144399898:G:A
NM_014795.4(ZEB2):c.73+6A>C	ZEB2		not provided|Mowat-Wilson syndrome	Benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000387907	2	145274839	2	144517272	387907	365590	rs756924190	NC_000002.12:144517271:T:G
NM_014795.4(ZEB2):c.2016T>C (p.Asp672=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000386556	2	145156738	2	144399171	386556	365545	rs1057522531	NC_000002.12:144399170:A:G
NM_014795.4(ZEB2):c.797G>A (p.Gly266Glu)	ZEB2	G266E, G242E	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2019)	criteria provided, conflicting interpretations	VCV000385903	2	145161493	2	144403926	385903	365553	rs1057522361	NC_000002.12:144403925:C:T
NM_014795.4(ZEB2):c.2646A>G (p.Pro882=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000385085	2	145156108	2	144398541	385085	365543	rs372224804	NC_000002.12:144398540:T:C
NM_014795.4(ZEB2):c.349T>C (p.Tyr117His)	ZEB2	Y117H	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2020)	criteria provided, conflicting interpretations	VCV000385055	2	145182417	2	144424850	385055	365578	rs1057522108	NC_000002.12:144424849:A:G
NM_014795.4(ZEB2):c.295A>G (p.Asn99Asp)	ZEB2	N99D	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2019)	criteria provided, conflicting interpretations	VCV000381504	2	145187372	2	144429805	381504	365581	rs150665982	NC_000002.12:144429804:T:C
NM_014795.4(ZEB2):c.225C>T (p.Ser75=)	ZEB2		Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381140	2	145187442	2	144429875	381140	365583	rs754754722	NC_000002.12:144429874:G:A
NM_014795.4(ZEB2):c.1526C>T (p.Pro509Leu)	ZEB2	P509L, P485L	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000380262	2	145157228	2	144399661	380262	365386	rs1051563603	NC_000002.12:144399660:G:A
NM_014795.4(ZEB2):c.3432C>T (p.Gly1144=)	ZEB2		Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379072	2	145147231	2	144389664	379072	365377	rs768007761	NC_000002.12:144389663:G:A
NM_014795.4(ZEB2):c.2457A>G (p.Ser819=)	ZEB2		Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Jan 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000378870	2	145156297	2	144398730	378870	365757	rs144184948	NC_000002.12:144398729:T:C
NM_014795.4(ZEB2):c.2256G>A (p.Thr752=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000378869	2	145156498	2	144398931	378869	365379	rs772121083	NC_000002.12:144398930:C:T
NM_014795.4(ZEB2):c.179C>T (p.Thr60Met)	ZEB2	T60M	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2021)	criteria provided, conflicting interpretations	VCV000378868	2	145187488	2	144429921	378868	365568	rs780890592	NC_000002.12:144429920:G:A
NM_014795.4(ZEB2):c.388A>G (p.Ile130Val)	ZEB2	I130V	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2019)	criteria provided, conflicting interpretations	VCV000377259	2	145182378	2	144424811	377259	364137	rs1057520175	NC_000002.12:144424810:T:C
NM_014795.4(ZEB2):c.1542G>T (p.Pro514=)	ZEB2		not specified|Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000374622	2	145157212	2	144399645	374622	361508	rs141674976	NC_000002.12:144399644:C:A
NM_014795.4(ZEB2):c.430T>A (p.Phe144Ile)	ZEB2	F144I, F120I	not specified|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373361	2	145162565	2	144404998	373361	359383	rs1057518371	NC_000002.12:144404997:A:T
NM_014795.4(ZEB2):c.297C>T (p.Asn99=)	ZEB2		Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331302	2	145187370	2	144429803	331302	281984	rs147603619	NC_000002.12:144429802:G:A
NM_014795.4(ZEB2):c.1410T>C (p.Thr470=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000331300	2	145157344	2	144399777	331300	284522	rs34890427	NC_000002.12:144399776:A:G
NM_014795.4(ZEB2):c.3640A>G (p.Met1214Val)	ZEB2	M1214V, M1190V	History of neurodevelopmental disorder|Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000331298	2	145147023	2	144389456	331298	284291	rs199951665	NC_000002.12:144389455:T:C
NM_014795.4(ZEB2):c.1446A>C (p.Glu482Asp)	ZEB2	E482D, E458D	not provided|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000287267	2	145157308	2	144399741	287267	271504	rs886043609	NC_000002.12:144399740:T:G
NM_014795.4(ZEB2):c.2281A>T (p.Thr761Ser)	ZEB2	T761S, T737S	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Mar 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281635	2	145156473	2	144398906	281635	265872	rs867243713	NC_000002.12:144398905:T:A
NM_014795.4(ZEB2):c.2886+4A>C	ZEB2		not provided|Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2020)	criteria provided, conflicting interpretations	VCV000281633	2	145155864	2	144398297	281633	265870	rs754532627	NC_000002.12:144398296:T:G
NM_014795.4(ZEB2):c.3046C>T (p.Arg1016Ter)	ZEB2	R1016*, R992*	Intellectual disability|Mowat-Wilson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280856	2	145154000	2	144396433	280856	264012	rs886041989	NC_000002.12:144396432:G:A
NM_014795.4(ZEB2):c.2932G>T (p.Asp978Tyr)	ZEB2	D978Y, D954Y	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jul 17, 2012)	criteria provided, single submitter	VCV000217029	2	145154114	2	144396547	217029	213524	rs863224942	NC_000002.12:144396546:C:A
NM_014795.4(ZEB2):c.674C>A (p.Ser225Ter)	ZEB2	S225*, S201*	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212637	2	145161616	2	144404049	212637	206852	rs797046122	NC_000002.12:144404048:G:T
NM_014795.4(ZEB2):c.3137C>A (p.Ser1046Ter)	ZEB2	S1046*, S1022*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	VCV000212636	2	145147526	2	144389959	212636	206846	rs797046121	NC_000002.12:144389958:G:T
NM_014795.4(ZEB2):c.2894T>A (p.Leu965Ter)	ZEB2	L965*, L941*	Inborn genetic diseases|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212635	2	145154152	2	144396585	212635	206847	rs797046120	NC_000002.12:144396584:A:T
NM_014795.4(ZEB2):c.1106T>A (p.Leu369Ter)	ZEB2	L369*, L345*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	VCV000212632	2	145157648	2	144400081	212632	206850	rs797046117	NC_000002.12:144400080:A:T
NM_014795.4(ZEB2):c.1877G>A (p.Gly626Glu)	ZEB2	G626E, G602E	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000198863	2	145156877	2	144399310	198863	196023	rs794727923	NC_000002.12:144399309:C:T
NM_014795.4(ZEB2):c.2641A>C (p.Asn881His)	ZEB2	N881H, N857H	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000198861	2	145156113	2	144398546	198861	196021	rs794727922	NC_000002.12:144398545:T:G
NM_014795.4(ZEB2):c.219C>T (p.His73=)	ZEB2		not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000196468	2	145187448	2	144429881	196468	193629	rs778851716	NC_000002.12:144429880:G:A
NM_014795.4(ZEB2):c.3219C>T (p.His1073=)	ZEB2		Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2019)	criteria provided, conflicting interpretations	VCV000193714	2	145147444	2	144389877	193714	190877	rs139944383	NC_000002.12:144389876:G:A
NM_014795.4(ZEB2):c.1027C>T (p.Arg343Ter)	ZEB2	R343*, R319*	Mowat-Wilson syndrome|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189281	2	145157727	2	144400160	189281	187166	rs786204815	NC_000002.12:144400159:G:A
NM_014795.4(ZEB2):c.1749C>A (p.Cys583Ter)	ZEB2	C583*, C559*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189274	2	145157005	2	144399438	189274	187158	rs786204808	NC_000002.12:144399437:G:T
NM_014795.4(ZEB2):c.1277T>G (p.Leu426Ter)	ZEB2	L426*, L402*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189273	2	145157477	2	144399910	189273	187163	rs786204807	NC_000002.12:144399909:A:C
NM_014795.4(ZEB2):c.660C>G (p.Tyr220Ter)	ZEB2	Y220*, Y196*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189269	2	145161630	2	144404063	189269	187168	rs111724246	NC_000002.12:144404062:G:C
NM_014795.4(ZEB2):c.2004G>T (p.Glu668Asp)	ZEB2	E668D, E644D	Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Apr 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000187816	2	145156750	2	144399183	187816	185720	rs767506087	NC_000002.12:144399182:C:A
NM_014795.4(ZEB2):c.10C>G (p.Pro4Ala)	ZEB2	P4A	not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181761	2	145274908	2	144517341	181761	179013	rs146394306	NC_000002.12:144517340:G:C
NM_014795.4(ZEB2):c.314C>T (p.Ala105Val)	ZEB2	A105V	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2020)	criteria provided, conflicting interpretations	VCV000181750	2	145187353	2	144429786	181750	179006	rs730881207	NC_000002.12:144429785:G:A
NM_014795.4(ZEB2):c.59C>T (p.Pro20Leu)	ZEB2	P20L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000181749	2	145274859	2	144517292	181749	179012	rs730881206	NC_000002.12:144517291:G:A
NM_014795.4(ZEB2):c.3337T>A (p.Leu1113Met)	ZEB2	L1113M, L1089M	Mowat-Wilson syndrome|not specified	Likely benign(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181747	2	145147326	2	144389759	181747	178962	rs730881204	NC_000002.12:144389758:A:T
NM_014795.4(ZEB2):c.2870G>A (p.Arg957Gln)	ZEB2	R957Q, R933Q	Mowat-Wilson syndrome|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	VCV000181744	2	145155884	2	144398317	181744	178970	rs371509136	NC_000002.12:144398316:C:T
NM_014795.4(ZEB2):c.2707G>T (p.Ala903Ser)	ZEB2	A903S, A879S	not provided|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181742	2	145156047	2	144398480	181742	178972	rs730881200	NC_000002.12:144398479:C:A
NM_014795.4(ZEB2):c.2486G>A (p.Ser829Asn)	ZEB2	S829N, S805N	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2020)	criteria provided, conflicting interpretations	VCV000181740	2	145156268	2	144398701	181740	178976	rs730881198	NC_000002.12:144398700:C:T
NM_014795.4(ZEB2):c.2248A>G (p.Ser750Gly)	ZEB2	S750G, S726G	not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181738	2	145156506	2	144398939	181738	178979	rs730881196	NC_000002.12:144398938:T:C
NM_014795.4(ZEB2):c.2084G>A (p.Arg695Gln)	ZEB2	R695Q, R671Q	not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2020)	criteria provided, conflicting interpretations	VCV000181737	2	145156670	2	144399103	181737	178982	rs147693839	NC_000002.12:144399102:C:T
NM_014795.4(ZEB2):c.1876G>A (p.Gly626Arg)	ZEB2	G626R, G602R	not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000181736	2	145156878	2	144399311	181736	178987	rs727504224	NC_000002.12:144399310:C:T
NM_014795.4(ZEB2):c.1735A>G (p.Thr579Ala)	ZEB2	T579A, T555A	not specified|not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181735	2	145157019	2	144399452	181735	178988	rs140593583	NC_000002.12:144399451:T:C
NM_014795.4(ZEB2):c.1678C>T (p.Arg560Cys)	ZEB2	R560C, R536C	not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181733	2	145157076	2	144399509	181733	178990	rs730881194	NC_000002.12:144399508:G:A
NM_014795.4(ZEB2):c.1565C>G (p.Thr522Ser)	ZEB2	T522S, T498S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000181732	2	145157189	2	144399622	181732	178992	rs730881193	NC_000002.12:144399621:G:C
NM_014795.4(ZEB2):c.1283T>C (p.Val428Ala)	ZEB2	V428A, V404A	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181731	2	145157471	2	144399904	181731	178993	rs730881192	NC_000002.12:144399903:A:G
NM_014795.4(ZEB2):c.385G>A (p.Ala129Thr)	ZEB2	A129T	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 6, 2018)	criteria provided, conflicting interpretations	VCV000181726	2	145182381	2	144424814	181726	179004	rs730881187	NC_000002.12:144424813:C:T
NM_014795.4(ZEB2):c.332-6C>T	ZEB2		not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2020)	criteria provided, conflicting interpretations	VCV000181725	2	145182440	2	144424873	181725	179005	rs730881186	NC_000002.12:144424872:G:A
NM_014795.4(ZEB2):c.304A>T (p.Ile102Phe)	ZEB2	I102F	not specified|History of neurodevelopmental disorder|Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000181724	2	145187363	2	144429796	181724	179007	rs201109457	NC_000002.12:144429795:T:A
NM_014795.4(ZEB2):c.139G>T (p.Ala47Ser)	ZEB2	A47S	Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181722	2	145187528	2	144429961	181722	179010	rs730881184	NC_000002.12:144429960:C:A
NM_014795.4(ZEB2):c.2495C>A (p.Ala832Asp)	ZEB2	A832D, A808D	not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2021)	criteria provided, conflicting interpretations	VCV000181717	2	145156259	2	144398692	181717	178975	rs730881179	NC_000002.12:144398691:G:T
NM_014795.4(ZEB2):c.2255C>G (p.Thr752Arg)	ZEB2	T752R, T728R	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 31, 2020)	criteria provided, conflicting interpretations	VCV000181716	2	145156499	2	144398932	181716	178978	rs143438888	NC_000002.12:144398931:G:C
NM_014795.4(ZEB2):c.2215A>G (p.Ile739Val)	ZEB2	I739V, I715V	Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181715	2	145156539	2	144398972	181715	178981	rs730881178	NC_000002.12:144398971:T:C
NM_014795.4(ZEB2):c.1638C>T (p.Asp546=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181712	2	145157116	2	144399549	181712	178991	rs149035844	NC_000002.12:144399548:G:A
NM_014795.4(ZEB2):c.1276T>A (p.Leu426Ile)	ZEB2	L426I, L402I	not specified|Mowat-Wilson syndrome|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000181711	2	145157478	2	144399911	181711	178994	rs201881288	NC_000002.12:144399910:A:T
NM_014795.4(ZEB2):c.905G>A (p.Arg302Gln)	ZEB2	R302Q, R278Q	not provided|Mowat-Wilson syndrome|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181709	2	145158777	2	144401210	181709	178998	rs730881174	NC_000002.12:144401209:C:T
NM_014795.4(ZEB2):c.768C>T (p.Leu256=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181707	2	145161522	2	144403955	181707	179000	rs370751674	NC_000002.12:144403954:G:A
NM_014795.4(ZEB2):c.374C>T (p.Thr125Met)	ZEB2	T125M	not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2021)	criteria provided, conflicting interpretations	VCV000167858	2	145182392	2	144424825	167858	176934	rs727504227	NC_000002.12:144424824:G:A
NM_014795.4(ZEB2):c.1876G>T (p.Gly626Ter)	ZEB2	G626*, G602*	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000167854	2	145156878	2	144399311	167854	177329	rs727504224	NC_000002.12:144399310:C:A
NM_014795.4(ZEB2):c.2206A>G (p.Met736Val)	ZEB2	M736V, M712V	not specified|not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000167853	2	145156548	2	144398981	167853	177065	rs139191491	NC_000002.12:144398980:T:C
NM_014795.4(ZEB2):c.9G>C (p.Gln3His)	ZEB2	Q3H	History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000160332	2	145274909	2	144517342	160332	168035	rs149882004	NC_000002.12:144517341:C:G
NM_014795.4(ZEB2):c.9G>A (p.Gln3=)	ZEB2		Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 9, 2021)	criteria provided, conflicting interpretations	VCV000160331	2	145274909	2	144517342	160331	168036	rs149882004	NC_000002.12:144517341:C:T
NM_014795.4(ZEB2):c.904C>T (p.Arg302Ter)	ZEB2	R302*, R278*	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160329	2	145158778	2	144401211	160329	168031	rs587784571	NC_000002.12:144401210:G:A
NM_014795.4(ZEB2):c.823C>T (p.Gln275Ter)	ZEB2	Q275*, Q251*	Inborn genetic diseases|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160328	2	145158859	2	144401292	160328	168032	rs587784570	NC_000002.12:144401291:G:A
NM_014795.4(ZEB2):c.747G>A (p.Thr249=)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	VCV000160327	2	145161543	2	144403976	160327	168033	rs587784569	NC_000002.12:144403975:C:T
NM_014795.4(ZEB2):c.3444C>T (p.Tyr1148=)	ZEB2		not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2018)	criteria provided, conflicting interpretations	VCV000160325	2	145147219	2	144389652	160325	168021	rs374141392	NC_000002.12:144389651:G:A
NM_014795.4(ZEB2):c.3141G>C (p.Arg1047Ser)	ZEB2	R1047S, R1023S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	VCV000160324	2	145147522	2	144389955	160324	168022	rs587784567	NC_000002.12:144389954:C:G
NM_014795.4(ZEB2):c.2761C>T (p.Arg921Ter)	ZEB2	R921*, R897*	Intellectual disability|not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000160323	2	145155993	2	144398426	160323	168023	rs587784566	NC_000002.12:144398425:G:A
NM_014795.4(ZEB2):c.2352T>C (p.Ser784=)	ZEB2		not provided|Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2020)	criteria provided, conflicting interpretations	VCV000160321	2	145156402	2	144398835	160321	168025	rs201990887	NC_000002.12:144398834:A:G
NM_014795.4(ZEB2):c.2329C>T (p.His777Tyr)	ZEB2	H777Y, H753Y	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	VCV000160320	2	145156425	2	144398858	160320	168026	rs587784564	NC_000002.12:144398857:G:A
NM_014795.4(ZEB2):c.1542G>A (p.Pro514=)	ZEB2		not specified|Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2020)	criteria provided, conflicting interpretations	VCV000160318	2	145157212	2	144399645	160318	168028	rs141674976	NC_000002.12:144399644:C:T
NM_014795.4(ZEB2):c.1438G>T (p.Ala480Ser)	ZEB2	A480S, A456S	History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000160317	2	145157316	2	144399749	160317	168029	rs143854197	NC_000002.12:144399748:C:A
NM_014795.4(ZEB2):c.375G>A (p.Thr125=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137956	2	145182391	2	144424824	137956	141659	rs138389836	NC_000002.12:144424823:C:T
NM_014795.4(ZEB2):c.150C>T (p.Asp50=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137955	2	145187517	2	144429950	137955	141658	rs587780996	NC_000002.12:144429949:G:A
NM_014795.4(ZEB2):c.2973C>T (p.Ile991=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137954	2	145154073	2	144396506	137954	141657	rs572507342	NC_000002.12:144396505:G:A
NM_014795.4(ZEB2):c.2766A>T (p.Pro922=)	ZEB2		Mowat-Wilson syndrome|not provided|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000137952	2	145155988	2	144398421	137952	141655	rs185223937	NC_000002.12:144398420:T:A
NM_014795.4(ZEB2):c.2601G>A (p.Lys867=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137951	2	145156153	2	144398586	137951	141654	rs139369265	NC_000002.12:144398585:C:T
NM_014795.4(ZEB2):c.2361T>C (p.Asn787=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137950	2	145156393	2	144398826	137950	141653	rs201567433	NC_000002.12:144398825:A:G
NM_014795.4(ZEB2):c.2205T>C (p.Pro735=)	ZEB2		not specified|Mowat-Wilson syndrome	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137949	2	145156549	2	144398982	137949	141652	rs149964599	NC_000002.12:144398981:A:G
NM_014795.4(ZEB2):c.2142G>A (p.Pro714=)	ZEB2		not specified|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137948	2	145156612	2	144399045	137948	141651	rs201180901	NC_000002.12:144399044:C:T
NM_014795.4(ZEB2):c.1840C>T (p.Leu614=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137947	2	145156914	2	144399347	137947	141650	rs145201706	NC_000002.12:144399346:G:A
NM_014795.4(ZEB2):c.1587G>A (p.Thr529=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137946	2	145157167	2	144399600	137946	141649	rs148709333	NC_000002.12:144399599:C:T
NM_014795.4(ZEB2):c.1533C>T (p.Val511=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Apr 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137945	2	145157221	2	144399654	137945	141648	rs587780994	NC_000002.12:144399653:G:A
NM_014795.4(ZEB2):c.798G>C (p.Gly266=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137944	2	145161492	2	144403925	137944	141647	rs34961586	NC_000002.12:144403924:C:G
NM_014795.4(ZEB2):c.759C>T (p.Arg253=)	ZEB2		History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137943	2	145161531	2	144403964	137943	141646	rs150853991	NC_000002.12:144403963:G:A
NM_014795.4(ZEB2):c.462G>A (p.Glu154=)	ZEB2		not specified|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137942	2	145162533	2	144404966	137942	141645	rs372940559	NC_000002.12:144404965:C:T
NM_014795.4(ZEB2):c.930C>T (p.Tyr310=)	ZEB2		Mowat-Wilson syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095643	2	145157824	2	144400257	95643	101541	rs6711223	NC_000002.12:144400256:G:A
NM_014795.4(ZEB2):c.807+3G>C	ZEB2		Mowat-Wilson syndrome|History of neurodevelopmental disorder|not provided|not specified	Benign/Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095642	2	145161480	2	144403913	95642	101540	rs144925893	NC_000002.12:144403912:C:G
NM_014795.4(ZEB2):c.73+2T>C	ZEB2		Mowat-Wilson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095639	2	145274843	2	144517276	95639	101537	rs398124282	NC_000002.12:144517275:A:G
NM_014795.4(ZEB2):c.489C>T (p.Ile163=)	ZEB2		History of neurodevelopmental disorder|not provided|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095637	2	145162506	2	144404939	95637	101535	rs138859323	NC_000002.12:144404938:G:A
NM_014795.4(ZEB2):c.3471C>T (p.Asp1157=)	ZEB2		not specified|Mowat-Wilson syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095636	2	145147192	2	144389625	95636	101534	rs149526010	NC_000002.12:144389624:G:A
NM_014795.4(ZEB2):c.3067+6A>T	ZEB2		not specified|Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095633	2	145153973	2	144396406	95633	101531	rs143450927	NC_000002.12:144396405:T:A
NM_014795.4(ZEB2):c.2887-4G>A	ZEB2		History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095632	2	145154163	2	144396596	95632	101530	rs147972125	NC_000002.12:144396595:C:T
NM_014795.4(ZEB2):c.2255C>T (p.Thr752Met)	ZEB2	T752M, T728M	Mowat-Wilson syndrome|not provided|not specified	Benign/Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095631	2	145156499	2	144398932	95631	101529	rs143438888	NC_000002.12:144398931:G:A
NM_014795.4(ZEB2):c.2230A>G (p.Ile744Val)	ZEB2	I744V, I720V	History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095630	2	145156524	2	144398957	95630	101528	rs112005830	NC_000002.12:144398956:T:C
NM_014795.4(ZEB2):c.2203C>T (p.Pro735Ser)	ZEB2	P735S, P711S	not specified|Mowat-Wilson syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095629	2	145156551	2	144398984	95629	101527	rs144154908	NC_000002.12:144398983:G:A
NM_014795.4(ZEB2):c.2141C>T (p.Pro714Leu)	ZEB2	P714L, P690L	History of neurodevelopmental disorder|not specified|not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095627	2	145156613	2	144399046	95627	101525	rs112581563	NC_000002.12:144399045:G:A
NM_014795.4(ZEB2):c.1848T>G (p.Pro616=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095625	2	145156906	2	144399339	95625	101523	rs144835963	NC_000002.12:144399338:A:C
NM_014795.4(ZEB2):c.1480C>T (p.Pro494Ser)	ZEB2	P494S, P470S	History of neurodevelopmental disorder|not provided|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095622	2	145157274	2	144399707	95622	101520	rs144952836	NC_000002.12:144399706:G:A
NM_014795.4(ZEB2):c.1410T>A (p.Thr470=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095621	2	145157344	2	144399777	95621	101519	rs34890427	NC_000002.12:144399776:A:T
NM_014795.4(ZEB2):c.1381C>T (p.Gln461Ter)	ZEB2	Q461*, Q437*	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095620	2	145157373	2	144399806	95620	101518	rs398124274	NC_000002.12:144399805:G:A
NM_014795.4(ZEB2):c.1306A>G (p.Met436Val)	ZEB2	M436V, M412V	Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095619	2	145157448	2	144399881	95619	101517	rs145812868	NC_000002.12:144399880:T:C
NM_014795.4(ZEB2):c.1161A>G (p.Leu387=)	ZEB2		History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095618	2	145157593	2	144400026	95618	101516	rs146673563	NC_000002.12:144400025:T:C
NM_014795.4(ZEB2):c.3134A>G (p.His1045Arg)	ZEB2	H1045R, H1021R	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000056827	2	145147529	2	144389962	56827	71450	rs397515449	NC_000002.12:144389961:T:C
NM_014795.4(ZEB2):c.3211T>C (p.Ser1071Pro)	ZEB2	S1071P, S1047P	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000056826	2	145147452	2	144389885	56826	71449	rs397515448	NC_000002.12:144389884:A:G
NM_014795.4(ZEB2):c.3356A>G (p.Gln1119Arg)	ZEB2	Q1119R, Q1095R	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000004768	2	145147307	2	144389740	4768	19807	rs137852983	NC_000002.12:144389739:T:C
NM_014795.4(ZEB2):c.-69-1G>A	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000004767	2	145274987	2	144517420	4767	19806	rs587776612	NC_000002.12:144517419:C:T
NM_014795.4(ZEB2):c.2555C>G (p.Ser852Ter)	ZEB2	S852*, S828*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004762	2	145156199	2	144398632	4762	19801	rs137852982	NC_000002.12:144398631:G:C
NM_014795.4(ZEB2):c.2083C>T (p.Arg695Ter)	ZEB2	R695*, R671*	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Apr 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004755	2	145156671	2	144399104	4755	19794	rs137852981	NC_000002.12:144399103:G:A
NM_014795.4(ZEB2):c.1645A>T (p.Arg549Ter)	ZEB2	R549*, R525*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004754	2	145157109	2	144399542	4754	19793	rs137852980	NC_000002.12:144399541:T:A
